¥È¥Ã¥×¥Ú¡¼¥¸¤ØÌá¤ë

¤³¤Î¥Ú¡¼¥¸¤Ï´ÉÍý¿Í¸Ä¿Í¤ÎÊÙ¶¯ÍѤޤȤá¥Ú¡¼¥¸¤Ç¤¹¡£¤½¤Î¾¤Î¤´ÍøÍѤˤÏÀÕǤ¤ò¤â¤Æ¤Þ¤»¤ó¡ÊÆâÍÆ¤â´ÉÍý¿Í¸Ä¿Í¤Î°Õ¸«¤¬Æþ¤Ã¤Æ¤¤¤ë²ÄǽÀ­¤â¤¢¤ê¤Þ¤¹¡Ë
¸ø¼°¤ÎÆüËÜÉÂÍý³Ø²ñÃæÉô»ÙÉô¤Î¥Ú¡¼¥¸¤Ï-->¤³¤Á¤é¤Ç¤¹

ÃæÉô¸ò¸«²ñ¡¡°ìÍ÷

³Æ¸ò¸«²ñ¤Î¥¿¥¤¥È¥ë¤ò¥¯¥ê¥Ã¥¯¤¹¤ë¤È¤½¤ÎÆâÍÆ¤¬¸«¤é¤ì¤Þ¤¹¡£

66²ó¸ò¸«²ñ(2010ǯ)¤«¤é¤Îȯɽ¥¹¥é¥¤¥É¤¬ÆüËÜÉÂÍý³Ø²ñÃæÉô»ÙÉôWeb²ñ°÷ÀìÍÑ¥Ú¡¼¥¸¤«¤édown load²Äǽ¤Ç¤¹.-->ÆüËÜÉÂÍý³Ø²ñÃæÉô»ÙÉôHP

¡ú:³Ø½Ñ¾©ÎåÍ¥½¨È¯É½¾Þ, ¡ú¡§³Ø½Ñ¾©Îå¾Þ

Âè84²ó¸ò¸«²ñ 2019ǯ12·î14Æü¡¡Ì¾¸Å²°»Ô¡¡Ì¾¸Å²°Âç³ØÉհɱ¡

¾ÉÎ㸡Ƥ

  • 1505 Pleomorphic fibroma of the skin 63yo ½÷À­¡¡º¸²¼ÂÜÈéÉæ(VS)¡¡Ì¾Å´É±¡ ¸¶ÅÄ ÃÒ»Ò
  • 1503 STUMP, myxoid type, Á°Î©Á£ Îë¼¯Ãæ±ûÁí¹çɱ¡ ±±°æ Èþ´õ¤Û¤«
  • 1504 Phosphoglicerid crystal deposition disease, 76ºÐ½÷À­ ¹ü¡¡´ôÉìÂç³Ø°å³ØÉôÉí°É±¡¡¡¾¾ËÜ ½¡Ï¤ۤ«
  • 1506 Alveolar rhabdomyosarcoma 10ÂåÁ°È¾½÷À­¡¡³°±¢ÉôÆðÉô¼ðáç¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡º´Æ£ ÌïÀ¸¤Û¤«
  • 1507 Ectopic hamartomatous thymoma(¤Û¤ó¤È¤Ï¶»Á£Í³Íè¤Ç¤Ï¤Ê¤¤) 64ºÐÃËÀ­¡¡ðôÉô¼ðáî °¦Ãΰå²ÊÂç³ØÉ±¡ ë¸ý ÆàÅÔ´õ¤Û¤«
  • 1508 Mixed medullary and follicular thyroid carcinoma(MMFTC) 70ºÐÂåÃËÀ­¡¡¹Ã¾õÁ£¼ðáî Ê¡°æÀÖ½½»úɱ¡ ȬÅÄ ÁïÈþ¤Û¤«
  • 1509 Mucoepidermoid carcinoma of the bronchus, 30ÂåÃËÀ­¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡¾å¸¶ ³¡¤Û¤«
  • 1510 Bronchial adenoma, distal type 65ºÐÃËÀ­ Ç٠̾¸Å²°°åÎÅ¥»¥ó¥¿¡¼ ÃÝÆâ Φ
  • 1511 SDHB deficient GIST of the stomach 10ºÐÂåÁ°È¾ ÃËÀ­¡¡Æ£Åİå²ÊÂç³ØÉÂÍý¿ÇÃdzء¡·¬¸¶ °ìɧ°ß
  • 1512 Fibrous rich hamartomatous polyp of the transverse colon, Cowden syndrome, 40ºÐÂå ÃËÀ­¡¡ÂçIJ(VS)²¬ºê»Ô̱ɱ¡¡¡¾®Âô ¹­ÌÀ
  • 1513 Visceral histoplasmosis, HIV infection, 50ºÐÂå½÷À­¡¡½½Æó»ØÄ²(VS)¡¡ÉÙ»³Âç³ØÉí°É±¡¡¡½»µÈ ¼ÓÂå»Ò
  • 1514 Tubular adenocarcinoma of the rectum with Shistosomiasis Japonicum 71ºÐÃËÀ­ ˵IJ´É¥ê¥ó¥ÑÀá °°Ï«ºÒɱ¡ °ËÆ£ ½¨ÌÀ¤Û¤«
  • 1515 Neuroendocrine carcinoma, small cell type 76ºÐÃËÀ­ °ß »ÔΩÅ×ÇÈÁí¹çɱ¡¡¡³ÀÆâ ¼÷»Þ»Ò¤Û¤«
  • 1516 EBV-positive B-cell lymphoproliferative disease 80ºÐÂå ÃËÀ­¡¡¾®Ä²¡¡Ì¾¸Å²°Âè°ìÀÖ½½»úɱ¡¡¡µÈÀî ²ÂÉÄ
  • 1517 Reactive follicular hyperplasia of the liver 65ºÐ ½÷À­¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡¿å¾å ÏÂÉ×
  • 1518 Transformed follicular lymphoma with prominent fibrosis(*) 70ºÐÂå ÃËÀ­ IJ´ÖËì¥ê¥ó¥ÑÀá ÀŲ¬¸©Î©Áí¹çɱ¡ ¼¾¾ ºÌ
  • 1519 Atypical teratoid/rhabdoid tumor 10ºÐ½÷À­¡¡º¸Â¦Ç¾¼¼»°³ÑÉô¼ðáî Ê¡°æ¸©Î©É±¡¡¡¾®¾å ±ÍÌé¤Û¤«
  • 1520 Neuronal intranuclear inclusion disease 70ºÐÂå¸åȾ ½÷À­ ¾®ËÒ»Ô̱ɱ¡·¬¸¶ ¶³»ÒǾ
  • 1521 Interdigitating cell sarcoma of the spinal cord 70ºÐÂåÃËÀ­¡¡ÀÔ¿ñ(VS) ÀÐÀî¸©Î©Ãæ±ûɱ¡¡¡Æó¥Äë ÀéÄá¤Û¤«
  • 1522 Amyloid tubulopahty, multiple myeloma 84ºÐ½÷À­ ¿Õ¡¡¡ÉÙ»³Âç³ØË¡°å³Ø¹ÖºÂ¡¡°ìèßÅÄ ÀµÆóϺ
  • 1523 Septic shock due to C. canimorsas infection (Dog bite) 66ºÐÃËÀ­ ¿´Â¡¡¢´Î¡¡¡Æ£»Þ»ÔΩÁí¹çɱ¡¡¡°ÂÅÄ ÏÂÀ¤¤Û¤«

¥é¥ó¥Á¥ç¥ó¥»¥ß¥Ê¡¼

¿Ê¹Ô¡¦ºÆÈ¯Æý´â¤Ë¤ª¤±¤ëPD-L1¸¡ºº¤Îα°ÕÅÀ -¥Æ¥»¥ó¥È¥ê¥¯¤òŬÀÚ¤ËÍѤ¤¤ë¤¿¤á¤Ë-
»°½ÅÂç³ØÉí°É±¡ÉÂÍý¿ÇÃDzʹֻա¡¾®ÄÍÍ´»Ê

Âè83²ó ¸ò¸«²ñ 2019ǯ7·î6Æü(ÅÚ)¡Á7Æü(Æü) ´ôÉìÂç³Ø°å³ØÉôµ­Ç°²ñ´Û

À¤Ïÿ͡¡´ôÉìÂç³Ø¡¡µÜºê ζɧ ÀèÀ¸

1. ¥¹¥¤¡¼¥Ä¥»¥ß¥Ê¡¼ ±é¼Ô¡§¹ñΩ¤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡¡¡Ã«ÅÄÉô ¶³ ÀèÀ¸

2. ´õ¾¯¤¬¤óÉÂÍý°å°éÀ®»ö¶ÈÃæÉô»ÙÉô¹Ö±é´õ¾¯¤¬¤ó¹Ö½¬²ñ¡Ê¾®»ù¼ðáç¡Ë ±é¼Ô¡§ºë¶Ì¸©Î©¾®»ù°åÎÅ¥»¥ó¥¿¡¼¡¡Ãæß· ²¹»Ò ÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1488 Malignant melanoma with spindle cell/desmoplastic feature / 70Âå½÷À­ / ÈéÉæ¡¡°¦Ãΰå²ÊÂç³ØÉ±¡¡¡»³ËÜÐÒµ¨
  • 1489 Adenoid cystic carcinoma and invasive ductal carcinoma(IDC), scirrhous type. / 40Âå½÷À­ / ÆýÁ£ Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡°ËÆ£ÃÎÈþ
  • 1490 Intraductal papilloma and benign epithelial transport /60Âå½÷À­ / ÆýÁ£¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡¡¡³ÀÆâ¼÷»Þ»Ò
  • 1491¡¡Fundic gland polyp with low grade dysplasia / 70ÂåÃËÀ­ / °ß¶âÂô°å²ÊÂç³ØÉ±¡¡¡±ö빸¹­¡¡
  • 1492 Plexiform fibromyxoma / 50Âå½÷À­ / °ß¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡¹â¶¶¡¡±û¡¡
  • 1493 Mucosal Schwann cell hamartoma¡¡ / 50Âå½÷À­ / ÂçIJÎë¼¯Ãæ±ûÁí¹çɱ¡¡¡Â¼ÅÄůÌé ¡¡
  • 1494¡¡Pancreatic hamartoma / 70ÂåÃËÀ­ / ç¹Â¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡È¬ÅÄÁïÈþ¡¡
  • 1495 Mucinous cystadenocarcinoma¡¡ / 40Âå½÷À­ / ç¹Â¡´ôÉìÂç³Ø°å³ØÉôÉí°É±¡¡¡¾®ÎÓ°ìÇî¡¡
  • 1496 HSV-1 hepatitis / 50ÂåÃËÀ­ / ´Î¡¡¡Ì¾¸Å²°Âè°ìÀÖ½½»úɱ¡¡¡¾®½ÐÃÎÈþ¡¡
  • 1497 Phosphaturic mesenchymal tumor (PMT) / 30ÂåÃËÀ­ / É¡¹Ð¡¡Æ£Åİå²ÊÂç³ØÉ±¡¡¡°ë¼¤Þ¤É¤«¡¡
  • 1498 Epithelial-myoepithelial carcinoma ex pleomorphic adenoma¡¡ / 80Âå½÷À­ / ÂñÕÁ£ÀŲ¬¸©Î©Áí¹çɱ¡¡¡Á𿼸ø½¨
  • 1499 Sinonasal glomangiopericytoma¡¡ / 70Âå½÷À­ / É¡¹Ð ÅÚ´ô»ÔΩÁí¹çɱ¡¡¡¿·µï½Óŵ
  • 1500 Primary intraosseous microcystic meningioma¡¡ / 70Âå½÷À­ / ¦Ƭ¹ü ÌÚÂôµ­Ç°É±¡¡¡ÃæÅç¡¡Î÷
  • 1501 Desmoplastic/nodular medulloblastoma¡¡ / 2ºÐÃË»ù / ÀÔ¿ñ ̾¸Å²°Âç³ØÉ±¡¡¡Ãæ¹õ¶©¿Í¡¡
  • 1502 Bilharziasis / 50ÂåÃËÀ­ / ç¯æù¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡ÂçÀ¾°ìÊ¿

Âè82²ó¸ò¸«²ñ 2018ǯ.12·î

¾ÉÎ㸡Ƥ

  • 1487 Sertoriform cystadenoma of the rete testis 60ÂåÃËÀ­ ÀºÁ㠹Ⲭ»Ô̱ɱ¡»°ÎØ ½Å¼£
  • 1486 EBV associated carcinoma with focal fundic gland differentiation 70ÂåÃËÀ­ °ß ÈÓÅÄ»ÔΩɱ¡ º´Æ£ Îɵª
  • 1485 Lanthanum phosphate deposition 40ÂåÃËÀ­ °ß ̾¸Å²°ÙպѲñɱ¡ À¾Àî ·ÃÍý
  • ¡ú1484 ALK-positive large B cell lymphoma 60ÂåÃËÀ­ ½Ä³Ö ̾¸Å²°Âè°ìÀÖ½½»úɱ¡ ¾®½Ð ÃÎÈþ
  • 1483 SMARCA4(BRG1)-deficient thoracic sarcoma 50ÂåÃËÀ­ ¶»ÊÉ °¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡ À¥¸Í ¹îǯ
  • 1482 Sclerosing angiomatoid nodular transformation (SANT) 80ÂåÃËÀ­ ç£Â¡ ̾¸Å²°»ÔΩÀ¾Éô°åÎÅ¥»¥ó¥¿¡¼ ¾®ÎÓ ¿ðÊæ
  • 1481 Ewing sarcoma/primitive neuroectodermal tumor(PNET) 40Âå½÷À­ ¿Õ¡ ÈØÅÄ»ÔΩÁí¹çɱ¡ ÂçÀ¾ °ìÊ¿
  • 1480 Malignant PEComa 60Âå½÷À­ »ÒµÜ ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ²ÏÅÄ ÂîÌé
  • 1479 STUMP associated with endometriotic cyst 40Âå½÷À­ ÍñÁã ÀÐÀî¸©Î©Ãæ±ûɱ¡ ²¬»³ ͧΤ·Ã
  • ¡ú1478 Cutaneous Langerhans cell sarcoma 70ÂåÃËÀ­ ÈéÉæ ´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ ¼ò¡¹°æ ²Æ»Ò
  • 1477 Desmoplastic small round cell tumor 20ÂåÃËÀ­ Ê¢Ëì ¶âÂôÂç³ØÉí°É±¡ µÈ¼ ¤«¤ª¤ê
  • 1476 Mucoepidermoid carcinoma 80Âå½÷À­ ´Î¡ »ÔΩÅ×ÇÈÁí¹çɱ¡ ³ÀÆâ ¼÷»Þ»Ò
  • 1475 Primary hepatic MALT lymphoma 60Âå½÷À­ ´Î¡ ÉÙ»³Âç³ØÉí°É±¡ Æîºä ¾°
  • 1474 Idiopathic myointimal hyperplasia of mesenteric vein 60ÂåÃËÀ­ ²¼Éô¾Ã²½´É ¾®ËÒ»Ô̱ɱ¡ ·¬¸¶ ¶³»Ò
  • 1473 Perforation of the descending colon, associated with systemic sclerosis 70Âå½÷À­ ÂçIJ °¦Ãΰå²ÊÂç³ØÉ±¡°ËÆ£ µ®»ê
  • 1472 Glandular malignant peripheral nerve sheath tumor (MPNST) 40ÂåÃËÀ­ ÆðÉô ĹÌî»Ô̱ɱ¡º´Æ£ Îɵª(2018.7Âè81²ó¸ò¸«²ñ)
  • 1471 Blastic plasmacytoid dendritic cell neoplasm 80ÂåÃËÀ­ ¥ê¥ó¥ÑÀá Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ Èõ¸ý æÆÊ¿
  • 1470 Sclerosing angiomatoid nodular transformation (SANT) 40ÂåÃËÀ­ ç£Â¡ ̾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡ ÇÏÞ¼ ÀÄÍÛ
  • 1469 Papillary carcinoma, cribriform-morular variant 40Âå½÷À­ ¹Ã¾õÁ£ Æ£Åİå²ÊÂç³ØÉ±¡ ݯ°æ ¹ÀÊ¿
  • 1468 Sinonasal renal cell-like adenocarcinoma 60ÂåÃËÀ­ É¡¡¦ÉûÉ¡¹Ð ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ Á𿼠¸ø½¨
  • 1467 HPV-related multiphenotypic sinonasal carcinoma 60ÂåÃËÀ­ Ǿ¡¦ÉûÉ¡¹Ð À»ÎìÉ;¾É±¡ ¿å¾å ÏÂÉ×
  • ¡ú1466 Tumors of the posterior pituitary 40Âå½÷À­ Ǿ ¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡±óÆ£ Àé¿Ò
  • 1465 Subependymoma 60ÂåÃËÀ­ Ǿ À»Îì»°Êý¸¶É±¡ ȬÌÚ ½ÕÆà
     

Âè81²óÃæÉô¸ò¸«²ñ 2018ǯ7·î7Æü(ÅÚ)-8Æü(Æü) AOSSA 8F Ê¡°æ¸©¸©Ì±¥Û¡¼¥ë

Âè81²óÆüËÜÉÂÍý³Ø²ñÃæÉô»ÙÉô¸ò¸«²ñ¤Ï½¸Ãæ¹ë±«¤Î¤¿¤áÃæ»ß¤È¤Ê¤ê¤Þ¤·¤¿¡£

 

Âè80²óÃæÉô¸ò¸«²ñ 2017ǯ12·î23Æü¡¡Ì¾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡3F²ñµÄ¼¼

¾ÉÎ㸡Ƥ

  • 1445 Granulomatosis with polyangiitis and bronchiectasis accompanied by adenocarcinoma and tumolets 70ºÐÂåÃËÀ­¡¡ÇÙ¡¡JA¸üÀ¸Ï¢³¤Æîɱ¡ ÀÐÀî Áà
  • 1446 Ciliated muconodular papillary tumor¡¡60ºÐÂåÃËÀ­ ÇÙ ÂçÆ±É±¡ ¾®Åç °Ë¿¥¤Û¤«
  • 1447 lymphomatoid granulomatosis, grade3 70ºÐÂåÃËÀ­ ÇÙ¡¡Ê¡°æ¸©Î©É±¡ ¾®¾å ±ÍÌé¤Û¤«
  • 1448 micronodular thymic carcinoma with lymphoid stroma 76ºÐÃËÀ­¡¡½Ä³Ö À»Îì»°Êý¸¶É±¡ ȬÌÚ ½ÕÆà
  • 1449 Adenocarcinoma showing signet ring feature of the thymic gland 78ºÐÃËÀ­¡¡¶»Á£ ÀŲ¬¸©Î©Áí¹çɱ¡ ¼¾¾ ºÌ
  • 1450 Extra nodal marginal lymphoma of MALT type of the thymus 47ºÐ½÷À­¡¡¶»Á£¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡¾¾ËÜ Í­µ¡
  • 1451¡¡papillary carcinoma of the thyroid, histological variant 71ºÐÃËÀ­¡¡¹Ã¾õÁ£¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡¡Á𿼠¸ø½¨
  • 1452¡¡physiologic C-cell hyperplasia 38ºÐ½÷À­¡¡¹Ã¾õÁ£¡¡°¦Ãΰå²ÊÂç³Ø¡¡ÏªÌÚ Âö»Ê
  • 1453¡¡primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder 69ºÐ½÷À­¡¡ÈéÉæ¡¡ÉÙ»³¸©Î©Ãæ±ûɱ¡¡¡Æâ»³ ÌÀ±û¤Û¤«
  • 1454¡¡malignant pheripheral nerve sheets tumor arising from ganglioneuroma 80ºÐÂå½÷À­¡¡Æ¬ðôÉô¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡»³¸ý°¦Æà¤Û¤«
  • 1455¡¡Mesenteric inflammatory veno-occulusive disease (MIVOD) 30ºÐÂåÃËÀ­·ëIJ¡¡À»ÎìÉ;¾É±¡ ÂÀÅÄæÆ¤Û¤«
  • 1456 Clear cell adenocarcinoma with tubular adenoma component 40ºÐÂå½÷À­¡¡ÂçIJ Îë¼¯Ãæ±ûÁí¹çɱ¡ ±±°æ Èþ´õ(Âå ÇϾìÍΰìϺ)
    • ²ñ¾ì¤Ïtubular adenoma with clear cell change.
  • 1457 Angiosarcoma of the ileum »ÔΩÅ×ÇÈÁí¹çɱ¡¡¡90ºÐÂåÃËÀ­¡¡²óIJ¡¡±üÌî ¤Î¤ê»Ò
  • 1458 Nodular fascitis 50ºÐÂåÃËÀ­¡¡Ê¢ÊÉ¡¡¶âÂôÂç³ØÉí°É±¡¡¡ºå¸ý ¿¿´õ
  • 1459 Hepatoblastoma 60ºÐÂåÃËÀ­¡¡´Î¡¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡¡¡Åç ´²ÂÀ
  • 1460 Reactive lymphoid hyperplasia, PBC 70ºÐÂå½÷À­¡¡´Î¡¡¡¿ÛˬÀÖ½½»úɱ¡¡¡º´Æ£ ÊË
  • 1461 Massive osteolysis, Gohram-Staut disease 20ºÐÂåÃËÀ­¡¡¹ü¡¡´ôÉìÂç³ØÂç³Ø°å³ØÉôÉí°É±¡¡¡¶â»³ Ãι°¤Û¤«
  • 1462 Renin producing tumor (juxtaglomerular cell tumor) ¿Õ¡̾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡ ±ü¼ ·ë´õ
  • 1463 Embryonal rhabdomyosarcoma in teratoma (teratoma with somatic-type malignancy) 2ºÐ4¥ö·î½÷»ù¡¡¸åÊ¢Ëì¡¡¶âÂô°å²ÊÂç³ØÉ±¡¡¡ÁêÀî ¤¢¤«¤Í
  • 1464 Malignant mixed mesonephric tumor (mesonephric carcinosarcoma) 60ºÐÂå¸åȾ½÷À­¡¡»ÒµÜ¡¡°ìµÜ»ÔΩ»Ô̱ɱ¡ÃæÅç ¹­À»

¥é¥ó¥Á¥ç¥ó¥»¥ß¥Ê¡¼ ÆÃÊֱ̹é

  • ÉÂÍý³Ø¤Î¶á̤Íè¤ÈÉÂÍý°å¤¬Ä¾Ì̤¹¤ë¤³¤È¡¡¹ñΩ¤¬¤ó¸¦µæ¥»¥ó¥¿¡¼Åìɱ¡¡¡ÉÂÍý¡¦Î×¾²¸¡ºº²ÊĹ¡¡·¬ÅÄ·ò

Âè79²óÃæÉô¸ò¸«²ñ 2017ǯ7·î1Æü-2Æü¡¡ÉÙ»³¹ñºÝ²ñµÄ¾ì¿ÌÜŪ²ñµÄ¼¼¡¦ÆÃÊ̲ñµÄ¼¼

À¤Ïÿ͡¡ÉÙ»³»Ô̱ɱ¡ ÉÂÍý¿ÇÃÇ²Ê ã·Æ£¾¡É§ÀèÀ¸¡¡

ã·Æ£ÀèÀ¸¤´Ìµº»ÂÁ¤·¤Æ¤ª¤ê¤Þ¤¹. ÌÖÆâ·Ï³Ø²ñ¤È½êÍѤ¬½Å¤Ê¤ê½ÐÀʤǤ­¤Þ¤»¤ó¤Ç¤·¤¿.¡¡¤¹¤ß¤Þ¤»¤ó(벬)

¾ÉÎ㸡Ƥ

  • 1444 Intravascular myopericytoma 70ºÐÂåÃËÀ­,ÆðÉô ÉÙ»³Âç³ØÉí°É±¡ Æîºä ¾°¤Û¤«
  • 1443 Inclusion body fibromatosis¡¡1ºÐ̤Ëþ½÷À­,»ØÆðÉô ¶âÂôÂç³ØÉí°É±¡¡¡²£»³ ÍýºÚ¤Û¤«
  • 1442 Cutaneous Rosai-Dorfman disease¡¡70ºÐÂå½÷À­,ÈéÉæ Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡ Åç ´²ÂÀ¤Û¤«
  • ¡ú1441(VS) Acquired cutaneous lymphangiectasia with mesothelial cells¡¡40ºÐÂå½÷À­, ÈéÉæ ¶âÂô°å²ÊÂç³ØÉ±¡ ·§Ã« ÀôÆá¤Û¤«
  • ¡ú1440 Neuroendocrine tumor with amyloid deposition associated NF type 1 40ºÐÂå½÷À­, ½½Æó»ØÄ² ¶âÂô°åÎÅ¥»¥ó¥¿¡¼ ³ÞÅç ΤÈþ¤Û¤«
  • 1439(ɸËÜ+VS) Enteropathy-associated T-cell lymphoma, type 2 50ºÐÂå½÷À­, ¾®Ä² ¾®ËÒ»Ô̱ɱ¡ ·¬¸¶ ¶³»Ò
  • 1438 Urothelial carcinoma, plasmacytoid variant¡¡50ºÐÂåÃËÀ­,¸åÊ¢Ëì¡¡¾ÆÄÅ»ÔΩÁí¹çɱ¡¡¡À¾ÅÄ ½¨¤Û¤«
  • 1437 Mucoepidermoid carcinoma of the thymus 70ºÐÂåÃËÀ­, ¶»Á£ ̾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡ Ãæ¹õ ¶©¿Í¤Û¤«
  • ¡ú1436 Lepidic adenocarcinoma with talcosis¡¡70ºÐÂåÃËÀ­, ÇÙ ´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ ÅÏÉô ľ¼ù¤Û¤«
  • ¡ú1435¡¡Metastatic postpubertal teratoma with somatic-type malignancy¡¡30ºÐÂåÃËÀ­, ÀºÁ㡦¥ê¥ó¥ÑÀá ¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡º´Æ£ Êˤۤ«
  • 1434 Seromucinous borderline tumor with microinvasion 50ºÐÂå½÷À­,ÍñÁã ÉÙ»³¸©Î©Ãæ±ûɱ¡ ÃæÀ¾ ¤æ¤¦»Ò¤Û¤«
  • 1433(VS) Extranodal NK/T cell lymphoma, nasal type 50ºÐÂå½÷À­, »ÒµÜ É;¾°åÎÅ¥»¥ó¥¿¡¼ ÂçÄÍ ½Ù²ð
  • 1432(ɸËÜ+VS) DCIS with giant cell tumor of soft tissue¡¡70ºÐÂå½÷À­, ÆýÁ£ ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡ÎëÌÚ Ä¬¿Í¤Û¤«
  • 1431 Encapsulated papillary carcinoma 70ºÐÂå½÷À­, ÆýÁ£ »ÔΩÅ×ÇÈÁí¹çɱ¡ ±üÌî ¤Î¤ê»Ò¤Û¤«
  • 1430 EBV-associated adenosquamous carcinoma 60ºÐÂåÃËÀ­, °ß¸üÀ¸Ï¢¹â²¬É±¡ ÌîËÜ °ìÇî¤Û¤«
  • 1429Large cell neuroendocrine carcinoma 80ºÐÂåÃËÀ­, ¿©Æ»¡¦°ß º´µ×°åÎÅ¥»¥ó¥¿¡¼ °ìèßÅÄ ÀµÆóϺ¤Û¤«
  • 1428 Malignant melanoma 60ºÐÂåÃËÀ­, ¿©Æ»¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡Àж¶ ÃÎÌÀ¤Û¤«
  • 1427¡ÊVS)¡¡Sclerosing sweat duct-like carcinoma of the tongue 80ºÐÂåÃËÀ­, Àå ²¬ºê»Ô̱ɱ¡¡¡Àв¬ µ×²Â¤Û¤«
  • 1426 Sarcomatoid carcinoma 80ºÐÂå½÷À­, ¼ª²¼Á£ ´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ ÃæÈø ¼÷Æà¤Û¤«
  • 1425 Glioblastoma, de novo, radiation-induced 10ºÐÂåÃËÀ­, ¾®Ç¾ ̾¸Å²°Âè°ìÀÖ½½»úɱ¡ °ÂÆ£ ÎÉÂÀ¤Û¤«
     

¥¤¥Ö¥Ë¥ó¥°¥»¥ß¥Ê¡¼ ¶¦ºÅ ³ô¼°²ñ¼Ò¥¤¥ó¥Æ¥Ã¥¯¡¦¥½¥Õ¥È¥Ð¥ó¥¯³ô¼°²ñ¼Ò

­µ¡¥¡Ö¥Ç¥¸¥¿¥ë¥Ñ¥½¥í¥¸¡¼¿·»þÂå¤ÎÅþÍè¡×¹ñºÝ°åÎÅÊ¡»ãÂç³Ø»°ÅÄɱ¡ÉÂÍýÉô ¿¹ °ìϺ ¶µ¼ø

­¶¡¥¡Ö¥Ç¥¸¥¿¥ë¥Ñ¥½¥í¥¸¡¼Æ³Æþ¤Î¼ÂºÝ¤ÈŸ˾¡×¥½¥Õ¥È¥Ð¥ó¥¯³ô¼°²ñ¼ÒAI»ö¶È¿ä¿ÊÉô »³ÅÄͺÆó ÉôĹ

¸ò¸«²ñ½éÆü¡¡ANA¥¯¥é¥¦¥ó¥×¥é¥¶¥Û¥Æ¥ëÉÙ»³£³³¬¡Ö˱¡×¤Çº©¿Æ²ñ¡Ê¾ðÊó¸ò´¹²ñ¡Ë

Âè78²óÃæÉô¸ò¸«²ñ 2016ǯ12·î17Æü¡¡Ì¾¸Å²°»Ô̾¸Å²°Âç³ØÉ±¡3³¬¹ÖƲ

À¤Ïÿ͡¡Ì¾¸Å²°ÂèÆóÀÖ½½»úɱ¡¡¡Á°ÅıʻÒÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1404 (VS) cutaneous leiomyosarcoma ŵ·¿Îã 50Âå ½÷À­ ÈéÉæÀþ°Ý¼ð Ãæµþɱ¡ ÉþÉô¹Ôµª¡¦º´Æ£Êþ»Ò
  • 1405(VS) endocrine mucin-producing swet gland carcinoma (EMPSGC) ´éÌÌÈéÉæ¼ðáî 51ºÍ ÃËÀ­ ÈéÉæ¡Ê´éÌÌ¡Ë̾¸Å²°°åÎÅ¥»¥ó¥¿¡¼ Àîºê ÊþÈϤۤ«
  • 1406 hydrophilic polymer embolism (VS) ±¦Â­ÈéÉæÈ¯ÀÖ ¥³¥ì¥¹¥Æ¥í¡¼¥ë·ë¾½ºÉÀò¾É¤Îµ¿¤¤ 70ºÐÂå ÃËÀ­ ²¬ºê»Ô̱ɱ¡ ¾®Âô¹­ÌÀ ºç¸¶°½»Ò
  • 1407 oncocytoma of the carncle ±¦Æâ´ã³ÑÉôÆýƬ¼ð¡¡80ºÐÂå ÃËÀ­¡¡´ã¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡°ËÆ£ÃÎÈþ¤Û¤«
  • 1408 sinonasal renal cell-like carcinoma É¡¹Ð·ì´É¼ð 60Âå¸åȾ ÃËÀ­¡¡É¡¹Ð¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø¡¡²Ï¹ç¤Û¤«
  • 1409 phosphaturic mesenchymal tumor ½Ð·ìÀ­É¡Âû 50ºÐÂå ½÷À­¡¡Æ¬·ÛÉô¡¡´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ Ìî¸ý ·Ä¤Û¤«
  • 1410 adenomatous ductal hyperplasia º¸¼ª²¼Á£¼ðáç 30ºÐÂå ½÷À­¡¡ÂñÕÁ£¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡ ¶ÌÅű¤Û¤«
  • 1411 minimaly invasive oncocytic carcinoma with clear cell change ¹Ã¾õÁ£´âµ¿¤¤¡¡56ºÐ ÃËÀ­¡¡¹Ã¾õÁ£¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡ ±üÌî¤Î¤ê»Ò¤Û¤«
  • 1412 angiofibroma of the soft tissue 56ºÐ ÃËÀ­ º¸¶»ÉôÆðÉô¼ðáç À»Îì»°Êý¸¶É±¡ ȬÌÚ½ÕÆà¤Û¤«
  • 1413 (VS+¥¬¥é¥¹)¡¡cellular solitary fibrous tumor 34ºÐ ÃËÀ­¡¡¹üÈׯâ¼ðáî¡¡°¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡ ±©º¬ÅÄÀµÎ´¤Û¤«
  • 1414 giant cell tumor of the tendon theath with chondromatous metaplasia 60ºÐÂå ÃËÀ­ ¼ê¾¸¼ðáî¡¡ÉÙ»³Âç³ØÉí°É±¡ Æîºä¾°¤Û¤«
  • 1415 hybrid sclerosing epitheioid fibrosarcoma/ low-grade fibromyxoid sarcoma 30ºÐÂå ½÷À­ ±¦²¼ÂÜÆðÉô¼ðáç É;¾°å²ÊÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍý¿ÇÃÇ²Ê Ê¡ÅèËãͳ¤Û¤«
  • 1416 plumonary enteric adenocarcinoma 80ºÐÂå À­ÊÌ ÃËÀ­ ±¦ÇÙ´â Ê¡°æÀÖ½½»úɱ¡ Èõ¸ýæÆÊ¿¤Û¤«
  • 1417 (VS+¥¬¥é¥¹) intinal sarcoma of the aorta metastasized to the gingiva 73ºÐ ÃËÀ­¡¡ÂçÆ°Ì®, º¸Â¦²¼³Ü»õÆù´â¤Îµ¿¤¤¡¡¾®ËÒ»Ô̱ɱ¡ ·¬¸¶¶³»Ò¤Û¤«
  • 1418 IgG4-related sclerosing disease 70ºÐÂå ½÷À­ ¿ñËì¼ð¤â¤·¤¯¤Ï¿À·Ð¾ä¼ð À»ÎìÉ;¾É±¡ ¿·°æµÁʸ¤Û¤«
  • 1419 neurenteric cyst(endodermal cyst) ŵ·¿Îã¡¡9ºÐ À­ÊÌ ½÷À­ ·Û¿ñ¿ñ¹ÅËìÆâ¿ñ³°¼ðáî ÉÙ»³¸©Î©Ãæ±ûɱ¡ ÃæÀ¾¤æ¤¦»Ò¤Û¤«
  • 1420 clear cell sarcoma-like gastrointestinal tumor 60ºÐÂå ½÷À­¡¡¾®Ä²¡¡Ì¾¸Å²°Âè°ìÀÖ½½»úɱ¡ °ËÆ£ Íõ¤Û¤«
  • 1421 secondary lymphangioma 80ºÐÂå ½÷À­¡¡Å¾°ÜÀ­ç£¼ðáç¤Îµ¿¤¤¡¡°ìµÜ»ÔΩ»Ô̱ɱ¡ ÃæÅç¹­À»¤Û¤«
  • 1422 (VS+¥¬¥é¥¹) undifferentiated endocervical tumor-Sp's Dx; (Angiosarcoma was favored )50ºÐÂå ½÷À­¡¡»ÒµÜ¼ðáç¡¡º´µ×Áí¹çɱ¡º´µ×°åÎÅ¥»¥ó¥¿¡¼ ±öß· ů¤Û¤«
  • 1423 Adenoid basal carcinoma (ÌäÂêÎã) 68ºÐ¡¡½÷À­ »ÒµÜ·Û´â¡¡°¦Ãΰå²ÊÂç³ØÉ±¡ ¹â¸¶Âç»Ö¤Û¤«
  • 1424 sclerosing stromal tumor of the ovary 24ºÐ ½÷À­¡¡º¸ÍñÁã¼ðá硡̾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡ ²ÏÌî ¾©¤Û¤«

Âè77²óÃæÉô¸ò¸«²ñ 2016ǯ7·î2Æü, 3Æü¡¡ÄŻԡ¡»°½ÅÂç³Ø°å³ØÉôÎ×¾²ÂèÆó¹ÖµÁ¼¼

À¤Ïÿ͡¡»°½ÅÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô¡¡¾®ÄÍÍ´»Ê¡¡ÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1382 ectopic hamartomatous thymoma(Branchial anlage mixed tumor) Á°¶»ÉôÆðÉô¼ðáç 40ºÐÂåÃËÀ­ ̾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡ ¾®ß· µý¹°¤Û¤«
  • 1383 hybrid sclerosing epithelioid fibrosarcoma/ low-grade fibromyxoid sarcoma(hybrid SEF/LGFMS) ±¦¸ªÆðÉô¼ðáç¡¡30ºÐÂå½÷À­ ´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ µ×¾¾ ·û¼£¤Û¤«
  • 1384 epithelial-myoepithelial carcinoma ¼ª²¼Á£¼ðáî¡¡78ºÐÃËÀ­¡¡¾®ËÒ»Ô̱ɱ¡ ·¬¸¶ ¶³»Ò¤Û¤«
  • 1385 recurrent pleomorphic adenoma Éû°öƬ´Ö·ä¼ðáç¡¡65ºÐ½÷À­¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ Á𿼠¸ø½¨¤Û¤«
  • 1386 spindle cell/sclerosing rhabdomyosarcoma 60ºÐÂåÁ°È¾½÷À­¡¡ÉûÉ¡¹Ð¡¡¶âÂô°å²ÊÂç³ØÉ±¡¡¡·§Ã« ÀôÆá¤Û¤«
  • ¡ú1397 myoepithelioma-like tumors of the vulvar region(MELTVR) 30ºÐÂå½÷À­¡¡²ñ±¢Éô¡¡Ë­¶¶»Ô̱ɱ¡¡¡Ê¡Åè Ëãͳ¤Û¤«
  • 1388 Müllerian cyst arising at mediastinum 63ºÐ½÷À­¡¡½Ä³Ö¡¡Îë¼¯Ãæ±ûÁí¹çɱ¡¡¡Â¼ÅÄ Å¯Ìé¤Û¤«
  • 1389 malignant solitary fibrous tumor 70ºÐÂå½÷À­¡¡½Ä³Ö¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡Èõ¸ý æÆÊ¿¤Û¤«
  • 1390 epithelioid hemangioendothelioma 77ºÐÃËÀ­¡¡¶»Ëì¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡ÂçÀ¾ °ìÊ¿¤Û¤«
  • 1391 follicular dendritic cell sarcoma 50ºÐÂå¡¡¶»ÊÉÆðÉôÁÈ¿¥¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡Âç·î ÁïÌÀ¤Û¤«
  • 1392 angiomatoid fibrous histiocytoma(AFH) 10Âå½÷À­¡¡µ¤´É̾¸Å²°°åÎÅ¥»¥ó¥¿¡¼¡¡´ä±Û ¼ëΤ¤Û¤«
  • 1393¡¡epithelial-myoepithelial carcinoma 70ºÐÂåÃËÀ­¡¡ÇÙ¡¡»°½ÅÂç³Ø°å³ØÉôÉí°É±¡¡¡ÅòÞÉ ÇîÅФۤ«
  • 1401 EBV-associated smooth muscle tumor 26ºÐÃËÀ­¡¡´Î¡¡¡¶âÂôÂç³ØÉí°É±¡ÉÂÍýÉô¡¡ÃÓÅÄ Çî»Ò¤Û¤«
  • 1387 gliosarcoma with rhabdomyosarcomatous differentiation, WHO GradeIV 71ºÐÃËÀ­¡¡Ç¾ »üÀô²ñÁê߷ɱ¡¡¡Èõ¸ý ²ÂÂå»Ò¤Û¤«
  • 1394 adenoid cystic carcinoma of the breast, solid variant 70ºÐÂå½÷À­¡¡ÆýÁ£ Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡ Åĸ¶ º»Í¤Èþ¤Û¤«
  • 1395 adenomyoepithelioma with sebaseous metaplasia, chondromyxoid matrix ÆýÁ£À»Îì»°Êý¸¶É±¡ ȬÌÚ ½ÕÆà¤Û¤«
  • 1396 mixed tumor of the vagina 40ºÐÂåÁ°È¾½÷À­¡¡ç´¡¡À»ÎìÉ;¾É±¡ Âç·î ´²Ïº¤Û¤«
  • ¡ú1398 extensive vacuolization of syncytiothrophoblasts and extravillous throphoblasts, suggestive of neonatalmucolipidosis II alpha/beta(I-cell disease)¡¡30ºÐÂå½÷À­¡¡ÂÛÈס¡²¬ºê»Ô̱ɱ¡ ¾®Âô ¹­ÌÀ
  • 1399 well differentiated papillary mesothelioma 20ºÐÂå½÷À­¡¡Ê¢Ë졡̾¸Å²°Âè°ìÀÖ½½»úɱ¡¡¡°ÂÆ£ ÎÉÂÀ¤Û¤«
  • ¡ú1400 idiopathic mesenteric phlebosclerosis(IMP) associated with chinese herb(kamishoyohsan) ·ëIJº´µ×°åÎÅ¥»¥ó¥¿¡¼ °ìèßÅÄ ÀµÆóϺ¤Û¤«
  • 1402 large cell neuroendocrine carcinoma of the gall baldder 60ºÐÃËÀ­¡¡Ë¶¸¡¡¡Ì¾¸Å²°»ÔΩÂç³ØÉ±¡¡¡Æ£µÈ ¹Ôͺ¤Û¤«
  • ¡ú1403 primary mucin-producing adenocarcinoma of the renal pelvis 70ºÐÃËÀ­¡¡¿Õ¡¡¡ÉÙ»³»Ô̱ɱ¡¡¡±öë ¹¸¹­¤Û¤«

¥¤¥Ö¥Ë¥ó¥°¥»¥ß¥Ê(ÆÃÊֱ̹é) ¡Ö°ß±ê¤ÎÉÂÍý¿ÇÃǡ׼¢²ì°å²ÊÂç³ØÎ×¾²¸¡ºº°å³Ø¹ÖºÂ¡¦Éí°É±¡ÉÂÍý¿ÇÃDzʡ¡¶åÅèμ¼£ÀèÀ¸

¸ò¸«²ñ½éÆü ÄŻ԰ì¿ÈÅĹâÅIJñ´Û(¿¿½¡¹âÅÄÇÉËÜ»³ À콤»û¶­Æâ¤Î½ÉË·»ÜÀß)¤Ë¤ª¤¤¤Æº©¿Æ²ñ

Âè76²óÃæÉô¸ò¸«²ñ 2015ǯ12·î19Æü¡¡Ì¾¸Å²°»Ô¡¡°¦Ãγر¡Âç³ØÆï¸µ¥­¥ã¥ó¥Ñ¥¹4¹æ´Û2F

À¤Ïÿ͡¡°¦Ãγر¡Âç³Ø»õ³ØÉô¸ý¹ÐÉÂÍý³Ø¹ÖºÂ¡¡Á°ÅĽéɧ¡¡ÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1360¡¡Collision tumor; clear cell renal cell carcinoma and multiple myeloma¡¡70ºÐÃËÀ­¡¡¿Õ¡¡¡Ì¾¸Å²°ÂèÆóÀÖ½½»úɱ¡¡¡Â¼À¥ÍÛÂÀ¤Û¤«
  • 1361 fundic gland polyp with dysplasia (VS) 70ºÐÂå½÷À­¡¡°ß¡¡ÆÈΩ¹ÔÀ¯Ë¡¿ÍÃϰè°åÎÅ¿ä¿Êµ¡¹½Ãæµþɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡ÉþÉô¹Ôµª¤Û¤«
  • 1362 malignant gastrointestinal neuroectodermal tumor(MGINET)/clear cell sarcoma-like tumor of gastrointestinal tumor(CCSLGT) 40ºÐÂå½÷À­¡¡Ä¾Ä²¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉÂÍý¿ÇÃDzʡ¡¶Í»³Í¡Ï¤ۤ«
  • 1363 ÆÃÄêÉÔǽ¤Î¥ê¥ó¥ÑÁý¿£À­¼À´µ (IPT-like FDCS?) 40ºÐÂåÁ°È¾½÷À­¡¡´Î¡ ¼Ò²ñ°åÎÅË¡¿Í¹¨½á²ñÂçÆ±É±¡¡¡ÉÂÍý¿ÇÃDzʡ¡¾®Åç°Ë¿¥¤Û¤«
  • 1364 gastric heterotopia of the gall bladder 60ºÐÂåÃËÀ­ ÃÀǹ¡¡¸øÎ©Æ«À¸É±¡¡¡¶â»³Ãι°¤Û¤«
  • 1365 large cell neuroendocrine carcinoma with tubular adenocarcinoma component 70ºÐÂåÃËÀ­¡¡ÃÀ´É¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍý¿ÇÃDzʡ¡¾®¾å±ÍÌé¤Û¤«
  • 1366 desmoid type fibromatosis of the pancreas 60ºÐÂå¸åȾÃËÀ­¡¡ç¹¡¡ÉÙ»³»Ô̱ɱ¡, ¶âÂô°å²ÊÂç³ØÎ×¾²ÉÂÍý³Ø¡¡ÃæÅÄÁï»Ò¤Û¤«
  • 1367 mature teratoma with a duplication cyst-like element ( or duplication cyst with mature teratoma-like element) 40ºÐÂåÃËÀ­¡¡¸åÊ¢Ëì¡¡¶âÂô°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡ÀîÅçÆÆ¹°¤Û¤«
  • 1368 small cell carcinoma ex intrathyroidal thymoma(VS1,2) 80ºÐÂåÃËÀ­¡¡¹Ã¾õÁ£¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡¡¡±üÌî¤Î¤ê»Ò¤Û¤«
  • 1369 metastasizing goiter/ extremly well-diff. follicular adenocarcinoma? 60ºÐÂå½÷À­ ¹Ã¾õÁ£, ´Î(VS) °¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡¡¡¶áÆ£Àé¾½¤Û¤«
  • 1370 clear cell odontogenic carcinoma of the mandible 64ºÐÂåÃËÀ­¡¡²¼³Ü¹ü¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡Á𿼸ø½¨¤Û¤«
  • 1371 mucoepidermoid carcinoma 50ºÐÂå½÷À­¡¡º¸Àå²¼Á£¡¡¿ÛˬÀÖ½½»úɱ¡¡¡¿ÀµÜˮɧ¤Û¤«
  • 1372 epithelioid hemangioendothelioma 60ºÐÂåÃËÀ­ º¸º¿¹ü²¼ÀÅÌ®¡¡¾¾ÇÈÁí¹çɱ¡¡¡ßÀÊݱѼù¤Û¤«
  • 1373 extra-axial chordoma 40ºÐÂåÃËÀ­¡¡¶»ÊÉ¡¡À»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃDzʡ¡¿·°æµÁʸ¤Û¤«
  • 1374 mucoepidermoid carcinoma, clear cell variant. 12ºÐÃË»ù¡¡µ¤´É¡¡Ì¾¸Å²°»ÔΩÂç³ØÉ±¡¡¡Â¼À¥µ®¹¬¤Û¤«
  • 1375 pulmonary placental transmogrification 40ºÐÂåÃËÀ­¡¡º´µ×Áí¹çɱ¡º´µ×°åÎÅ¥»¥ó¥¿¡¼¡¡±ö߷ů¤Û¤«
  • 1376 chordoid glioma of the third ventricle(VS) 20ºÐÂå ½÷À­¡¡Ç¾¡¡À»Îì»°Êý¸¶É±¡ÉÂÍý¿ÇÃDzʡ¡È¬ÌÚ½ÕÆà¤Û¤«
  • 1377 cryptococcosis(cryptococcal choroid plexitis)(VS) 80ºÐÂå½÷À­¡¡ÂçǾ¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡º´Æ£Êˤۤ«
  • 1378 paraneoplastic extralimbic encephalopathy(encephalitis) 50ºÐÂå½÷À­¡¡ÂçǾ¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡¡¡°ÂÇܲí¿Í
  • 1379 cutaneous carcinosarcoma, status post skin transplantation 60ºÐÂåÃËÀ­¡¡ÈéÉæ¡¡´ôÉìÂç³Ø°å³ØÉôÉí°É±¡¡¡ÀîÅ緼ͤ¤Û¤«
  • 1380 dedifferentiated liposarcoma 60ºÐÂåÃËÀ­¡¡Ä²´ÖËì¡¡À¾Èø»Ô̱ɱ¡¡¡°ËÆ£¿¿Ê¸¤Û¤«
  • 1381 endometrial stromal sarcoma with sex-cord like element(ETSCLE) 20ºÐÂå¸åȾ¡¡»ÒµÜ¡¡»°½ÅÂç³ØÉ±¡ÉÂÍýÉô¡¡¸Å¶¶Ä¾¼ù¤Û¤«

Âè75²óÃæÉô¸ò¸«²ñ 2015ǯ7·î4Æü, 5Æü¡¡¾¾Ëܻԡ¡¿®½£Âç³ØÉí°É±¡4³¬²ñµÄ¼¼

À¤Ïÿ͡¡»üÀô²ñÁê߷ɱ¡¡¡Èõ¸ý ²ÂÂå»Ò¡¡ÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1338¡¡ciliated muconodular papillary tumor(CMPT) of the peripheral lung¡¡ÇÙ¡¡80Âå½÷À­Áê߷ɱ¡ÉÂÍý¿ÇÃDzʡ¡¾®Æ¦Èª¹¯»ù¤Û¤«¡¡ÇÙ
  • 1339¡¡ALK-rearranged lung adenocarcinoma with partially squamous differentiation(adenosquamous carcinoma) ÇÙ¡¡50Âå¸åȾ½÷À­¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡ÂçÀ¾°ìÊ¿¤Û¤«¡¡
  • 1340¡¡pleuropulmonary blastoma¡¡ÇÙ 4ºÐ½÷»ù¡¡Ì¾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô¡¡ÏªÌÚͪÂÀ¤Û¤«¡¡
  • 1341¡¡intimal sarcoma, pulmonary artery ÇÙÆ°Ì®¡¡70Âå½÷À­¡¡º´µ×Áí¹çɱ¡º´µ×°åÎÅ¥»¥ó¥¿¡¼Î×¾²ÉÂÍýÉô¡¡ÀÄÌøÂç¼ù¤Û¤«¡¡
  • 1342¡¡epithelioid trophoblastic tumor(ETT) 50ºÐÂåÁ°È¾½÷À­¡¡»ÒµÜ¡¡°ìµÜ»ÔΩ»Ô̱ɱ¡ÉÂÍý¿ÇÃDzʡ¡ÃæÅç¹­À»¤Û¤«
  • 1343¡¡signet-ring stromal tumor¡ú 10Âå¸åȾ½÷À­¡¡ÍñÁã¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉÂÍý¿ÇÃDzʡ¡ÃæÀîËþ¤Û¤«
  • 1344¡¡Indeterminated cell histiocytosis¡ú¡¡80ºÐÂåÁ°È¾ÃËÀ­¡¡ÈéÉæ¡¡ÌÚÂôµ­Ç°É±¡¡¡¿ù»³À¿¼£¤Û¤«
  • 1345¡¡malignant eccrine spiradenoma¡¡80Âå½÷À­¡¡ÈéÉæ(Èé²¼) ̾¸Å²°Âè°ìÀÖ½½»úɱ¡¡¡°ÂÆ£ÎÉÂÀ¤Û¤«
  • 1346¡¡epithelioid glioblastoma(speaker's Dx) Ǿ¡¡30Âå½÷À­¡¡¶âÂôÂç³ØÉí°É±¡ÉÂÍýÉô/ÉÂÍý¿ÇÃDzʡ¡ÃÓÅÄÇî»Ò¤Û¤«
  • 1347¡¡insulin injection related amyloidosis¡¡70ºÐÂå½÷À­¡¡¾¾ÇÈÁí¹çɱ¡¡¡ßÀÊݱѼù¤Û¤«
  • 1348¡¡myxoid/ossifying synovial sarcoma¡ú¡¡ÂçÂÜÆðÉôÁÈ¿¥¡¡10ÂåÁ°È¾ÃË»ù¡¡´ôÉìÂç³ØÉí°É±¡¡¡ÉðÆâ¾¡¾Ï¤Û¤«
  • 1349¡¡synovial sarcoma, poorly differentiated round cell type¡¡¿Õ¼þ°ÏÁÈ¿¥¡¡40ÂåÃËÀ­¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡Î×¾²¸¡ººÉô¡¡º´Æ£Êˤۤ«(ȯɽ¤Ï1350¤Î¸å)
  • 1350¡¡Lantanum deposition¡ú¡¡½½Æó»ØÄ²¡¡60Âå¸åȾÃËÀ­¡¡¸üÀ¸Ï¢¹â²¬É±¡¡¡ÌîËܰìÇî
  • 1351¡¡myeloid sarcoma (M4Eo)¡¡½½Æó»ØÄ²¼ðáî¡¡60ÂåÃËÀ­¡¡¸øÎ©Æ«À¸É±¡¡¡ÂìůϺ¤Û¤«
  • 1352¡¡undifferentiated carcinoma ÂçIJ¡¡60ÂåÃËÀ­¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡¡¡±üÌî¤Î¤ê»Ò¤Û¤«
  • 1353¡¡bile duct adenoma with oxiphilic change¡ú¡¡´Î¡¡¡60Âå½÷À­¡¡»°½ÅÂç³Ø°å³ØÉôÉí°É±¡É±¡ÉÂÍýÉô¡¡Æ£¸¶²íÌé¤Û¤«
  • 1354¡¡nesidioblastosis¤òÇØ·Ê¤Ë¤·¤ÆÀ¸¤¸¤¿A-cell¤Ø¤Îʬ²½¤ò¼¨¤¹non-functioning pancreatic endocrine tumor(speaker's Dx) ç¹ 60Âå½÷À­¡¡¾®ËÒ»Ô̱ɱ¡ÉÂÍý¿ÇÃDzʡ¡·¬¸¶¶³»Ò¤Û¤«
  • 1355¡¡EBV-associated inflammatory pseudotumor-like follicular dendritic cell tumor(speaker's Dx)¡ú 70Âå½÷À­¡¡ÉÙ»³¸©Î©Ãæ±ûɱ¡ÉÂÍý¿ÇÃDzʡ¡Æâ»³ÌÀ±û¤Û¤«
  • 1356¡¡glandular odontogenic cyst with hamartomatous tooth formation of mandible ²¼³Üǹ˦¡¡40Âå¸åȾÃËÀ­¡¡¾¾ËÜ»õ²ÊÂç³Ø¸ý¹ÐÉÂÍý³Ø¹ÖºÂ¡¡Íî¹çδ±Ê¤Û¤«
  • 1357¡¡papillary carcinoma, diffuse sclerosiong variant(ŵ·¿Îã) ¹Ã¾õÁ£ 10ÂåÁ°È¾½÷»ù¡¡´¢Ã«Ë­ÅÄÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡º´Æ£½ÓÇ·¤Û¤«
  • 1358¡¡undifferentiated carcinoma rhabdoid variant ¹Ã¾õÁ£¡¡60Âå¸åȾ½÷À­¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍý¿ÇÃDzʡ¡ÃÝÆâʸ¤Û¤«
  • 1359¡¡malignant struma ovari (speaker's Dx) ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡°ËÆ£°ÊÃÎϺ¤Û¤«

¥¤¥Ö¥Ë¥ó¥°¥»¥ß¥Ê¡¼

ALKÍÛÀ­ÇÙ´â¤ÎºÇ¿·Ãθ«¡¡-ALK¸¡ºº¤¬¤â¤¿¤é¤¹¤â¤Î- ¿·³ãÂç³ØÂç³Ø±¡°å»õ³ØÁí¹ç¸¦µæ²Ê¸ÆµÛ´ïÆâ²Ê³ØÊ¬Ìî½õ¶µ¡¡ÅÏÉô ÁïÀèÀ¸

Âè74²óÃæÉô¸ò¸«²ñ¡¡2014ǯ12·î20Æü¡¡Ì¾¸Å²°»Ô¡¡Ì¾¸Å²°Âç³ØÉí°É±¡¹ÖƲ

À¤Ïÿ͡¡Ì¾¸Å²°Âç³ØÉí°É±¡ÉÂÍýÉô¡¡²¼»³¡¡Ë§¹¾ÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1315 primary cutaneous CD30-positive anaplastic large cell lymphoma 38ºÐÃËÀ­ ÈéÉæ ÀŲ¬»ÔΩÀجɱ¡ÉÂÍý¿ÇÃÇ²Ê ¹¾²Ïͦ¼ù¤Û¤«
  • 1316 pigmented epithelioid melanocytoma 18ºÐ½÷À­ ÈéÉæ ¸øÎ©¾¾Ç¤ÀÐÀîÃæ±ûɱ¡ÉÂÍý¿ÇÃÇ²Ê Ã°±©½¨¼ù¤Û¤«
  • 1317 composite hemangioendothelioma 22ºÐ½÷À­ ±¦ÙÅìæÈéÉæ ¸©Î©Ãæ±ûɱ¡ÉÂÍý¿ÇÃÇ²Ê Æâ»³ÌÀ±û¤Û¤«
  • 1318 sand flear bite (VS) 60ºÐÂåÁ°È¾½÷À­ ±¦ìûÈéÉæ ¿ÛË¬Ãæ±ûɱ¡ÉÂÍý¿ÇÃÇ²Ê ÀõÌî¸ù¼£
  • 1319 apocrine DCIS arising in ductal adenoma with myoepithelial hyperplasia 82ºÐ½÷À­ ÆýÁ£ À¾Èø»Ô̱ɱ¡ÉÂÍý¿ÇÃÇ²Ê °ËÆ£¿¿Ê¸
  • 1320 invasive carcinoma of no special type, triple negative arising in microglandular adenosis of the breast. 60ºÐÂå½÷À­ ÆýÁ£ °¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡°äÅÁ»ÒÉÂÍý¿ÇÃÇÉô ¼¾åÁ±»Ò¤Û¤«
  • 1321 primary pulmonary NUT midline carcinoma with NSD3-NUT fusion transcripts (VS) 36ºÐ½÷À­ ÇÙ ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃÇ²Ê ÎëÌÚĬ¿Í¤Û¤«
  • 1322 classical Hodgkin lymphoma, nodular sclerosis 80ºÐÂåÁ°È¾ÃËÀ­ ½Ä³Ö ´¢Ã«Ë­ÅÄÁí¹çɱ¡ÉÂÍý¿ÇÃÇ²Ê º´Æ£½ÓÇ·¤Û¤«
  • 1323 choroid plexus carcinoma (adenocarcinoma) 40ºÐÂå½÷À­ ÂçǾ À»ÎìÉ;¾É±¡ÉÂÍý¿ÇÃÇ²Ê ¿·°æµÁʸ¤Û¤«
  • 1324 middle ear adenoma (carcinoid tumor) 40ºÐÂåÃËÀ­ Ãæ¼ª »ÔΩÅ×ÇÈÁí¹çɱ¡ ¿ù¸ý½Ó¤Û¤«
  • 1325 bizzare periosteal osteochondromatous proliferation (VS) 15ºÐÃËÀ­ ¸ý¹Ð(¾å³Ü»õÆù) Ä«ÆüÂç³ØÉ±¡ÉÂÍý¿ÇÃÇ²Ê ±Ê»³¸µÉ§¤Û¤«
  • 1326 salivary duct carcinoma (muchin-rich variant) 70ºÐÂåÃËÀ­ ÂñÕÁ£ Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍý¿ÇÃÇ²Ê ¾®¾å±ÍÌé¤Û¤«
  • 1327 hybrid carcinoma ex pleomorphic adenoma 72ºÐÃËÀ­ ÂñÕÁ£(±¦¼ª²¼Á£)°ìµÜ»ÔΩ»Ô̱ɱ¡ÉÂÍý¿ÇÃÇ²Ê ÏªÌÚÂö»Ê¤Û¤«
  • 1328 Adult Wilmus' tumor 20ºÐÂå½÷À­ ¿Õ¡ ¿·¾ë»Ô̱ɱ¡, Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉÂÍý¿ÇÃÇ²Ê Ý¯°æ±Ç»Ò¤Û¤«
  • 1329 IgG4-related sclerosing diseas 70ºÐÂåÃËÀ­ º¸¿Õâ³ ÌÚÂôµ­Ç°É±¡ÉÂÍý¿ÇÃDzÊ/ÉÂÍý¿ÇÃÇ¥»¥ó¥¿¡¼ ¿ù»³À¿»Ê¤Û¤«
  • 1330 Adenocarcinoma in situ/ high-grade PIN (VS) 70ºÐÂå ÃËÀ­ Á°Î©Á£ JA°¦ÃθüÀ¸Ï¢³¤Æîɱ¡ÉÂÍý¿ÇÃÇ²Ê ÀÐÀîÁà¤Û¤«
  • 1331 mesenchymal hamartoma 22ºÐ½÷À­ ´Î ¿®½£Âç³Ø°å³ØÉôÉí°É±¡Î×¾²¸¡ººÉô °ìèßÅÄÀµÆóϺ¤Û¤«
  • 1332 IPNB arising peribiliary glands (VS) 70ºÐÂå¸åȾ ÃËÀ­ ´Î ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ³ÑÅÄÍ¥»Ò¤Û¤«
  • 1333 polypoid carcinosarcoma of the bile duct 70ºÐÂå ÃËÀ­ JAĹÌî¸üÀ¸Ï¢º´µ×Áí¹çɱ¡ º´µ×°åÎÅ¥»¥ó¥¿¡¼ Àеµ×¢¼ù¤Û¤«
  • 1334 undifferentiated carcinoma with osteoclast-like giant cells 56ºÐÃËÀ­ ç¹ Ì¾¸Å²°»ÔΩÂç³ØÎ×¾²ÉÂÂÖÉÂÍý³Ø °ËÆ£ÍÎÊ¿¤Û¤«
  • 1335 solitary fibrous tumor of the uterus 40ºÐÂå¸åȾ½÷À­ »ÒµÜ ¶âÂô°å²ÊÂç³ØÎ×¾²ÉÂÍý³Ø ÃæÅÄÁï»Ò¤Û¤«
  • 1336 borderline mucinous cystadenoma with mural nodule of anaplastic carcinoma (VS) 58ºÐ½÷À­ ÍñÁã JA»°½Å¸üÀ¸Ï¢¾¾ºåÃæ±ûɱ¡ÉÂÍý¿ÇÃÇ²Ê ¿ùËÜ´²»Ò¤Û¤«
  • 1337 intraplacental choriocarcinoma ÊìÂÛ´ÖÍ¢·ì¾É¸õ·²¹çÊ» 30ºÐÂå½÷À­ ÂÛÈ× ¸øÎ©Æ«À¸É±¡ÉÂÍý¿ÇÃÇ²Ê ÂìůϺ¤Û¤«

Âè73²óÃæÉô¸ò¸«²ñ¡¡2014ǯ7·î5, 6Æü¡¡´ôÉ츩¹â»³»Ô¡¡¹â»³ÀÖ½½»úɱ¡3³¬Ãϰ踦½¤¼¼

À¤Ïÿ͡¡¹â»³ÀÖ½½»úɱ¡¡¡²¬ËÜÀ¶¾°ÀèÀ¸¡¡

¾ÉÎ㸡Ƥ

  • 1290 Balamuthia mandrillaris(¼«Í³À¸³è¥¢¥á¡¼¥Ð¤Î°ì¼ï) encepharitis Ǿ 57ºÐ½÷À­ ¿®½£Âç³Ø°å³ØÉôÉí°É±¡ ¾®ÎÓæÆÂÀ¤Û¤«
  • 1291 (infantile) myofibromatosis Ǿ¼ðáî 36ºÐ ÃËÀ­ ¶âÂô°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃÇ²Ê ÀîÅçÆÆ¹°¤Û¤«
  • 1292 conjunctival herniated orbital fat ´ããݼðáî 80ºÐÂå ÃËÀ­ ĹÌî¸üÀ¸Ï¢º´µ×Áí¹çɱ¡º´µ×°åÎÅ¥»¥ó¥¿¡¼ ±öß· ů
  • 1293 extraskeletal mesenchymal chondrosarcoma ´ããݼðáî 9ºÐ½÷»ù À»ÎìÉ;¾É±¡ Âç·î´²Ïº¤Û¤«
  • 1294 Rosai-Dorfman disease of the nasal cavity É¡¹Ð¼ðáî 50ºÐÂå ½÷À­ Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø ±ºÌî À¿¤Û¤«
  • 1295 Methotorexate-related lymphproliferative disease »õÆùÄÙáç·ÁÀ®¼ðáî 85ºÐ ½÷À­ ¹õÉô»Ô̱ɱ¡ ¹âÀîÀ¶
  • 1296 "Giant" fibrovascular polyp ²¼°öƬ¼ðáç 72ºÐ½÷À­ °åÎÅË¡¿ÍË­ÅIJñ´¢Ã«Ë­ÅÄÁí¹çɱ¡ º´Æ£½ÓÇ·¤Û¤«
  • 1297 mammary analogue secretory carcinomaº¸¼ª²¼Á£¼ðáç 29ºÐÃËÀ­ ¶âÂô°å²ÊÂç³ØÉ±¡ º´Æ£¾¡ÌÀ¤Û¤«
  • 1298 lung adenocarcinoma, ROS1 rearranged type ÇÙ¼ðáç 64ºÐÃËÀ­ ̾¸Å²°Âè°ìÀÖ½½»úɱ¡ ϪÌÚÆØ»Î¤Û¤«
  • 1299 pseudomesotheliomatous adenocarcinoma of the lung ¶»Ëì¿·ëÀá¾õ¼ðáî 64ºÐÃËÀ­ ¶âÂôÂç³ØÉí°É±¡ÉÂÍýÉô ÃÓÅÄÇî»Ò¤Û¤«
  • 1300 growing teratoma syndrome (metastatic teratoma, testicular tumor origin) ÇÙ¼ðáç 44ºÐÃËÀ­ ÉÙ»³¸©Î©Ãæ±ûɱ¡ ÁêÀ¤«¤Í¾
  • 1301 low-grade myxofibrosarcoma arising at esophagus ¸å½Ä³Ö¼ðáç 50ºÐÂå¸åȾÃËÀ­ ĹÌî»Ô̱ɱ¡ÉÂÍý¿ÇÃÇ²Ê ¾®Ê¿ Æü¼Â»Ò¤Û¤«
  • 1302 Äã°Û·¿ÅÙ¹âʬ²½°ßÄìÁ£·¿°ß´â¡¡°ß¼ðáç 68ºÐÃËÀ­ »ÔΩÅ×ÇÈÁí¹çɱ¡ ºû¸¶ ¤Î¤ê»Ò¤Û¤«
  • 1303 malignant solitary fibrous tumor (floar¤è¤êmalignant GIST¤È¤Î´ÕÊ̤¬É¬ÍפȰÛÏÀ¤¢¤ê) ¾®Ä²¼ðáç 70ºÐÃËÀ­ ̾¸Å²°ÂèÆóÀÖ½½»úɱ¡ ¼À¥ÍÛÂÀ¤Û¤«
  • 1304 uterine tumor resembling ovarian sex-cord tumors(UTROSCT) »ÒµÜÂÎÉô¼ðáç 76ºÐ½÷À­ ¾®ËÒ»Ô̱ɱ¡ ·¬¸¶¶³»Ò¤Û¤«
  • 1305 unclassified malignant uterine tumor »ÒµÜÂÎÉô¼ðáç 40ºÐÂå½÷À­ ÀÐÀî¸©Î©Ãæ±ûɱ¡ ¾®ÎÓ¿å½ï¤Û¤«
  • 1306 undifferentiated carcinoma/ small cell carcinoma hypercalcemic type ±¦ÍñÁã¼ðáç 50ºÐÂåÁ°È¾½÷À­ ¸üÀ¸Ï¢¹â²¬É±¡ÉÂÍý¿ÇÃÇ²Ê ÌîËܤۤ«
  • 1307 inlammatory myofibroblastic tumor ç¯æù¼ðáç 10ºÐÂå¸åȾ(¹â¹»À¸) ½÷À­ »°½ÅÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô ÆâÅÄ ¹îŵ¤Û¤«
  • 1308 Epithelioid angiomyolipoma(recurrence, status post embolization therapy) ¸åÊ¢Ëì¼ðáç 40ºÐÂåÃËÀ­ ÉÙ»³Âç³ØÉÂÍý¿ÇÃdzعֺ ÎÓ ¿­°ì¤Û¤«
  • 1309 G-CSF and IL-6 producing diffuse deciduoid mesotheliomaÊ¢Ëì¼ðáç 60ºÐÂåÃËÀ­ ´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ ¾®ÎÓ°ìÇî¤Û¤«
  • 1310 intraductal tubular carcinoma with minimal invasion ç¹´ÉÆâ¼ðáç 73ºÐÃËÀ­ ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃÇ²Ê ÂçÀ¾ °ìÊ¿¤Û¤«
  • 1311 blastic plasmacytoid dendritic cell neoplasm º¸¶»ÉôÈéÉæ¼ðáî 70ºÐÂåÃËÀ­ ÌÚÂôµ­Ç°É±¡ ¿ù»³¤Û¤«
  • 1312 neuroendocrine tumor, well-differentiated ÆýÁ£¼ðáî 70ºÐÂå½÷À­ Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô ¾®¾å ±ÍÌé¤Û¤«
  • 1313 sebaseous carcinoma of the breast ÆýÁ£¼ðáî 70ºÐÂå½÷À­ Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô ¼ò°æ ¹¯¹°¤Û¤«
  • 1314 fibromatosis-like metaplastic carcinoma ÆýÁ£¼ðáî 60ºÐÂå½÷À­ ¶âÂô°å²ÊÂç³ØÎ×¾²ÉÂÍý³Ø ±öë ¹¸¹­¤Û¤«

ÆÃÊֱ̹é

ÇÙ´â¤Ë¤ª¤±¤ë°äÅÁ»Ò¿ÇÃǤθ½¾õ-ALKÍ»¹ç°äÅÁ»ÒÍÛÀ­ÇÙ´â¤ò¼çÂΤË

¹áÀîÂç³Ø°å³ØÉôÉí°É±¡¡¡ÉÂÍý¿ÇÃDzʡ¦ÉÂÍýÉô¡¡±©¾ì¡¡Î鼡ÀèÀ¸

Âè72²óÃæÉô¸ò¸«²ñ 2013ǯ12·î21Æü¡¡Ì¾¸Å²°»Ô̾¸Å²°»ÔΩÂç³ØÉհɱ¡3³¬¹ÖƲ

̾¸Å²°»ÔΩÂç³Ø°å³Ø¸¦µæ²Ê¡¦¼Â¸³ÉÂÂÖÉÂÍý³Ø¡¡»³²¼°Í»ÒÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1272 sinonasal non-intestinal type adenocarcinoma low-grade¡¡É¡¹Ð 50ºÐÂå½÷À­¡¡ÉÙ»³Âç³ØÉÂÍý¿ÇÃdzء¡ÃæÅç δɧ¤Û¤«
  • 1273 mammary analogue secretory carcinoma ËËÇ´Ëì 30ºÐÂå½÷À­ °¦ÃΤ¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡°äÅÁ»ÒÉÂÍý¿ÇÃÇÉô¡¡Ä¹Ã«Àî ½ÓÇ·¤Û¤«
  • 1274 myofibroma of the tongue 10¥ö·îÃË»ù¡¡Àå¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡ÉÂÍý²Ê¡¡¿ù¸ý ½Ó¤Û¤«
  • 1275 liopfibroadenoma 20ºÐÂå¡¡ÃËÀ­¡¡½Ä³Ö¡¡ÂçÆ±É±¡ÉÂÍý¿ÇÃDzʡ¡¾®Åç °Ë¿¥
  • 1276 cardiac papillary fibroelastoma arising in pulmonary artery 70ºÐÂåÃËÀ­¡¡ÇÙÆ°Ì®¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉÂÍý¿ÇÃDzʡ¡Ý¯°æ ±Ç»Ò¤Û¤«
  • 1277 myofibroblastoma, classic type 75ºÐÃËÀ­¡¡ÆýÁ£¡¡Ì¾¸Å²°Âè°ìÀÖ½½»úɱ¡ÉÂÍýÉô¡¡ÏªÌÚ ÆØ»Î¤Û¤«
  • 1278¡ú phosphaturic mesenchymal tumor, mixed connective tissue variant, associated with hypophosphatemic osteomalacia 60ºÐÂå¸åȾ¡¡ÆðÉô¡¡É;¾°å²ÊÂç³Ø°å³ØÉôÉí°É±¡É±¡ÉÂÍý¿ÇÃDzʡ¡Ê¡Åè Ëãͳ¤Û¤«
  • 1279 dermatofibroma, aneurysmal and cellular variant 20ºÐÂå¸åȾ¡¡ÈéÉæ¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡Î×¾²¸¡ººÉô ¿ÀµÜ ˮɧ¤Û¤«
  • 1280 mycosis fungoides with large cell transformation 65ºÐÃËÀ­¡¡ÈéÉæ¡¡ÈÓÅÄ»ÔΩɱ¡ÉÂÍý¿ÇÃDzʡ¡Õú ´Á¾¡
  • 1281 epithelioid angiosarcoma 70ºÐÂåÃËÀ­¡¡ÈéÉæ¡¡ÉÙ»³»Ô̱ɱ¡ÉÂÍý¿ÇÃDzʡ¡ÃæÅÄ Áï»Ò¤Û¤«
  • 1282 desmoplastic melanoma ÈéÉæ¡¡60ºÐÂå¸åȾ½÷À­¡¡¶âÂô°å²ÊÂç³ØÎ×¾²ÉÂÍý³Ø¡¡Ê¡ÅÄ ²Ú»Ò¤Û¤«
  • 1283 thymoma associated graft-versus-host like disease 40ºÐÂå¸åȾÃËÀ­¡¡ÈéÉæ, ¾®Ä²¡¡´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô ¾®ÎÓ °ìÇî¤Û¤«
  • 1284 superficial cervicovaginal myofibroblastoma 40ºÐÂå¸åȾ½÷À­¡¡ç´¡¡ÉÙ»³¸©Î©Ãæ±ûɱ¡ÉÂÍý¿ÇÃÇ²Ê ÃæÀ¾ ¤æ¤¦»Ò¤Û¤«
  • 1285 ependymoma of the uterine ligament 20ºÐÂå½÷À­¡¡ÍñÁ㡡̾¸Å²°»ÔΩÂç³ØÎ×¾²ÉÂÂÖÉÂÍý³Ø¡¡ÉþÉô Æü½Ðͺ¤Û¤«
  • 1286 Nephroblastoma, rt. kidney and intralobular nephrogenic rests, lt. kidney 4¥ö·î½÷»ù¡¡¿Õ¡¡¶âÂôÂç³ØÉí°É±¡ÉÂÍýÉô¡¡ÃÓÅÄ Çî»Ò¤Û¤«
  • 1287 epithelioid angiomyolipoma of the liver 33ºÐ½÷À­¡¡´Î¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô¡¡º´¡¹ÌÚ ÍÛ»Ò¤Û¤«
  • 1288 hepatocellular adenoma, unclassified type 29ºÐÃËÀ­¡¡´Î¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡ÂçÀ¾ °ìÊ¿¤Û¤«
  • 1289 adenocarcinoid of the appendix (MANEC Mixed adenoneuroendocrine carcinoma) 48ºÐÃËÀ­¡¡Ãî¿â¡¡Ì¾Å´É±¡ÉÂÍýÉô¡¡¸¶ÅÄ ÃÒ»Ò

ÆÃÊֱ̹é

¡ÖÄÙáçÀ­ÂçIJ±ê¤ÎÀ¸¸¡¿ÇÃÇ(±ê¾ÉÀ­ÂçIJ¼À´µ¤ÎÀ¸¸¡¿ÇÃÇÍ×ÅÀ)¡×ËÌΦ¥·¡¼¥Ô¡¼¥¨¥ë¡¡¾®À¾¡¡Æó»°ÃËÀèÀ¸

Âè71²óÃæÉô¸ò¸«²ñ 2013ǯ7·î13, 14Æü Ê¡°æ»Ô Ê¡°æ¸©Î©É±¡3³¬¹ÖƲ

Ê¡°æ¸©Î©É±¡Î×¾²ÉÂÍý²Ê¡¡³¤ºêÂÙ¼£ÀèÀ¸

¾ÉÎ㸡Ƥ

  • 1249 carcinosarcoma(malignant mixed muellelian tumor) 70 ºÐÂå ½÷À­ ±¦ÍñÁã ÉÙ»³Âç³ØÉÂÍý¿ÇÃÇ³Ø¹ÖºÂ ÃæÅèδɧ¤Û¤«
  • 1250 endometrioid carcinoma resembling sex cord-stromal tumor (sertori form variant) 50ºÐÂå ½÷À­ »ÒµÜ¡¡À»ÎìÉ;¾É±¡ ¿·°æµÁʸ¤Û¤«
  • 1251-1,2 1:Endometrial storomal sarcoma, low-grade 2: Tuberous sclerosis complex-related perivascular epithelioid tumor(PEComa) 40ºÐÂå ½÷À­¡¡»ÒµÜ¡¡¾ÆÄÅ»ÔΩÁí¹çɱ¡ µ×ÎÏ ¸¢
  • 1252 Rosai-Dorfman disease 60 ºÐÂåÁ°È¾ ½÷À­¡¡¹ÅËì¡¡¶âÂô°å²ÊÂç³Ø Î×¾²ÉÂÍý³Ø »°ÎØ Í­¹á»Ò¤Û¤«
  • 1253 sino-nasal undifferentiated carcinoma(SNUC) of the left nasal cavity 74 ºÐ ÃËÀ­É¡¹Ð ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃÇ²Ê Á𿼸ø½¨
  • 1254¡ú NUT midline carcinoma µ©¾¯Åµ·¿Îã ÉûÉ¡¹Ð 18 ºÐ ½÷À­ ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃÇ²Ê ÎëÌÚĬ¿Í¤Û¤«
  • 1255 sebaceous carcinoma(*) ·ÛÉôÈéÉæ¡¡55 ºÐ ÃËÀ­ ¹õÉô»Ô̱ɱ¡ ¹âÀîÀ¶
  • 1256 carcinoma showing thymus-like differentiation (CASTLE) of the neck (poorly differentiated squamous cell carcinoma) ¹Ã¾õÁ£¥ê¥ó¥ÑÀá¡¡60ºÐÂå ÃË¡¡ÉÙ»³¸©Î©Ãæ±ûɱ¡ Æâ»³ÌÀ±û¤Û¤«
  • 1257 myoepithelial carcinoma ex pleomorphic adenoma ¼ª²¼Á£¡¡74 ºÐ ÃËÀ­¡¡»°½ÅÂç³Ø°å³ØÉôÉհɱ¡ÉÂÍýÉô ¿ùËÜ´²»Ò¡Ê¸½¿¦ ¾¾ºåÃæ±ûɱ¡Î×¾²ÉÂÍý²Ê¡Ë¤Û¤«
  • 1258 papilloma 52 ºÐ ½÷À­ ÇÙ °¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡ ¿·ÅÄÁÔÊ¿
  • 1259 calcifying fibrous tumors ŵ·¿Îã¡¡30 ºÐÂå À­ÊÌ ½÷À­¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡ ÃæÀîËþ¤Û¤«
  • 1260 dediffrentiated liposarcoma 80ºÐÂåȾ¤Ð¡¡½÷À­ Ê¢Ë졦ÆðÉô Îë¼¯Ãæ±ûÁí¹çɱ¡ ¼ÅÄůÌé¤Û¤«
  • 1261 low-grade fibromyxoid sarcoma 70 ºÐÂå À­ÊÌ ÃËÀ­ ±¦ÂçÂÜÉôÆðÉô¼ðáç ¿®½£Âç³Ø°å³ØÉôÉհɱ¡Î×¾²¸¡ººÉô ¾®Ê¿Æü¼Â»Ò¤Û¤«
  • 1262 plasmablastic lymphoma °ß 50ºÐÂå À­ÊÌ ½÷À­ ´ôÉì»Ô̱ɱ¡ »³ÅÄÅ´Ìé¤Û¤«
  • 1263 pyloric gland adenoma of the duodenum ½½Æó»ØÄ² 70 ºÐ ÃËÀ­ ÀÐÀî¸©Î©Ãæ±ûɱ¡ ÄÅ»³ æÆ¤Û¤«
  • 1264 inflammatory myofibrobastic tumor (IMT) ¾å¹Ô·ëIJ¡¡£¶£°ºÐÂå ½÷À­¡¡¶âÂô°åÎÅ¥»¥ó¥¿¡¼ ÀîÅçÆÆ¹°¤Û¤«
  • 1265 synovial sarcoma ľIJ ̾¸Å²°Âè°ìÀÖ½½»úɱ¡ÉÂÍýÉô Áҽſ¿º»»Ò¤Û¤«¡¡30ºÐÂå ½÷À­
  • 1266 fibrolammelar carcinoma ´Î¡ 12 ºÐ ½÷À­ ̾¸Å²°Âç³Ø°å³ØÉôÉí°É±¡ º´Æ£·¼¤Û¤«
  • 1267 adenocarcinoma of the pelvis 70ºÐÂå¸åȾ ½÷À­¡¡¿Õ¡ ¾®ËÒ»Ô̱ɱ¡ ·¬¸¶¶³»Ò¤Û¤«
  • 1268 extranodular NK/T-celllymphoma, nasal type 60ºÐÂåÃËÀ­¡¡ÀºÁã Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡ Âç±ÛÃéϤۤ«
  • 1269-1,2 AILT with hyperplastic germinal center and diffuse large B-cell lymphoma 59ºÐÃËÀ­ »ÔΩÅ×ÇÈÁí¹çɱ¡ ¿ù¸ý ½Ó¤Û¤«
  • 1270 ¥ê¥ó¥ÑÀá ¶âÂôÂç³Ø°å³Ø·Ï¸¦µæ²Ê ʬ»ÒºÙ˦ÉÂÍý¡¤ÅÄ¿¬Î¼Êå¤Û¤«
  • 1271 intimal sarcoma of the aorta 61ºÐ¡¡ÃËÀ­ ÂçÆ°Ì® Ê¡°æ¸©Î©É±¡ »³¸ý¿¿´õ¤Û¤«

¥¤¥Ö¥Ë¥ó¥°¥»¥ß¥Ê¡¼¡¡2013ǯ7·î13Æü

GIST¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó²þÄû¤ÎÊý¸þÀ­¡¡Ê¼¸Ë°å²ÊÂç³ØÉ±¡ÉÂÍýÉô¶µ¼ø¡¡×¢ÅÄÀ¿°ìÀèÀ¸

Âè70²ó¸ò¸«²ñ 2012ǯ12·î15Æü¡¡Ì¾¸Å²°»Ô ̾¸Å²°Âè°ìÀÖ½½»úɱ¡2³¬¡¡Æâ¥öÅç¹ÖƲ

̾¸Å²°Âè°ìÀÖ½½»úɱ¡ ɱ¡ÉÂÍýÉô¡¡Æ£Ìî ²íɧÀèÀ¸

¾ÉÎ㸡Ƥ²ñ¡¡±é¼Ô¿ÇÃÇ

  • 1227 Neuromyelitis Optica¡Êspectrum disorder) (NMOÎà±ï¼À´µ) ÀÔ¿ñ/ 57ºÐÃËÀ­¡¡Ì¾¸Å²°»ÔΩÂç³ØÎ×¾²ÉÂÂÖÉÂÍý³Ø¡¡»³ÅÄ Àª»ê¤Û¤«
  • 1228 Oral mucosal malignant melanoma¡¡»õÆù/ 85ºÐ½÷À­¡¡¾¾ËÜ»õ²ÊÂç³Ø»õ³ØÉô¸ý¹ÐÉÂÍý³Ø¡¡ÃæÌî ·É²ð¤Û¤«
  • 1229 Inflammatory myofibroblastic tumor of the sinonasal tract¡¡É¡¶õ/ 10ºÐÃË»ù¡¡¶âÂô°å²ÊÂç³ØÎ×¾²ÉÂÍý³Ø¡¡¾®ÎÓ ±ÑÍý»Ò¤Û¤«¡¡
  • 1230 Sclerosing hemangioma ÇÙ/ 62ºÐ ½÷À­ °¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡°äÅÁ»ÒÉÂÍý¿ÇÃÇÉô¡¡ºÙÅÄ Ïµ®¤Û¤«
  • 1231 Desmoplastic mesothelioma¡¡¶»Ë졦ÇÙ/ 70ºÐÂå ÃËÀ­¡¡Ì¾¸Å²°°åÎÅ¥»¥ó¥¿¡¼Î×¾²¸¡ºº²Ê¡¡´ä±Û ¼ëΤ¤Û¤«
  • 1232 Granulocytic sarcoma (type M0) arising in mediastinum¡¡¶»Á£/ 30ºÐÂå ÃËÀ­ ¡¡´ôÉì»Ô̱ɱ¡ µ×¾¾·û¼£¤Û¤«
  • 1233 Mediastinal goiter and seminoma(microscopic) ¶»Á£/¡¡50ºÐÂåÁ°È¾ ÃËÀ­ º´µ×Áí¹çɱ¡¡¡±öß· ů¤Û¤«
  • 1234 Low-grade myxofibroblastic sarcoma (LGMS) °ß/ 14ºÐ½÷À­¡¡¿ÛˬÀÖ½½»úɱ¡ÉÂÍýÉô ¼ò°æ ¹¯¹°¤Û¤«
  • 1235 Embryonal sarcoma ´Î/ 15ºÐÃËÀ­¡¡Ê¡°æÂç³Ø¼ðáçÉÂÍý³Ø Ĺ¾Â À¿Æó¤Û¤«
  • 1236 Primary myelofibrosis evolving into acute leukaemia ¹ü¿ñ¡¦´Î/ 85ºÐ½÷À­¡¡¶âÂôÂç³ØÊ¬»ÒºÙ˦ÉÂÍý³Ø ÃæÂ¼ Χ»Ò¤Û¤«
  • 1237 Wilson disease, highly likely case ´Î/ 60ºÐÂå½÷À­ ¶âÂôÂç³Ø·ÁÂÖµ¡Ç½ÉÂÍý³Ø¡¡º´Æ£ Êݧ¤Û¤«
  • 1238 Acinar cell carcinoma of the pancreas ç¹/ 30ºÐÂå¡¡½÷À­¡¡Ä¹Ìî»Ô̱ɱ¡ÉÂÍý¿ÇÃDzʡ¡Âç·î ÁïÌÀ¤Û¤«
  • 1239 Clear cell renal cell carcinoma and chromophobe renal cell carcinoma ¿Õ/ 63ºÐÃËÀ­¡¡Ê¡°æÂç³Ø°å³ØÉôÉհɱ¡ÉÂÍýÉô¡¡Àîºê ¸øÈþ·Ã¤Û¤«
  • 1240 Chromophobe renal cell carcinoma, eosinophilic variant ¿Õ/ 82ºÐ½÷À­¡¡ÉÙ»³Âç³Ø°å³ØÉôÉÂÂÖÉÂÍý³Ø¡¡ßÀÅç¡¡¾æ¤Û¤«
  • 1241 Adenomatoid tumor Éû¿Õ/ 60ºÐÂå¡¡½÷À­¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø°å³ØÉôÉÂÍý¿ÇÃDzʡ¡²¬Éô Ëã»Ò¤Û¤«
  • 1242 Endometrial stromal sarcoma (low or high-grade?) »ÒµÜ/ 50ºÐÂå¸åȾ½÷À­¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡ÉÂÍý²Ê¡¡¿ù¸ý ½Ó¤Û¤«
  • 1243¡ú Angiosaroma of the corpus uteri »ÒµÜ/ 62ºÐ½÷À­¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡ÎëÌÚĬ¿Í¤Û¤«
  • 1244 Malignant mucinous tumor(mucinous cystadenocarcinoma arising from mucinous cystadenoma) with foci of anaplastic carcinoma ÍñÁã/ 40ºÐÂå½÷À­ ¸øÎ©Æ«À¸É±¡ÉÂÍýÉô¡¡Â¼À¥ ÍÛÂÀ¤Û¤«
  • 1245»ÒµÜÆâÂÛ»ù»àË´¡¦ÂÛÈס¡À»ÎìÉ;¾É±¡ÉÂÍý²Ê¡¡¹¾²Ï ͦ¼ù¤Û¤«
  • 1246 Kaposi's sarcoma¡¡±¦Â­Æâ¦ÉôÈéÉæ/ 40ºÐÂåÃËÀ­¡¡¾ÆÄÅ»ÔΩɱ¡¡¡µ×ÎÏ¡¡¸¢
  • 1247 Epithelioid sarcoma Ê¢ÊÉÃѹü¾åÉô/ 40ºÐÂåÁ°È¾¡¡¾®ËÒ»Ô̱ɱ¡ÉÂÍý²Ê¡¡·¬¸¶ ¶³»Ò
  • 1248 Extraskeletal myxoid chondrosarcoma ŵ·¿Îã ±¦ÂçÂÜÆðÉô/ 80ºÐÂåÃËÀ­¡¡Ê¡°æÂç³Ø°å³ØÉôÉհɱ¡ÉÂÍýÉô¡¡ËÙ¹¾ ľÀ¤¤Û¤«

¥é¥ó¥Á¥ç¥ó¥»¥ß¥Ê¡¼

Ž¢°ß´â¤ÎtrastuzumabÅêÍ¿¤Ë·¸¤ï¤ëHER2¸¡ººŽ£¡¡¹ñΩ¤¬¤ó¸¦µæ¥»¥ó¥¿-Åìɱ¡¡¡Î×¾²³«È¯¥»¥ó¥¿¡¼Î×¾²¼ðáçÉÂÍýʬÌʬÌîĹ¡¡Íî¹ç ½ß»ÖÀèÀ¸

 

Âè69²ó¸ò¸«²ñ 2012ǯ6·î30Æü, 7·î1Æü¡¡É;¾»ÔÃϰè¾ðÊ󥻥󥿡¼1F¥Û¡¼¥ë

É;¾°å²ÊÂç³Ø¼ðáçÉÂÍý³Ø¶µ¼¼(µìÂè°ìÉÂÍý³Ø¹ÖºÂ) ¿ú¼ ½ÕɧÀèÀ¸

¾ÉÎ㸡Ƥ²ñ¡¡±é¼Ô¿ÇÃÇ

  • 1201 -1.Acute hepatitis with centrizonal necrosis, probably drug-induced liver injury (AIH¤Î´ØÍ¿ÈÝÄê¤Ç¤­¤Ê¤¤). -2. Chronic hepatitis, autoimmune, F3, A2/3 ¶âÂôÂç³Ø·ÁÂÖµ¡Ç½ÉÂÍý¡¡¸¶ÅÄ·û°ì, Ãæ¾Â°ÂÆó
  • 1202 inflammatory hepatic angiomyolipoma¡¡50ºÐ ½÷À­/ ´Î¡¡ÉÙ»³¸©Î©Ãæ±ûɱ¡¡¡Æâ»³¤Û¤«
  • 1203 EBV-associated leiomyoma/ smooth muscle tumor of the liver ´ôÉìÂç³Ø°å³ØÉôÉհɱ¡¡¡¾®ÎÓ°ìÇî¤Û¤«¡¡
  • 1204 early gastric cancer pT1b2(SM2) and plamablastic lymphoma (°ß¸¶È¯) 70ºÐÂåÃËÀ­/ °ß¡¡ ¶âÂô°åÎÅ¥»¥ó¥¿¡¼¡¡ÀîÅç, ³ÞÅç¡¡
  • 1205 Myxoid liposarcoma of the ileum 70ºÐÂå½÷À­/ ¾®Ä²¡¡ À»ÎìÉ;¾É±¡¡¡Âç·î´²Ïº¤Û¤«
  • 1206 Mesonephric adenocarcinoma of the uterus¡¡62ºÐ½÷À­/ »ÒµÜ ¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡¡¡¿ù¸ý ½Ó¤Û¤«
  • 1207 Endometorioid adenocarcinoma, Sertoli form variant¡¡80ºÐÂåÁ°È¾½÷À­/ ÍñÁ㡡̾¸Å²°Âè°ìÀÖ½½»úɱ¡¡¡ÅÏÊÕÎлҤۤ«
  • 1208 Endometrial stromal sarcoma(ESS), low-grade¡¡52ºÐ½÷À­/ »ÒµÜ¡¡Ì¾¸Å²°ÙպѲñɱ¡¡¡Ë̼ºÌ¤Û¤«
  • 1209 Myxoid leiomyosarcoma of the uterus 70ºÐÂå½÷À­/ »ÒµÜ¡¡¿®½£Âç³Ø°å³ØÉôÉհɱ¡Î×¾²¸¡ººÉô¡¡Àõ¹á»ÖÊæ¤Û¤«
  • 1210 Microcystic stromal tumor of the ovary¡¡20ºÐÂå½÷À­/ ÍñÁã¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø°å³ØÉô¡¡ÉÂÍý¿ÇÃDzʡ¡²¬ÉôËã»Ò¤Û¤«
  • 1211 Anaplastic ependymoma, grade­·¡¡62ºÐ ÃËÀ­/ Ǿ¡¡Îë¼¯Ãæ±ûÁí¹çɱ¡¡¡Â¼ÅÄůÌé¤Û¤«
  • 1212 Spindle cell oncocytoma of adenohypophysis(SCO) [¤Þ¤ì¤Êŵ·¿¾ÉÎã] 52ºÐÃËÀ­/ ²¼¿âÂΡ¡Ì¾¸Å²°Âç³ØÉ±¡ÉÂÍýÉô ÎëÌÚÍ¥¹á¤Û¤«
  • 1213¡¡low grade myofibroblastic sarcoma 39ºÐ¡¡½÷À­/ ÆðÉô(ç½Éô¡Ë»°½ÅÂç³ØÉհɱ¡¡¡¾®ÄÍÍ´»Ê¤Û¤«
  • 1214 Metastatic malignant melanoma with cartilaginous differentiation 60ºÐÂå¸åȾÃËÀ­/ ¥ê¥ó¥ÑÀá(Èé²¼)¡¡¶âÂô°å²ÊÂç³ØÎ×¾²ÉÂÍý³Ø¡¡¹õÀ¥Ë¾¤Û¤«
  • 1215¡¡histiocytic sarcoma [Dx¤Ë°ÛÏÀ¿¤¤¾ÉÎã, Åêɼ¤â¤ï¤ì¤ë] 60ºÐÂåÃËÀ­/ ¹ü¡¡¶âÂôÂç³ØÉհɱ¡ÉÂÍýÉô¡¡ÃÓÅÄÇî»Ò¤Û¤«

¥¤¥Ö¥Ë¥ó¥°¥»¥ß¥Ê¡¼

2ÆüÌܾÉÎ㸡Ƥ

  • 1216 Osteomyelitis was favored? (rather than LCH) [Dx¡©¥ê¥ó¥Ñ¼ð¤äÂå¼ÕÀ­¼À´µ¤â´ÕÊ̤¹¤ë¤Ù¤­¤È¤Î°Õ¸«¤¢¤ê]¡¡70ºÐÂå½÷À­/ Ƭ³¸¹ü¡¡Ä¹Ìî»Ô̱ɱ¡¡¡Âç·îÁïÌÀ, Êݺäŵ»Ò
  • 1217 malignant melanoma 83ºÐ½÷À­/ É¡¡¡Ì¾¸Å²°»ÔΩÂç³ØÎ×¾²ÉÂÂÖÉÂÍý¡¡Æ£µÈ¹Ôͺ
  • 1218 carcinosarcoma arising in pleomorphic adenoma 48ºÐ½÷À­/ ¼ª²¼Á£¡¡
  • 1219 Squamous cell papilloma with (or condyloma-like lesion )intraductal component 70ºÐÂå½÷À­/ ËËÉôÇ´Ëì¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡ÎëÌÚĬ¿Í¤Û¤«
  • 1220 -1. Metastatic malignant phyllodes tumor with mesenchymal to epithelial transition ? [ÆýÁ£¤Î¿ÇÃǤˤϰÛÏÀ¤Ï¤Ê¤¤¤¬¡¢Ù¨ÅíÉÂÊѤοÇÃǤ¬ÌäÂê¤È¤Ê¤ë] °¦Ãΰå²ÊÂç³Ø¡¡²£°æË­¼£¤Û¤«
  • 1221¡¡Squamous cell carcinoma of the breast arising from low-grade adenosquamous carcinoma [tentative Dx.]¡¡60ºÐ½÷À­/ Æý˼¥Þ¥ó¥â¥È¡¼¥àÁÈ¿¥ ¡¡ÀŲ¬¸©Î©Áí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡ÎëÌÚÀ¿¤Û¤«
  • 1222 smoking-related interstitial lung disease; combined pulmonary fibrosis and emphysema 62ºÐÃËÀ­/ ÇÙ¡¡ÉÙ»³Âç³ØÉհɱ¡ÉÂÍýÉô¡¡ÅÄȪϹ¨¤Û¤«
  • 1223 Minute menigothelioid nodule of the lung ¡¡76ºÐÃËÀ­/ ÇÙ¡¡°¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡¡¡°äÅÁ»ÒÉÂÍý¿ÇÃÇÉô¡¡¿¿º½¾¡ÂÙ¤Û¤«
  • 1224 Adenomatoid tumor 60ºÐÂå¸åȾ½÷À­/ Á°½Ä³Ö ¾®ËÒ»Ô̱ɱ¡¡¡·¬¸¶¶³»Ò¤Û¤«
  • 1225 Thymic carcinoma; Squamous cell carcinoma¡¡70ºÐÂåÃËÀ­/ ½Ä³Ö¼ðáç¡¡º´µ×Áí¹çɱ¡ÉÂÍýÉô¡¡ÀÄÌøÂç¼ù¤Û¤«
  • 1226 Clear cell papillary renal cell tumor(ž°Ü¤¬¤Ê¤¤¤Î¤Çcarcinoma¤Ï»È¤ï¤Ê¤¤Êý¸þ¤Ë¤¢¤ë) 66ºÐÃËÀ­/ ¿Õ¡¡ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃÇ²Ê ÅÏî´Îï»Ò¤Û¤«

Âè68²ó¸ò¸«²ñ 2011ǯ12·î10Æü¡¡¥¦¥¤¥ó¥¯¤¢¤¤¤Á(°¦Ãθ©»º¶ÈϫƯ¥»¥ó¥¿¡¼)5³¬¾®¥Û¡¼¥ë1

ºÑÀ¸²ñ¾¾ºåÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡ÃæÌî¡¡ÍÎÀèÀ¸

¾ÉÎ㸡Ƥ²ñ¡¡±é¼Ô¿ÇÃÇ

  • 1183 mucoepidermoid carcinoma, clear cell type, low-grade 30ºÐÃËÀ­/ »õÆù¡¡´ôÉ츩Ω¿¼£¸«É±¡¡¡µÈÅÄÌïÀ¸¤Û¤«
  • 1184 inflammatory myofibroblastic tumor, ALK-EML4 positive 70ºÐÂåÃËÀ­/ ÇÙ¡¡Ì¾¸Å²°Âè°ìÀÖ½½»úɱ¡¡¡¹¾ÃæËÒ»Ò¤Û¤«
  • 1185 melanotic oncocytic metaplasia[¤Þ¤ì¤Êŵ·¿¾ÉÎã] 70ºÐÂåÃËÀ­/ °öƬ¡¡¸øÎ©Æ«À¸É±¡¡¡Á°ÅÄ¿¿Íý¤Û¤«
  • 1186 chronic hypersensitivity pneumonitis, UIP pattern 60ºÐÂåÃËÀ­/ ÇÙ¡¡ÉÙ»³Âç³ØÉí°É±¡É±¡ÉÂÍý¡¡ÅÄÃæÈ¼Â§ (VS)
  • 1187 anaplastic large cell lymphoma 5ºÐÃË»ù/ ¹ü¡¡Ì¾¸Å²°»ÔΩÂç³ØÎ×¾²ÉÂÂÖÉÂÍý³Ø¶µ¼¼ º´Æ£Ê¸É§¤Û¤« (VS)
  • 1188 epithelioid sarcoma, proxymal type 50ºÐÂåÃËÀ­/ ²ñ±¢Éô¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡ËÙ¹¾Ä¾À¤¤Û¤«
  • 1189 dedifferentiated liposarcoma 60ºÐÂåÃËÀ­/ ÂçÂÜÉôÆðÉôÁÈ¿¥¡¡¶âÂôÂç³ØÊ¬»ÒºÙ˦ÉÂÍý³Ø¡¡ÎëÌÚĬ¿Í¤Û¤«
  • 1190 metastatic cancer in thoracic lymph nodes without a primary site 60ºÐÂåÃËÀ­/½Ä³Ö¥ê¥ó¥ÑÀá¡¡¿®½£Âç³Ø°å³ØÉôÉհɱ¡¡¡Åª¾ìµ×ŵ¤Û¤«¡¡
  • 1191 plasmablastic lymphoma¡¡70ºÐÂåÃËÀ­/°ß, ¥ê¥ó¥ÑÀá ¾®ËÒ»Ô̱ɱ¡¡¡·¬¸¶¶³»Ò¤Û¤«
  • 1192 enteropathy-associated T cell lymphoma type2 70ºÐÂåÃËÀ­/ °ß¡¦¾®Ä²¡¡ÃæÄÅÀî»Ô̱ɱ¡¡¡´äºêÇîʸ¤Û¤«
  • 1193 mixed adenoneuroendocrine carcinoma(MANEC), cecum (WHO2010) 60ºÐÂåÃËÀ­/ ÌÕIJ¡¡º´µ×Áí¹çɱ¡¡¡ÀÄÌøÂç¼ù¤Û¤«
  • 1194 inflammatory myofibroblastic tumor (favor, angiomyxoid myofibroblastic tumor)¡¡40ºÐÂåÃËÀ­/ °ßÇ´Ëì²¼¼ðáî¡¡´ôÉìÂç³Ø°å³ØÉôÉí°É±¡¡¡¹â¾¾¤Û¤«
  • 1195¡¡Beckwith-Wiedemann syndrome »à»º½÷»ù(21½µ)/ Éû¿Õ¡¡À»ÎìÉ;¾É±¡¡¡¹¾²Ïͦ¼ù¤Û¤«
  • 1196 matrix-producing carcinoma¡¡60ºÐÂå½÷À­/ ÆýÁ£¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡¡¡¿ù¸ý½Ó¤Û¤«
  • 1197 adult Wilmus tumor, epithelioid type 40ºÐÂå½÷À­/ ¿Õ¡¡´ôÉì»Ô̱ɱ¡¡¡»³ÅĤۤ«
  • 1198 combined hepatocellular-cholangiocarcinoma with stem cell features, cholangiocellular type (intermediate type was favored ?) 60ºÐÂåÃËÀ­/ ¿ȯ´Î¼ðáî¡¡Ê¡°æÂç³Ø°å³ØÉô¡¡¼ðáçÉÂÍý³Ø¡¡°ËÆ£¹À¼¡
  • 1199 acinar cell cystadenoma 20ºÐÂå½÷À­/ 繡¡Ì¾¸Å²°°åÎÅ¥»¥ó¥¿¡¼¡¡´ä±Û¼ëΤ¤Û¤«
  • 1200 septic thrombophlebitis of the portal vein 70ºÐÂåÃËÀ­/ ´Î

¹Ö½¬²ñ¡¡¡Ö¼ÂÁ©ÉÂÍý¿ÇÃÇ -¼ã¼êÉÂÍý°å¤Îµ¿Ìä¤ËÅú¤¨¤ë- ç¯æùÀ¸¸¡ÊÔ¡×

̾¸Å²°ÂèÆóÀÖ½½»úɱ¡¡¡ÅÔÃÛË­ÆÁ

Âè67²ó¸ò¸«²ñ 2011ǯ7·î9Æü, 8Æü¡¡¿®½£Âç³Ø°å³ØÉôÉհɱ¡4FÂç²ñµÄ¼¼

ÈÓÅÄ»ÔΩɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡°ËÆ£¿®É×ÀèÀ¸

¾ÉÎ㸡Ƥ²ñ¡¡±é¼Ô¿ÇÃÇ

  • 1167 clear cell tumor of the lung ¡¡40ºÐÂåÃËÀ­/ ÇÙ¼ðáî¡¡ÀÐÀî¸©Î©Ãæ±ûɱ¡ÉÂÍý¿ÇÃDzʡ¡Ã°±©½¨¼ù¤Û¤«
  • 1168 fetal adenocarcinoma, well differentiated (L-FLAC/WDFA) 80ºÐÂå½÷À­/ Ç٠ĹÌî»Ô̱ɱ¡ÉÂÍý¿ÇÃDzʡ¡Âç·îÁïÌÀ¤Û¤«
  • 1169 squamous cell carcinoma with intrapulomonary metastasis and rare deletion of p53 gene 70ºÐÂå¸åȾÃËÀ­/ ÇÙ¡¡°¦Ã詤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡¡¡°äÅÁ»ÒÉÂÍý¿ÇÃÇÉô¡¡Â¼¾åÁ±»Ò¤Û¤«
  • 1170 granulomatous necrotizing aortitis, Takayasu type¡¡70ºÐÂå½÷À­/ ÂçÆ°Ì®¡¡ JAĹÌî¸üÀ¸Ï¢º´µ×Áí¹çɱ¡¡¡ÉÂÍýÉô ±ö߷ů¤Û¤«
  • 1171 squamous cell carcinoma of the breast¡¡80ºÐÂå½÷À­/ ÆýÁ£¡¡ ¾ÆÄÅ»ÔΩÁí¹çɱ¡¡¡ÉÂÍý²Ê¡¡µ×Îϸ¢¤Û¤«
  • 1172 mucoepidermoid carcinoma of the breast 60ºÐÂåÁ°È¾½÷À­/ ÆýÁ£¡¡Ê¡°æÂç³Ø°å³ØÉôʬ»ÒÉÂÍý³Ø¡¡Âç±ÛÃéϤۤ«
  • 1173 endometrial stromal sarcoma with endometriosis¡¡30ºÐÂå¸åȾ½÷À­/ ÍñÁã¡¡ »ÔΩÅ×ÇÈÁí¹çɱ¡ÉÂÍý²Ê¡¡»ûȪ¿®ÂÀϺ¤Û¤«
  • 1174 ovarian sarcoma with osteoclastic giant-cell tumor and pleomorphic leiomyosarcoma 70ºÐÂåÁ°È¾½÷À­/ ÍñÁã¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡Ã«²¬½ñɧ¤Û¤«
  • 1175 epithelioid sarcoma proximal type of the rectum¡¡60ºÐÂåÃËÀ­/ æêÌç¼þ°ÏÈéÉæ¡¡ ¶âÂô°å²ÊÂç³ØÎ×¾²ÉÂÍý³Ø¡¡¹õÀ¥Ë¾¤Û¤«
  • 1176 autoimmune enteric leiomyositis¡ú¡ú¡ú¡¡ÍÄ»ù(5ºÐ°Ê²¼)ÃË»ù/ °ß¾®Ä²ÂçIJ¡¡ »°½ÅÂç³Ø°å³ØÉôÉհɱ¡¡¡ÉÂÍýÉô¡¡¿ùËÜ´²»Ò¤Û¤«
  • 1177 MPNST showing perineural cell differentiation, Perneural MPNST 60ºÐÂå½÷À­/ Ê¢¹ÐÆâ¼ðáç¡¡À»ÎìÉ;¾É±¡ÉÂÍý²Ê¡¡À¶¿å¿Ê°ì¤Û¤«
  • 1178 papillary renal cell carcinoma with low grade spindle cell foci 60ºÐÂåÃËÀ­/ ¿Õ¡¡¡Ê¡°æÂç³Ø°å³ØÉôÉհɱ¡¡¡ÉÂÍýÉô¡¡ËÙ¹¾Ä¾À¤¤Û¤«
  • 1179 desmoplastic spitz nevus¡¡20ºÐÂåÃËÀ­/ ²¼ÂܸåÌÌÈéÉæ¡¡ Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡¡¡ÉÂÍý¿ÇÃDzʡ¡·§ß·Ê¸µ×¤Û¤«
  • 1180 myxoid neurothekeoma¡¡ÍÄ»ù(5ºÐ°Ê²¼)ÃË»ù/ ¸åƬÉôÈéÉæ¡¡ ¿ÛˬÀÖ½½»úɱ¡¡¡¿ù±ºÁ±Ìï¤Û¤«
  • 1181 neuroendocrine tumor(NET) 40ºÐÂå½÷À­/ Ǿ, º¸Á°Æ¬ÍÕ²¼Éô¡¡¶âÂô°åÎÅ¥»¥ó¥¿¡¼Î×¾²¸¡ºº²Ê¡¡ÀîÅçÆÆ¹°¤Û¤«
  • 1182 orbital teratoma 10ºÐÂåÁ°È¾½÷À­/ ´ããÝÆâ¼ðáî¡¡¿®½£Âç³Ø°å³ØÉôÉհɱ¡Î×¾²¸¡ººÉô¡¡¿ÀµÜˮɧ¤Û¤«

(¼ÂºÝ¤Î¹Ö±é¤Ç¤Ï1176¤È1182¤¬Æþ¤ìÂØ¤¨¤Çȯɽ¤µ¤ì¤¿)

¹Ö±é²ñŽ¢°ß´â¤ÎTrastuzumabÅêÍ¿¤Ë·¸¤ï¤ëHER2¸¡ººŽ£¡¡¹ñΩ¤¬¤ó¸¦µæ¥»¥ó¥¿¡¼Åìɱ¡¡¡Î×¾²³«È¯¥»¥ó¥¿¡¼Î×¾²¼ðáçÉÂÍýÉôÉôĹ¡¡Íî¹ç½ß»Ö

Âè66²ó¸ò¸«²ñ 2010ǯ12·î18Æü¡¡Ì¾¸Å²°»ÔΩÂç³Ø°å³Ø¸¦µæÅï11FÎ×¾²¹ÖµÁ¼¼

̾¸Å²°»ÔΩÂç³ØÉ±¡ÉÂÍýÉô¡¡¹â¶¶¡¡ÃÒÀèÀ¸

¾ÉÎ㸡Ƥ²ñ No.1149- No.1166

  • 1149. malignant triton tumor (malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation ) 18ºÐ½÷À­/ ¸åÊ¢Ëì ¿ÛˬÀÖ½½»úɱ¡¡¡¿ù±ºµÁÌï¤Û¤«
  • 1150 lymphoangiomyoma(LAM) of the retroperioneum 40ºÐÂå½÷À­/ ¸åÊ¢Ëì¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡º£Â¼¹¥¾Ï¤Û¤«
  • 1151 Non-tuberculous Mycobacterial infection of the skin; Buruli Ulcer [M. ulcerans or M. ulcerans subsp. shinshuense Infection] ¡¡50ºÐÂå½÷À­/ ÈéÉæ¡¡´ôÉì»Ô̱ɱ¡Ãæ±û¸¡ººÉô¡¡»³ÅÄÅ´Ìé¤Û¤«
  • 1152 angiotensin receptor blocker fetopathy (ARB¤¬¸¶°ø¤ÎÂÛ»ùÉÂ)¡¡3¥ö·î½÷»ù/ ¿Õ¡¡¼Ò²ñÊݸ±Ãæµþɱ¡¡¡º´Æ£Êþ»Ò
  • 1153 invasive urothelial carcinoma, plasmacytoid variant¡¡70ºÐÂåÃËÀ­/ ç¯æù¡¡¸øÎ©Æ«À¸É±¡¡¡ÇòÌÚÇ·¹À¤Û¤«
  • 1154 inflammatory myofibroblastic tumor¡¡40ºÐÂå½÷À­/ ç¯æù¡¡Îë¼¯Ãæ±ûÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¡Æâ»³ÃÒ»Ò¤Û¤«
  • 1155 adenoid cystic/ basal cell carcinoma¡¡50ºÐÂå¸åȾÃËÀ­/ Á°Î©Á£¡¡Ä¹Ìî»Ô̱ɱ¡¡¡Âç·îÁïÌÀ¤Û¤«¡¡
  • 1156 speaker's diagnosis; ?. favor myoepithelial carcinoma(floar) ¡¡70ºÐÂå½÷À­/ ¼ª²¼Á£¡¦´Î¡¡¡º´µ×Áí¹çɱ¡Î×¾²ÉÂÍýÉô¡¡ÀÄÌøÂç¼ù¤Û¤«
  • 1157 sclerosing polycystic adenosis of the rt. parotid gland¡¡72ºÐ½÷À­/ ÂñÕÁ£¡¡ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡Á𿼡¡¸ø½¨
  • 1158 pigmented atypical carcinoid tumor of the nasal cavity¡¡70ºÐÂå¸åȾÃËÀ­/¡¡É¡¹Ð¡¡¶âÂô°å²ÊÂç³ØÉ±¡¡¡Èø»³ Éð¤Û¤«
  • 1159 histiocytoid carcinoma (signet-ring cell carcinoma) of the eyelid¡¡70ºÐÂåÃËÀ­/ ´ãµå¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡´äë¡¡Éñ¤Û¤«
  • 1160 solitary capillary hemangioma of the lung¡¡30ºÐÂå½÷À­/ ÇÙ¡¡°¦Ã詤¬¤ó¥»¥ó¥¿¡¼¡¡¿ûÌî ²í¿Í¤Û¤«
  • 1161 pulmonary capillary hemangiomatosis¡¡0ºÐÃË»ù/ ÇÙ¡¡Ì¾¸Å²°ÂèÆóÀÖ½½»úɱ¡¡¡¸åÆ£·¼²ð¤Û¤«
  • 1162 pulmonary venous hypertention¡¡10ºÐÂåÃË»Ò/ ÇÙ¡¡»°½ÅÃæ±û°åÎÅ¥»¥ó¥¿¡¼¡¡ÃæÎÓ ÍΤۤ«
  • 1163 syringocystoadenoma papilliferum (SCAP) of the breast¡¡20ºÐÂåÃËÀ­/ ÆýÁ£¡¡³ÞÅç ΤÈþ¤Û¤«
  • 1164 inflammatory myofibroblastic tumor of the stomach¡¡80ºÐÂåÃËÀ­/ °ß¡¡ÉÙ»³¸©Î©Ãæ±ûɱ¡¡¡ÁêÀî ¤¢¤«¤Í¤Û¤«
  • 1165 myeloid sarcoma of the small intestine (M4Eo)¡¡30ºÐÂåÃËÀ­/ ¾®Ä²¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡¡¡·§ß· ʸµ×¤Û¤«
  • 1166 Marburg type multiple sclerosis (tentative diagnosis)¡¡60ºÐÂå½÷À­/ Ǿ¡¡ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡ÅÏî´ Îï»Ò

¹Ö±é²ñ¡ÖHER2¸¡ºº¤Î¸½¾õ¤Èº£¸å¤Î²ÝÂê¡×

¹ñΩ¤¬¤ó¸¦µæ¥»¥ó¥¿¡¼Ãæ±ûɱ¡¡¡ÉÂÍý²Ê¡¦Î×¾²¸¡ºº²Ê²ÊĹ¡¡ÄÅÅÄ ¶Ñ

Âè65²ó¸ò¸«²ñ 2010ǯ7·î10,11Æü¡¡´ôÉì»Ôʸ²½»º¶È¸òή¥»¥ó¥¿¡¼(¤¸¤å¤¦¤í¤¯¥×¥é¥¶)

´ôÉìÂç³Ø°å³ØÉôÉí°É±¡ÉÂÍýÉô¡¡×¢À¥¡¡Á±¿®ÀèÀ¸

¾ÉÎ㸡Ƥ²ñ No.1130- No.1148

  • 1130 uterine smooth muscle tumor of uncertatin malignancy (metastasis to mediastinum)70ºÐÂå½÷À­/ ¶»Á£¡¡°¦Ãΰå²ÊÂç³ØÉ±¡¡¡ÉÂÍýÉô¡¡¹â¶¶·ÃÈþ»Ò
  • 1131 Spindle cell metaplasia of nodular goiter ºÐÂå½÷À­/ ¹Ã¾õÁ£¼ð¡¡»ÔΩÅ×ÇÈÁí¹çɱ¡¡¡ÉÂÍý²Ê¡¡Ã°±©½¨¼ù
  • 1132 Dyshormonogenic goiter ºÐÂå½÷À­/ ¹Ã¾õÁ£¡¡¿®½£Âç³Ø°å³ØÉôÉí°É±¡¡¡Î×¾²¸¡ººÉô¡¡±óÆ£¿¿µª
  • 1133 Metastatic thyroid carcinoma, poorly differentiated carcinoma 60ºÐÂåÃËÀ­/ ÂçÂܹüž°ÜÀ­¼ðáî¡¡Ê¡°æÂç³Ø°å³ØÉôʬ»ÒÉÂÍý³Ø¡¡Âç±ÛÃéÏÂ
  • 1134 Malignant solitary fibrous tumor of the brain (related with radiation therapy?), dedifferentiated case ? 50ºÐÂå½÷À­/ Ãæ¿õ¿À·Ð¡¡Ì¾¸Å²°°åÎÅ¥»¥ó¥¿¡¼¡¡ÉÂÍý¿ÇÃÇ²Ê ¿¹Ã«Îë»Ò
  • 1135 Glioblastoma with oligodendroglioma component 70ºÐÂåÃËÀ­/ ÂçǾ¡¡¶âÂô°å²ÊÂç³Ø Î×¾²ÉÂÍý³Ø ¹Ó»³¤ï¤«¤Ê
  • 1136 Extranodal NK/T lymphoma, nasal type of the lt. testis 20ºÐÂåÃËÀ­/ º¸ÀºÁã¼ðáî ̾¸Å²°ÂèÆóÀÖ½½»úɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡¸åÆ£·¼²ð
  • 1137 Spermatophores of the squid(¥¤¥«Àºè²»ÉÆþ¾É) 20ºÐÂå½÷À­/ ¸ý¹ÐÆâ°Ûʪ¡¡¸øÎ©Æ«À¸É±¡ ÉÂÍýÉô¡¡ÇòÌÚÇ·¹À
  • 1138 Acinic cell carcinoma of the breast 40ºÐ½÷À­/ º¸Æý˼¼ðáî¡¡ÈÓÅÄ»ÔΩɱ¡ ÉÂÍý¿ÇÃÇ²Ê Àõ¹á»ÖÊæ
  • 1139 Sexcord stromal tumor showing malignant potential 50ºÐÂå½÷À­/ ÍñÁã¼ðáç¡¡¶âÂô°åÎÅ¥»¥ó¥¿¡¼ Î×¾²¸¡ºº²Ê ³ÞÅçΤÈþ
  • 1140 PEComa of the uterus 30ºÐÂå½÷À­/ »ÒµÜ¶Ú¼ð¡¡ÉÙ»³¸©Î©Ãæ±ûɱ¡ ÉÂÍý¿ÇÃÇ²Ê ÁêÀ¤«¤Í
  • 1141 synovial sarcoma of the stomach 20ºÐÂåÃËÀ­/ °ß¼ðáç¡¡À»ÎìÉ;¾É±¡ ÉÂÍý¿ÇÃÇ²Ê ¹¾²Ïͦ¼ù
  • 1142 Enteropathy-associated T cell lymphoma (EATL) 60ºÐÂåÃËÀ­/ ²óIJ¼ðáî¡¡¶âÂôÂç³Ø ʬ»ÒºÙ˦ÉÂÍý³Ø ÎëÌÚĬ¿Í
  • 1143 Gastrointestinal stomal tumor with deverticum-like feature 60ºÐÂå½÷À­/ ²óIJ, ¥á¥Ã¥±¥ë·Æ¼¼µ¿¤¤¡¡¶âÂôÂç³Ø°å³ØÉôÉí°É±¡¡¡ÉÂÍýÉô¡¡Ë̼À±»Ò
  • 1144 Malignant PEComa(/ Leiomyosarcoma?) 50ºÐÂå½÷À­/ ¸åÊ¢Ëì¼ðá羮IJ¿»½á¡¡Ë­¶¶°åÎÅ¥»¥ó¥¿¡¼ Î×¾²¸¡ºº²Ê ÃæÂ¼±Ù»Ò
  • 1145 Prostatic duct carcinoma presenting as a urethral polyp 70ºÐÂåÃËÀ­/ Á°Î©Á£ÉôǢƻ¼ðáç¡¡¸üÀ¸Ï¢¹â²¬É±¡ ÉÂÍý²Ê¡¡ÁýÅÄ¿®Æó
  • 1146 carcinoma (sarcomatoid carcinoma) of the ureter 90ºÐÂå½÷À­/ ±¦Ç¢´É¼ðáç¡¡ ¸øÎ©¾¾Ç¤ÀÐÀîÃæ±ûɱ¡ ÅÚ»³¹î¼ù
  • 1147 carcinosarcoma ( sarcomatoid carcinoma) of the urinary bladder 80ºÐÂåÃËÀ­/ ç¯æù´â¡¡Ê¡°æÂç³Ø°å³ØÉôÉí°É±¡¡¡ÉÂÍýÉô¡¡ËÙ¹¾Ä¾À¤
  • 1148 ¿Õ¿»½áÀ­Ç¢Ï©¾åÈé´â invasive urothelial carcinoma 60ºÐÂå½÷À­/ ¿ÕºÙ˦´â¡¡Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø°å³ØÉôÉÂÍý¿ÇÃÇ²Ê ¶Í»³Í¡ÏÂ

¹Ö±é²ñ ¡ÖOSNAË¡¤Ë¤è¤ëÆý´â¥»¥ó¥Á¥Í¥ë¥ê¥ó¥ÑÀá´âž°Ü¿ÇÃǤμºݡ×~

Âçºå·Ù»¡É±¡ÉÂÍý¿ÇÃDzʡ¡ÄÔËÜÀµÉ§

Âè64²ó¸ò¸«²ñ¡¡2009ǯ12·î12Æü¡¡¹ñΩɱ¡µ¡¹½Ì¾¸Å²°°åÎÅ¥»¥ó¥¿

̾¸Å²°°åÎÅ¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡¿¹Ã«¡¡Îë»ÒÀèÀ¸

¾ÉÎ㸡Ƥ¡Ö´µ¼Ô¤µ¤ó¤«¤é³Ø¤Ö¡×¾ÉÎã No.1112-No.1129

  • 1112 Myxomatous leiomyosarcoma of the uterus Âç³À»Ô̱ɱ¡¡¡¹õÀî·Ê/ 74ºÐ½÷À­/ »ÒµÜ¼ðáî
  • 1113 Endometrial stromal sarcoma, low-grade ¾ÆÄÅ»ÔΩÁí¹çɱ¡ÉÂÍý²Ê¡¡µ×Îϸ¢/ 65ºÐ½÷À­/ »ÒµÜ¼ðáî
  • 1114 poorly differentiated neuroendocrine carcinoma of the cervix uteri Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉ±¡¡¡¶Í»³Í¡ÏÂ/ 30ºÐÂå½÷À­/ »ÒµÜ·ÛÉô
  • 1115 teratocarcinosarcoma, sinonasal type ÀŲ¬¤¬¤ó¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡¿¼Áð¸ø½¨/ 69ºÐÃËÀ­/ ¸ý¹Ð-- carcinosarcoma¤Î°Õ¸«¤¬Â¿¤¤
  • 1116 intravascular myopericytoma, benign ̾¸Å²°Âç³Ø°å³ØÉôÉհɱ¡¡¡ÅçÅÄÁí»Ò/ 53ºÐ½÷À­/ ËËÉô
  • 1117 dedifferentiated liposarcoma ̾¸Å²°Âè°ìÀÖ½½»úɱ¡ÉÂÍýÉô¡¡¾®ÆîÍýÈþ/ 83ºÐÃËÀ­/ ·ÛÉô
  • 1118 follicular carcinoma (ÇÛÉÛɸËܤǤÏadenomatous goiter or follicular adenoma¤Îdiagnosis¤·¤«¤Ç¤­¤Ê¤¤¡£) Îë¼¯Ãæ±ûÁí¹çɱ¡¡¡ÎÓ¾¼¿­/ 50ºÐÂå½÷À­/ ¹Ã¾õÁ£
  • 1119 malignant mesothelioma (long-term survivor?) ¾®ËÒ»Ô̱ɱ¡ÉÂÍý²Ê¡¡·¬¸¶¶³»Ò¡¡30ºÐÂå½÷À­/¶»Ëì
  • 1120 pulmonary hamartoma with pleural dissemination º´µ×Áí¹çɱ¡Î×¾²ÉÂÍýÉô¡¡±ö߷ů¡¡50ºÐÂåÃËÀ­/ÇÙ
  • 1121 gliosarcoma with adenoid and squamous cell metaplasia ¶âÂôÂç³ØÉհɱ¡ÉÂÍýÉô¡¡Ë̼À±»Ò 50ºÐÂåÃËÀ­/Ãæ¿õ¿À·Ð
  • 1122 oligdendroglioma, grade­¶¢ªanaplastic oligodendroglioma, grade­·¡¡¶âÂô°åÎÅ¥»¥ó¥¿Î×¾²¸¡ºº²Ê¡¡ÀîÅçÆÆ¹° 60ºÐÂåÃËÀ­/ÂçǾ
  • 1123¡¡optic glioma; pilocytic glioma, grade­µ Ë­ÅĸüÀ¸É±¡¡¡²¬ºêÂÙ¾»¡¡60ºÐÂå½÷À­/´ãµå
  • 1124¡¡superficial acral fibromyxoma ¿ÛˬÀÖ½½»úɱ¡ÉÂÍýÉô¡¡¼ò°æ¹¯¹°¡¡40ºÐÂåÃËÀ­/ÆðÉô, ±¦Â裳
  • 1125 desmoid-type fibromatosis º´µ×Áí¹çɱ¡Î×¾²ÉÂÍýÉô¡¡Àеµ×¢¼ù¡¡72ºÐ½÷À­/ÆðÉô, ±¦²¼ÂÜÈé²¼
  • 1126 low grade sclerosing and inflammatory tumor of the retroperitoneum, favor inflammatory liposarcoma ÉÙ»³¸©Î©Ãæ±ûɱ¡Î×¾²ÉÂÍý²Ê¡¡Æâ»³ÌÀ±û¡¡60ºÐÃËÀ­/¸åÊ¢Ëì
  • 1127 sinonasal adenoid cystic carcinoma (CHUBU case 836¤Îfollow up)Ê¡°æÂç³Ø°å³ØÉôÉհɱ¡ÉÂÍýÉô¡¡º£Â¼¹¥¾Ï 67ºÐÃËÀ­/¿Õ¡
  • 1128 microcapsel-induced granulomatous peritonitis (±ö»À¥ê¥å¡¼¥×¥ê¥óÃí¼Í¤¬¸¶°ø¤È¹Í¤¨¤é¤ì¤ë¡Ë³¤Æîɱ¡ÉÂÍýÉô¡¡¸åÆ£·¼²ð¡¡80ºÐÃËÀ­/Ê¢Ëì
  • 1129 reactive hyperplasia (infectious mononucleosis?) °Â¾ë¸üÀ¸É±¡¡¡ÁáÀîÀ¶½ç¡¡27ºÐÃËÀ­/¥ê¥ó¥ÑÀá

Âè63²ó¸ò¸«²ñ¡¡2009ǯ7·î11,12Æü¡¡ÉÙ»³»ÔÉÙ»³¸©Ì±²ñ´Û

ÉÙ»³Ãæ±ûɱ¡Î×à®ÉÂÍý²Ê¡¡»ûȪ¡¡¿®ÂÀϺÀèÀ¸

¹Ö±é²ñ

¡ÖEGFR°äÅÁ»ÒÊѰۤÎÎ×¾²°ÕµÁ-¬Äê¤È¼£ÎŤˤª¤±¤ëÌäÂêÅÀ-¡× ¶âÂôÂç³Ø¤¬¤ó¹âÅÙÀè¿Ê¼£ÎÅ¥»¥ó¥¿¡Ý¡¡ÌðÌî¡¡À»ÆóÀèÀ¸

¾ÉÎ㸡Ƥ No.1090-No.1111

Speaker's Diagnosis

  • 1090. EML4-ALK adenocarcinoma of the lung ÉÙ»³Âç³ØÉÂÂÖÉÂÍý³Ø¡¡ÀÐß·¿­¤Û¤«/ 23ºÐÃËÀ­/ ÇÙ¼ðáî
  • 1091.Mixed ductal-endocrine carcinoma ÉÙ»³¸©Î©Ãæ±ûɱ¡¡¡ÃæÀ¾¤æ¤¦»Ò¤Û¤«/ 70ºÐÂåÃËÀ­/ ç¹Æ¬Éô¼ðáî
  • 1092. Pseudolipoma of Glisson's capsule ¶âÂôÂç³Ø·ÁÂÖµ¡Ç½ÉÂÍý³Ø¡¡¸þ½¡ÆÁ¤Û¤«/ 90ºÐÂåÃËÀ­/ ´ÎɽÌ̼ðáî
  • 1093. Well differentiated liposarcoma inflammtory type ¾®ËÒ»Ô̱ɱ¡ÉÂÍý²Ê¡¡·¬¸¶¶³»Ò/ 63ºÐÃËÀ­/ ÁÍ·ÂÉô¥ê¥ó¥ÑÀá
  • 1094. Solitary fibrous tumor arising in the lt. lateral ventricle ÈÓÅÄ»ÔΩɱ¡¡¡Î×¾²ÉÂÍý²Ê ÃÓ»³´Ä¤Û¤«/ 79ºÐÃËÀ­/ º¸Â¦Ç¾¼¼¼ðáî
  • 1095. Medulloblastoma with extensive neuronal differentiation ¶âÂô°å²ÊÂç³Ø¡¡ÉÂÂÖ¿ÇÃÇ°å³Ø¡¡¹õÀ¥Ë¾¤Û¤«/ 5ºÐÃË»ù/ ¸åƬ³¸ãݼðáî
  • 1096. Mixed germ cell tumor of the testis [±é¼Ô¤Î¤¤¤¦central-PNETÀ®Ê¬¤¬ÌäÂê¤È¤Ê¤Ã¤¿]¶âÂô°å²ÊÂç³Ø¡¡ÉÂÍýÉÂÂֳء¡º´Æ£¾¡ÌÀ¤Û¤«/ 36ºÐÃËÀ­/ ÀºÁã¼ðáç
  • 1097. Bisphosphonate-related osteonecrosis of the jaw ¸üÀ¸Ï¢¹â²¬É±¡¡¡ÁýÅÄ¿®Æó¤Û¤«/ 70ºÐÂå½÷À­/ ξ¦¾å³Ü¹ü
  • 1098. Reactive lesion ( pseudomalignant erosive and ulcerative lesion) º´µ×Áí¹çɱ¡¡¡Î×¾²ÉÂÍýÉô¡¡±ö߷ů¤Û¤«/ 70ºÐÂåÃËÀ­/ ¿©Æ»Ç´Ëì²¼¼ðáî
  • 1099. Malignant melanoma of the EC junction Ê¡°æÂç³Ø°å³ØÉôÉհɱ¡ÉÂÍýÉô¡¡ÂÀÅÄÎʤۤ«/ 8ºÐ½÷»ù/ ¿©Æ»°ßÀܹçÉô¥Ý¥ê¡¼¥×
  • 1100. Malignant peripheral nerve sheath tumor »ÔΩÅ×ÇÈÁí¹çɱ¡¡¡ÉÂÍý²Ê¡¡Ã°±©½¨¼ù¤Û¤«/ 43ºÐ½÷À­/ ¶õIJ¼ðáî
  • 1101?. B ell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma Ê¡°æÀÖ½½»úɱ¡¡¦Ê¡°æÂç³Ø¼ðáçÉÂÍý³Ø¡¡Ä¹¾ÂÀ¿Æó¤Û¤«/ 69ºÐ½÷À­/ ÌÕIJ¼ðáç
  • 1102. Ganglion cell inclusion? ̾¸Å²°°åÎÅ¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡Ä¹Ã«ÀîÀµµ¬¤Û¤«/ 90ºÐ½÷À­/ ·ëIJ¼ðáç
  • 1103. myxoinflammatory fibroblastic sarcoma Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø¡¡ÉÂÍý¿ÇÃÇ²Ê ·§Âôʸµ×¤Û¤«/ 50ºÐÂåÃËÀ­/ ±¦¼ê´ØÀá
  • 1104. Undifferentiated sarcoma of the uterus or metastatic ductal carcinoma of the breast(late metastasis)? ̾¸Å²°Âè°ìÀÖ½½»úɱ¡ ¾®ÆîÍýÈþ¤Û¤«/ 58ºÐ½÷À­/ »ÒµÜ¼ðáç
  • 1105. Collecting duct carcinoma of Belini ¶âÂô°åÎÅ¥»¥ó¥¿¡¼¡¡Î×¾²¸¡ºº²Ê¡¡³ÞÅçΤÈþ¤Û¤«/ 60ºÐÂå¸åȾÃËÀ­/ º¸¿Õ¼ðáç
  • 1106. Renal carcinoma associated with Xp11.2 translocation/TFE3 gene fusion ´ôÉìÂç³Ø°å³ØÉôÉհɱ¡¡¡ÉÂÍýÉô¡¡ã·¶¿ÃÒ·ÃÈþ¤Û¤«/ 18ºÐÃËÀ­/ ±¦¿Õ¼ðáç
  • 1107. Mediastinal germ cell tumor (seminoma) ¿®½£Âç³ØÉհɱ¡¡¡Î×¾²¸¡ººÉô¡¡ÀõÌî¸ù¼£¤Û¤«/ 30ºÐÂåȾ¤ÐÃËÀ­/ ½Ä³Ö¼ðáç
  • 1108. Dermatofibrosarcoma protuberance with fibrosarcomatous change¶âÂôÂç³ØÉհɱ¡¡¡ÉÂÍýÉô¡¡ÃÓÅÄÇî»Ò¤Û¤«/ 30ºÐÂåÃËÀ­/ ±¦Á°¶»ÉôÈé²¼¼ðáî
  • 1109. Desmoplastic round cell tumor Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø¡¡ÉÂÍý¿ÇÃDzʡ¡ËÌÀîÍ¡¤Û¤«/ 30ºÐÂåÃËÀ­/ Ê¢¹ÐÆâ¼ðáç
  • 1110. Atypical fibrous histiocytoma Ë­¶¶°åÎÅ¥»¥ó¥¿¡¼¡¡Î×¾²¸¡ºº²Ê¡¡ÃæÂ¼±Ù»Ò / 30ºÐÂåȾ¤Ð½÷À­/ ±¦¾åÏÓÈéÉæ¼ðáî
  • 1111. Langerhans cell histiocytosis/histiosarcoma É;¾°å²ÊÂç³ØÉհɱ¡¡¡ÉÂÍýÉô¡¡Ìܹõ»Ë¿¥/ 70ºÐÂå¸åȾÃËÀ­/ ±¦É¨¾åÉôÈéÉæ¹Å·ë

Âè62²ó¸ò¸«²ñ¡¡2008ǯ12·î19,20Æü¡¡Ì¾¸Å²°»Ô

̾¸Å²°Âç³Ø°å³ØÉôÊÝ·ò³Ø²Ê¡¡²£°æ¡¡Ë­¼£ÀèÀ¸

¾ÉÎ㸡Ƥ No.1064-No.1089

  • 1064¡¥Desmoplastic small round cell tumor Ë­¶¶°åÎÅ¥»¥ó¥¿¡¼¡¦ÃæÂ¼±Ù»Ò/ 30ºÐÂåÃËÀ­ / Ê¢¹ÐÆâ¿ȯÀ­¼ðáî
  • 1065¡¥Bile duct polyp with marked deposition of Liesegang rings ¼î½§»ÔÁí¹çɱ¡¡¦º´Æ£Êݧ¡¡¤Û¤« / 70ºÐÂåÃËÀ­ / ´Î¡
  • 1066¡¥Adenomatoid tumor of the left adrenal gland £Ê£Á°¦ÃθüÀ¸Ï¢¹¾Æî¸üÀ¸É±¡¡¦Ê¡»³Î´°ì¡¡¤Û¤« / 40ºÐÂåÃËÀ­ / Éû¿Õ
  • 1067¡¥Inflammatory myofibroblastic tumor (IMT) ¿ÛˬÀÖ½½»úɱ¡¡¦ÀõÌî¸ù¼£¡¡¤Û¤« / 60ºÐÂå½÷À­ / ç¹
  • 1068¡¥Mixed epithelial and stromal tumor ¶âÂô°å²ÊÂç³Ø¡¦º´Æ£¾¡ÌÀ¡¡¤Û¤« / 60ºÐÂå½÷À­ / ¿Õ
  • 1069¡¥Primary adenocarcinoma of renal pelvis and ureter Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³Ø¡¦¶Í»³Í¡Ï¡¡¤Û¤« / 70ºÐÂå½÷À­ / Ç¢´É¸ý
  • 1070¡¥Leiomyosarcoma ̾¸Å²°»ÔΩÂç³Ø¡¦Ã滳¡¡¤Û¤« / 40ºÐÂå½÷À­ / ¿Õ
  • 1071¡¥Mucinous tubular and spindle cell carcinoma with high grade atypia Ê¡°æÂç³Ø¡¦º£Â¼¹¥¾Ï¡¡¤Û¤« / 50ºÐÂå½÷À­ / ¿Õ
  • 1072¡¥Micronodular thymoma with lymphoid stroma ÈÓÅÄ»ÔΩɱ¡¡¦ÃÓ»³´Ä¡¡¤Û¤« / 60ºÐÂåÃËÀ­ / ½Ä³Ö
  • 1073¡¥Synovial sarcoma, monophasic fibrous type ¸øÎ©¾¾Ç¤ÀÐÀîÃæ±ûɱ¡¡¦Ä¹¾ÂÀ¿Æó¡¡¤Û¤« / 30ºÐÂåÃËÀ­ / ½Ä³Ö
  • 1074¡¥Cylindroma of the breast É;¾°å²ÊÂç³Ø¡¦ÌÚ²¼¿¿Æà¡¡¤Û¤« / 50ºÐÂå½÷À­ / ÆýÁ£
  • 1075¡¥Low grade adenosquamous carcinoma ¾®ËÒ»Ô̱ɱ¡¡¦·¬¸¶¶³»Ò / 30ºÐÂå½÷À­ / ÆýÁ£
  • 1076¡¥Hamartoma ¸øÎ©Æ«À¸É±¡¡¦Ãæ¹õ¶©¿Í¡¡¤Û¤« / 40ºÐÂå½÷À­ / ÆýÁ£
  • 1077¡¥Teratoid carcinosarcoma »ÔΩÅ×ÇÈÁí¹çɱ¡¡¦¿ù¸ý½Ó¡¡¤Û¤« / 70ºÐÂå½÷À­ / ¹üÈ×Éô
  • 1078¡¥Rhabdomyosarcoma, »°½ÅÃæ±û°åÎÅ¥»¥ó¥¿¡¼¡¦ÃæÎÓÍÎ / 30ºÐÂå½÷À­ / »ÒµÜ
  • 1079¡¥Placental mesenchymal dysplasia ¿®½£Âç³Ø¡¦±óÆ£¿¿µª¡¡¤Û¤« / 20ºÐÂå½÷À­ / ÂÛÈ×
  • 1080¡¥Serous borderline tumor of the peritoneum £Ê£ÁĹÌî¸üÀ¸Ï¢º´µ×Áí¹çɱ¡¡¦±öß·¡¡¤Û¤« / 50ºÐÂå½÷À­ / Ê¢ÊÉ
  • 1081. Biphasic synovial sarcoma Ê¡°æÂç³Ø¡¦Âç±ÛÃéÏ¡¡¤Û¤« / 30ºÐÂåÃËÀ­ / À庬Éô
  • 1082¡¥Spindle cell carcinoma ŵ·¿Îã¡¡¶âÂô°å²ÊÂç³Ø¡¦ÌÚ²¼±ÑΤ»Ò¡¡¤Û¤« / 50ºÐÂåÃËÀ­ / ¹¢Æ¬
  • 1083¡¥Lymphadenoma, non-sebaceous ¶âÂô°åÎÅ¥»¥ó¥¿¡¼¡¦³ÞÅçΤÈþ¡¡¤Û¤« / 70ºÐÂå½÷À­ / ¼ª²¼Á£
  • 1084¡¥Adenocarcinoma in Barrett¡Çs esophagus ¶âÂôÂç³Ø¡¦Âç°æ¾Ï»Ë¡¡¤Û¤« / 70ºÐÂåÃËÀ­ / ¿©Æ»
  • 1085. Soft tissue perineurioma with atypical feature °¦Ã詤¬¤ó¥»¥ó¥¿¡¼°¦ÃÎɱ¡¡¦¹â·¬¹¯À®¡¡¤Û¤« / 20ºÐÂåÃËÀ­ / Á°ÏÓ
  • 1086¡¥Myopericytoma ̾¸Å²°°åÎÅ¥»¥ó¥¿¡¼¡¦»Ô¸¶¼þ¡¡¤Û¤« / 50ºÐÂå½÷À­ / ¸å½Ä³Ö
  • 1087¡¥Erdheim-Chester disease ¸üÀ¸Ï¢¹â²¬É±¡¡¦ÁýÅÄ¡¡/ ÃæÇ¯ÃËÀ­ / Ê¢Éô¥ê¥ó¥ÑÀá
  • 1088¡¥Endolymphatic sac tumor ̾¸Å²°°åÎÅ¥»¥ó¥¿¡¼¡¦Ä¹Ã«ÀîÀµµ¬¡¡¤Û¤« / 60ºÐÂå½÷À­ / ¾®Ç¾¶¶³ÑÉô
  • 1089¡¥Squamous cell carcinoma, spindle cell type »°½ÅÂç³Ø¡¦À¾Â¼·¼²ð¡¡¤Û¤« / 80ºÐÂå½÷À­ / ËËÉôÈéÉæ

¡¡

Âè61²ó¸ò¸«²ñ¡¡2008ǯ7·î19,20Æü¡¡¶âÂô»Ô

ÀÐÀî¸©Î©Ãæ±ûɱ¡¡¡¼Öë¡¡¹¨ÀèÀ¸

¾ÉÎ㸡Ƥ No.1043-No.1063

  • 1042. MALT lymphoma (20ºÐÂå½÷À­/ ¶»º¿ÆýÆÍ¶ÚÆâ¼ðáî)Æñ²ò¾ÉÎã ¡¡Floar¤«¤éSpeaker¤Î¿ÇÃǤËÂФ¹¤ëÈ¿ÏÀ¤¬Â¿¤¤¡£
  • 1043. Atypical lymphoid proliferation with PTCG-like folicles (30ºÐ½÷À­/ ±¦Éª´ØÀá/ ¿À·Ð¾ä¼ð¤Îµ¿¤¤) Floral type¤È¤Ï¡©¡©
  • 1044. Angiomatoid fibrous histiocytoma ŵ·¿Îã (14ºÐÃËÀ­/ º¸ÉªÈé²¼ÆðÉô¼ðáî/Epdermoid tumor? )
  • 1045. Clear cell myoepithelial carcinoma of the breast(46ºÐ½÷À­/ ÆýÁ£/ ÆýÁ£¼ðáç)
  • 1046. Malignant peripheral nerve sheath tumor (73ºÐ½÷À­/ ¸ý¹Ð/ ¹Å¸ý³¸¼ðáç)
  • 1047. Odontoma, early stage(developing odontoma) (9ºÐ/±¦²¼³Ü/ ²¼³Ü¼ðáç)
  • 1048. Low-grade cribriform cystadenocarcinoma (Low-grade salivary duct carcinoma) (60ºÐÂåÃËÀ­/ ÂñÕÁ£/ ±¦¼ª²¼Á£¼ðáç)
  • 1049. Chordoid glioma ŵ·¿Îã(40ºÐÂå½÷À­/ Ǿ/ °È¾åÉô¡ÁÂ軰Ǿ¼¼¼ðáç)
  • 1050. Gastric adenocarcinoma with mucous neck cell/ chief cell differentiation(50ºÐÂå½÷À­/ °ß/ °ß´â)
  • 1051. Adenomatoid tumor with well-differentiated papillary mesothelioma(-like change?)(44ºÐÃËÀ­/ Ê¢Ëì/ ¾®ÌÖ¼ðáî)
  • 1052. Lymphangioleiomyomatosis(LAM) (60ºÐÂåÁ°È¾½÷À­/ ¥ê¥ó¥ÑÀá/ »ÒµÜðô´â˵ÂçÆ°Ì®¥ê¥ó¥ÑÀឰܵ¿¤¤)
  • 1053. Sarcomatoid carcinoma (70ºÐÂåÃËÀ­/ ÇÙ/ ÇÙ¼ðáî)
  • 1054. Sjoegren' Sx¤Ëȼ¤¦´Ö¼ÁÀ­Çٱꡩ²áÉÒÀ­ÇÙ¡±ê¡©(70ºÐÂåÃËÀ­/ ÇÙ/ ´Ö¼ÁÀ­ÇÙ±ê) ·ëÏÀ¤¬¤Ê¤«¤Ê¤«¤Ç¤Ê¤¤¾ÉÎã
  • 1055. Poorly differentiated synovial sarcoma (60ºÐÂå½÷À­/ / ±¦ðôÉô¼ðáî) ðôÉôÆðÉôÁÈ¿¥¤ÎȯÀ¸
  • 1056. Cardiac fibroma (40ºÐÂå½÷À­/ ¿´Â¡/) [ǯÎ𤬹⤤¤¬Åµ·¿Îã]
  • 1057. Biliary cystadenoma, serous type(=Serous cystadenoma) (45ºÐ½÷À­/ ´Î/ ´Î´â¡©)
  • 1058. Enteric duplication cyst (Forgut cyst) (30ºÐÂå½÷À­/ ç¹/ IPMN?)
  • 1059. Nephrogenic adenoma(=Nephrogenic metaplasia) (60ºÐÂåÃËÀ­/ ç¯æù/ ç¯æù´âºÆÈ¯)
  • 1060. Metastatic carcinoma, Vaginal cancer late recurrence (41ºÐ½÷À­/ ç´/ »ÒµÜðô´âÈÕ´üºÆÈ¯¡©) Radiation-induced sarcoma¤Î¿ÇÃǤ¬¤ª¤ª¤«¤Ã¤¿¡£
  • 1061. Adenosarcoma (with sarcomatous overgrowth) (53ºÐ½÷À­/ »ÒµÜ/ ÊÑÀ­»ÒµÜ¶Ú¼ð)
  • 1062. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in an adult ŵ·¿Îã¡¡(46ºÐÃËÀ­/±¦¿Õ´â)
  • 1063. Takayasu arteritis (40ºÐÂå¸åȾÃËÀ­/ ÂçÆ°Ì®ÊÛ)

Âè60²ó¸ò¸«²ñ¡¡2007ǯ12·î15Æü¡¡Ì¾¸Å²°»Ô

̾¸Å²°»ÔΩÂç³Ø°å³ØÉô¡¡°ð³À ¹¨ÀèÀ¸

¾ÉÎ㸡Ƥ No.1016-No.1042

  • 1015. Progressive multifocal leukoencepharopathy ( 60ºÐÂå½÷À­ / Ǿ / ÂçǾÇò¼ÁÉÂÊÑ)
  • 1016. Primary malignant myoepithelioma(myoepithelial carcinoma) of the pituitary gland ? ¿ÇÃǺ¤Æñ¾ÉÎã[²¼¿âÂÎȯÀ¸¤ÎÂñÕÁ£·¿¼ðáç¡©¤½¤¦¤À¤È¤¹¤ë¤ÈÀ¤³¦Âè°ìÎã¤á-Speaker]
  • 1017. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfmann disease)ŵ·¿Îã ( 4ºÐ½÷»ù/¥ê¥ó¥ÑÀá /·ÛÉô¥ê¥ó¥ÑÀá¼ðÂç)
  • 1018. T-lymphoblastic lymphoma (20ºÐÃËÀ­ / Ù¨Åí/ ±¦Ù¨Åí¼ðáç)
  • 1019. Follicular lymphoma of the thyroid gland, papillary carcinoma and Hashimoto's thyroiditis (50ºÐÂå½÷À­ / ¹Ã¾õÁ£ / ±¦¹Ã¾õÁ£¼ðáî)
  • 1020. Micronodular thymoma with lymphoid stroma (59ºÐ½÷À­ / Á°½Ä³Ö / ¶»Á£¼ðáî)
  • 1021. Metaplastic thymoma Masaoka stage I (60ºÐÂå½÷À­ / ½Ä³Ö / ¶»Á£¼ðáî)
  • 1022. Pulmonary epithelioid hemangioendothelioma (59ºÐÃËÀ­ / ÇÙ / ÇÙ¼ðáî)
  • 1023. Leiomyosarcoma, low-grade malignancy (speaker's Dx)(ºÐÃËÀ­/ ¿´Â¡/ º¸¿´Ë¼Êɼðáî)--Intimal sarcoma, low-grade myofibroblastic sarcoma¤Þ¤¿¤Ïmyxoma variant¤Î°Õ¸«¤¢¤ê¡¡ÌäÂêÎã
  • 1024. Displaced epithelium following core needle biopsy ÆýÁ£¤ÎÉѲó¿ËÀ¸¸¡¹çÊ»¾É¤«¡©
  • 1025. Epithelial inclusion cyst of the rt breast (51ºÐ½÷À­/ ÆýÁ£ /±¦ÆýÁ£¼ðáç)
  • 1026. Adenomyoepithelioma with collagenous sphelosis (30ºÐÂå½÷À­/ ÆýÁ£/ ÆýÁ£¼ðáî)
  • 1027. Malignant myoepithelioma(speaker's Dx) (70ºÐÂå½÷À­/ ÆýÁ£ /±¦Æý˼¼ðáç)
  • 1028. Mammary tissue overgrowth with Cowden syndrome (20ºÐÂå½÷À­/ ÆýÁ£ /±¦ÆýÁ£¼ðáî)
  • 1029. Gastric plasmacytoma kappa type (¡¡ºÐÂåÀ­/ °ß /¡¡°ßÂÎÉô¼ðáî)
  • 1030. Invasive pancreatic cancer with focal sarcomatoid change derived from mucinous cystic tumor(MCT) (32ºÐ½÷À­/ ç¹ /ç¹Ç¹Ë¦À­¼ðáî)
  • 1031. Malignant epithelioid angiomyolipoma associated with tuberous sclerosis(36ºÐÃËÀ­/ ¿Õ¡/ º¸¿Õ¼ðáî)
  • 1032. Syphilitic lymphadenitis; Secondary syphylis. (20ºÐÂå¸åȾÃËÀ­/ ¥ê¥ó¥ÑÀá/ ±¦Áͷ¥إë¥Ë¥¢ä½ÆÜ, ÁÍ·ÂÉô¼ðáî)
  • 1033. Inflammatory pseudotumor (pseudosarcomatous myofibroblastic proliferation; proliferative funiculitis) (79ºÐÃËÀ­/ Àºº÷/¡¡±¦Àºº÷¼ðáç)
  • 1034. Placental site trophoblastic tumor in a late recurrence of mixed germ cell tumor of the testis(60ºÐÂåÃËÀ­/ ÀºÁã/¡¡ÀºÁã¼ðá瞰ܵ¿¤¤)
  • 1035. IgG4 related prostatitis accompanied by autoimmune pancreatitis(66ºÐÃËÀ­/ Á°Î©Á£´âµ¿¤¤)
  • 1036. Necrotizing fascitis and sepsis. Vibrio vulnificas infection. (50ºÐÂåÃËÀ­)
  • 1037. Monophasic fibrous synovial sarcoma (19ºÐ½÷À­/ ÆðÉôÁÈ¿¥/ ±¦ÂçÂÜÆâ¦ÉôÈé²¼¼ðáî)
  • 1038. Uterine cervical cancer, neuroendocrine tumor (atypical carcinoid) and adenocarcinoma with microinvasion(39ºÐ½÷À­/ »ÒµÜ/ »ÒµÜðô´â,¿ȯÀ­´Îž°Ü)
  • 1039. Gliomatosis peritonei(24ºÐ½÷À­/ ÍñÁã/ º¸ÍñÁã¼ðáç)
  • 1040. Endometrial stromal sarcoma with neuroendocrine differentiation(61ºÐ½÷À­/ »ÒµÜ/ »ÒµÜÆù¼ðµ¿¤¤)
  • 1041. Sertoliform endometrioid carcinoma of the endometrium(SEC)(40ºÐÂå½÷À­ / »ÒµÜ / »ÒµÜ¼ðáç)

Âè59²ó¸ò¸«²ñ¡¡2007ǯ7·î21,22Æü¡¡É;¾

À»ÎìÉ;¾É±¡ÉÂÍý¡¡¾®ÎÓ´²ÀèÀ¸

¾ÉÎ㸡Ƥ No.993-No.1015

  • 992¡¥Post-transplant lymphoproliferative disorder (DLBCL) ŵ·¿Îã(50ºÐÂåÃËÀ­ / Ǿ/°­À­¥ê¥ó¥Ñ¼ð)
  • 993¡¥Malignant external otitis( 70ºÐÂå½÷À­ / ³°¼ª / ³°¼ª±ê)
  • 994¡¥Primary sinonasal malignant melanoma, myxoid and small cell variant (80ºÐÂå½÷À­ / É¡¹Ð / º¸É¡¹Ð¼ðáç) Speaker's Dx ¤Ë¤ÏÈÝÄêŪ¤Ê°Õ¸«¤¢¤ê
  • 995¡¥Poorly differentiated carcinoma (follicular carcinoma) (50ºÐÂåÃËÀ­ / ¹Ã¾õÁ£ / ¹Ã¾õÁ£¼ðáç)
  • 996¡¥Malignant adenomyoepithelioma (40ºÐÂå½÷À­ / ÆýÁ£ / ±¦ÆýÁ£¼ðáç)
  • 997¡¥Giant cell tumor vs Undifferentiated carcinoma with osteoclast-like giant cells (70ºÐÂå½÷À­ / °ß / GIST)
  • 998¡¥Malignant mesothelioma vs undifferentiated tumor with epithelial differentiation (50ºÐÂåÃËÀ­ / ²óIJ / °­À­¥ê¥ó¥Ñ¼ð)
  • 999¡¥Mantle cell lymphoma of the ileum (20ºÐÂåÃËÀ­ / ²óIJ / ²óIJ¼ðáç¤ÈIJ½ÅÀÑ)
  • 1000¡¥Carcinoid-tumorlet, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (60ºÐÂå½÷À­ / ÇÙ / ÇÙ´â)
  • 1001¡¥Myoepithelial carcinoma (80ºÐÂåÃËÀ­ / ÇÙ / ÇÙ´â)
  • 1002¡¥Intestinal-type adenocarcinoma, papillotubular carcinoma from thymic cyst (70ºÐÂå½÷À­ / ¶»Á£ / Á°½Ä³Ö¼ðáç)
  • 1003¡¥Extranodal NK/T cell lymphoma with invasion of the heart (40ºÐÂåÃËÀ­ / ¶»ÊÉ / ¶»Êɼðáç)
  • 1004¡¥Dermatofibroma, cellular type (60ºÐÂåÃËÀ­ / ÈéÉæ / δµ¯À­ÈéÉæÀþ°ÝÆù¼ð)
  • 1005¡¥Rheumatoid vasculitis, compatible with malignant rheumatoid arthritis (60ºÐÂåÃËÀ­ / º¸Â­ / ­²õáÔ)
  • 1006¡¥Cellular angiofibroma (50ºÐÂåÃËÀ­ / Àºº÷ / Àºº÷¼ðáç)
  • 1007¡¥Malignant melanoma, amelanotic (50ºÐÂå½÷À­ / çµ / çµ´â)
  • 1008¡¥Superficial cervicovaginal myofibroblastoma (50ºÐÂå½÷À­ / çµ / 絥ݥ꡼¥×)
  • 1009¡¥Mixed epithelial and stromal tumor (70ºÐÂå½÷À­ / ¿Õ¡ / ±¦¿Õ¼ðáç)
  • 1010¡¥Metanephric adenoma (30ºÐÂå½÷À­ / ¿Õ¡ / ±¦¿Õ¼ðáç)
  • 1011¡¥Papillary renal cell carcinoma, oncocytic variant (30ºÐÂå½÷À­ / ¿Õ¡ / ¿Õ¼ðáç)
  • 1012¡¥Clear cell renal cell carcinoma with angiomyolipoma (70ºÐÂå½÷À­ / ¿Õ¡ / º¸¿Õ´â)
  • 1013¡¥IgG4-related disease, inflammatory pseudotumor (50ºÐÂåÃËÀ­ / ¸åÊ¢Ëì / °­À­¥ê¥ó¥Ñ¼ð)
  • 1014¡¥IgG4-related periaortitis / periarteritis(60ºÐÂå½÷À­ / ·ì´É / Ê¢ÉôÂçÆ°Ì®áî¤È´§Æ°Ì®áî)
     

Âè58²óÃæÉô»ÙÉô¸ò¸«²ñ 2006ǯ12·î2ÌÜ(ÅÚ)¡¢Ì¾¸Å²°ÂèÆóÀÖ½½»úɱ¡

̾¸Å²°ÂèÆóÀÖ½½»úɱ¡ÉÂÍýÉôÅÔÃÛË­ÆÁÀèÀ¸

¾ÉÎ㸡Ƥ No.967-No.992

  • 967. Sebaceous carcinoma(20ºÐÂåÃËÀ­, ÂñÕÁ£/ÂñÕÁ£¼ðáç)
  • 968. Small cell carcinoma, neuroendocrine type (10ºÐÂå½÷À­, Ƭ·ÛÉô/ÉûÉ¡¹Ð¼ðáç)
  • 969. Ameloblastoma, unicystic type (20ºÐÂåÃËÀ­,Ƭ·ÛÉô/¾å³Üǹ˦)
  • 970, AVM-associated oligodendroglial hyperplasia (50ºÐÂå½÷À­, Ǿ/ưÀÅÌ®´ñ·Á)
  • 971. cribriform-morula variant papillary carcinoma (10ºÐÂå½÷À­, ¹Ã¾õÁ£/¹Ã¾õÁ£¼ð)
  • 972. Adenomatous nodule with bizarre nuclei (50ºÐÂåÃËÀ­,¹Ã¾õÁ£/¹Ã¾õÁ£¼ðáç)
  • 973. Carcinoma showing thymus-like differentiation (60ºÐÂåÃËÀ­, ¹Ã¾õÁ£/·ÛÉô¼ðáç)
  • 974. Adenoid cystic carcinoma(70ºÐÂå½÷À­, ÆýÁ£/Æý´â)
  • 975. Solitary reticulohistiocytoma (30ºÐÂå½÷À­, ÈéÉæ/ÈéÉæÀþ°Ý¾É)
  • 976. Undifferentiated carcinoma (60ºÐÂåÃËÀ­, ½Ä³Ö/½Ä³Ö¼ðáç)
  • 977. Sarcomatoid carcinoma (40ºÐÂåÃËÀ­, ½Ä³Ö/Á°½Ä³Ö¼ðáç)
  • 978. Angiosarcoma (30ºÐÂå½÷À­, ¿´Â¡/±¦¿´Ë¼¼ðáç)
  • 979. lnterdigitating dendritic cell tumor (60ºÐÂå½÷À­, ÇÙ/ÇÙÁ£´â)
  • 980. Mucinous adenocarcinoma (44ºÐÂå½÷À­, ÇÙ/±¦ÇÙ¼ðáç)
  • 981. Early gastric cancer with EBV-associated lymph node metastases (70ºÐÂåÃËÀ­,°ß/°ß´â)
  • 982. Early cirrhosis with fatty change, cryptogenic (70ºÐÂå½÷À­, ´Î¡/´ÎºÙ˦´â)
  • 983. Multicystic peritoneal mesothelioma (50ºÐÂåÃËÀ­, Ê¢Ëì/ÃæÈé¼ð)
  • 984. Enterocolic lymphocytic phlebitis (30ºÐÂå½÷À­, Ãî¿â/µÞÀ­Ãî¿â±ê)
  • 985. Idiopathic mesenteric phlebosclerosis (50ºÐÂå½÷À­, ÂçIJ/IJÊĺÉ)
  • 986. Clear cell sarcoma of the kidney (½÷»ù, ¿Õ¡/Willmus tumor)
  • 987. Epithelioid angiomyolipoma(70ºÐÂåÃËÀ­, ¿Õ¡/¿Õ¼ðáç)
  • 988. Disseminated Fusarium falciforme infection (¹âÎð½÷À­, ¿Õ¡/¿¿¶Ý¾É)
  • 989. Clear cell adenofibroma, borderline malignancy (60ºÐÂå½÷À­, ÍñÁã/ÍñÁã¼ðáç)
  • 990. Nodal marginal zone lymphoma, floral variant (50ºÐÂåÃËÀ­, ¥ê¥ó¥ÑÀá/°­À­¥ê¥ó¥Ñ¼ð)
  • 991.Low-grade fibromyxoid sarcoma(50ºÐÂåÃËÀ­, ÆðÉô/ÆðÉô¼ðáç)

Âè57²óÃæÉô»ÙÉô¸ò¸«²ñ 2006ǯ7·î1Æü, 2Æü¡¡JA»°½Å¸üÀ¸Ï¢Îë¼¯Ãæ±ûÁí¹çɱ¡

JA»°½Å¸üÀ¸Ï¢Îë¼¯Ãæ±ûÁí¹çɱ¡Â¼ÅÄůÌéÀèÀ¸

¾ÉÎ㸡Ƥ No.943-No.966

  • 943. Sebacecus adenoma of the salivary gland (60ºÐÂåÃËÀ­/Ƭ³¸Äì/Ƭ³¸Äì¼ðáç)
  • 944. Medulloblastoma with extensive nodularity and advanced neuronal differentiation(11¥ö·îÃË»ù/¾®Ç¾/¾®Ç¾¼ðáç)
  • 945. Ameloblastic carcinoma (40ºÐÂå½÷À­/³Ü¹ü/¥¨¥Ê¥á¥ë¾åÈé¼ð)
  • 946. Sebaceaus adenoma (¹âÎð¼Ô/¼ª²¼Á£/º¸¼ª²¼Á£¼ðµ¿)
  • 947. Metastatic thyroidal Papillary carcinoma (70ºÐÂåÃËÀ­/ÇÙ/ÇÙ´â)
  • 948. Histiocytic sarcoma (80ºÐÂå½÷À­/¥ê¥ó¥ÑÀá/½Ä³Ö¼ðáç¡Ë
  • 949. Metastatic gallbladder cancer (70ºÐÂå½÷À­/²£³ÖËì/¶»Ê¢¿åÃùα)
  • 950. Secretory carcinoma (40ºÐÂå½÷À­/ÆýÁ£/ÆýÁ£¼ðáç)
  • 951. Apocrine DCIS involving sclerosing papilloma wirth possible microinvasion (40ºÐÂå½÷À­/ÆýÁ£/º¸Æý˼¼ðáî)
  • 952. Lipid-rich carcinoma (70ºÐÂå½÷À­/ÆýÁ£/Æý´â)
  • 953. Sarcomatoid carcinoma, round cell variant arising from intrahepatic cholangiocarcinoma(80ºÐÂåÃËÀ­/´Î¡/´ÎÆâÃÀ´É´â)
  • 954. Cholangiolocellular carcinoma (60ºÐÂå½÷À­/´Î¡/´Î¼ð³Ç)
  • 955. Mesenchymal hamartoma (50ºÐÂåÃËÀ­/´Î¡/´Î¼ðáç)
  • 956. Solid pseudopapillary tumor(50ºÐÂåÃËÀ­/ç¹Â¡/ç¹¼ðáç)
  • 957. Sarcoidosis(50ºÐÂå½÷À­/ç£Â¡/磸¶È¯°­À­¥ê¥ó¥Ñ¼ð)
  • 958. Cutaneous mastocytosis (2ºÐÃË»ù/ÈéÉæ/¿§ÁÇÈÃ)
  • 959. Chromophobe renal cell carcinoma with sarcomatous components (40ºÐÂå½÷À­/¿Õ¡/±¦¿Õ´â)
  • 960. Retroperitoneal fibrosis (30ºÐÂå½÷À­/¸åÊ¢Ëì/°­À­¥ê¥ó¥Ñ¼ð)
  • 961. Ossifying fibromyxoid tumor, malignant variant (60ºÐÂåÃËÀ­/ÆðÉô±¦ÉªÈé²¼¼ðÉÎ)
  • 962. Undifferentiated pleomorphic and spindle cell tumor, Unclassfied (80ºÐÂå½÷À­/¹ü/IJ¹ü¹ü¼ðáç)
  • 963. Alveolar Soft part sarcoma (50ºÐÂå½÷À­/»ÒµÜ/»ÒµÜÆù¼ð)
  • 964. Follicular carcinoma arising from giant struma ovarii (40ºÐÂå½÷À­/ÍñÁã/¹üÈׯâ¼ðáç)
  • 965. Serous papillary carcinoma of the peritoneum (60ºÐÂå½÷À­/Ê¢Ëì/¿Ê¹ÔľIJ´â¡Ë
  • 966. Endometrioid adenocarcinoma arising from endometriosis (60ºÐÂå½÷À­/ç´/ç´´â)

Âè56²ó¸ò¸«²ñ 2005ǯ¡¡12·î3Æü¥È¥è¥¿µ­Ç°É±¡

¥È¥è¥¿µ­Ç°É±¡Î×¾²¸¡ºº²Ê¡¡ÅÄÂåϹ°ÀèÀ¸

¾ÉÎ㸡Ƥ-20Îã No.923-No.942

  • 923¡¥Malignant eccrine spiradenoma (30ºÐÂå, ÃËÀ­ ÈéÉæ/Í­ÛùºÙ˦´â)¡¡
  • 924¡¥Desmoplastic fibroma (10ºÐÂåÃËÀ­, ¹ü/³Ü¹ü¼ðáç)
  • 925¡¥Polymorphous low grade adenocarcinoma¡¡(70ºÐÂåÃËÀ­, ÂñÕÁ£/¿·ÁÁ£¼ð)
  • 926¡¥High grade dysplastic nodule (40ºÐÂå½÷À­,¡¡´Î¡/´Î´â)
  • 927¡¥Well differentiated endocrine tumor with vacuolated lipid-rich cytoplasm(50ºÐÂå¡¡½÷À­¡¡ç¹Â¡/ç¹¼ðáç )
  • 928¡¥Inflammatory pseudotumor (60ºÐÂå¡¡ÃËÀ­¡¡ç£Â¡/磼ðáç)
  • 929¡¥Colonic necrosis due to calcium polystyrene sulfonate in a uremic patient¡¡(Ãæ¹âǯ¡¡ÃËÀ­¡¡ÂçIJ/IJÀü¹¦ )
  • 930¡¥ Poorly diff. adenocarcinoma with choriocarcinomatous differentiation (70ºÐÂå¡¡ÃËÀ­¡¡ÂçIJ/ÂçIJ¼ðáç)
  • 931¡¥Myelolipoma (70ºÐÂå¡¡ÃËÀ­¡¡ÇÙ/ÇÙ¼ðáî)
  • 932¡¥Malignant mesothelioma(60ºÐÂå½÷À­, ¶»Ëì/°­À­ÃæÈé¼ð)
  • 933¡¥Lymphangiomatosis (40ºÐÂå¡¡ÃËÀ­¡¡¹ü/¹ü¼ðáç)
  • 934¡¥Low grade fibromyxoid sarcoma (70ºÐÂå¡¡½÷À­¡¡ÆðÉô/±¦ÂçÂÜÉôÆðÉô¼ðáç)
  • 935¡¥Castleman disease¡¡(50ºÐÂå½÷À­,¡¡¥ê¥ó¥ÑÀá/°­À­¥ê¥ó¥Ñ¼ð)
  • 936¡¥Bilateral myelolipoma (50ºÐÂåÃËÀ­,¡¡Éû¿Õ/°Àγ·ë³Ë)
  • 937¡¥Sertoli cell tumor, NOS or unclassified (30ºÐÂåÃËÀ­¡¡ÀºÁã/ÀºÁãÇ¿áç)
  • 938¡¥Gonadoblastoma, pure type¡¡(10ºÐÂå½÷À­,¡¡À­Á£/Turner¾É¸õ·²)
  • 939¡¥Malignant mixed epithelial tumor, including undifferentiated carcinoma with sarcomatoid features (50ºÐÂå½÷À­,¡¡ÍñÁã/ÍñÁã¼ðáç)
  • 940¡¥Malignant granular cell tumor¡¡(40ºÐÂå½÷À­,¡¡çµÊÉ/çµÊɼðáç)
  • 941¡¥Carcinosarcoma with rhabdoid features (60ºÐÂå½÷À­,¡¡»ÒµÜ/»ÒµÜ¼ðáç)
  • 942¡¥Intarvascular leiomyomatosis¡¡(50ºÐÂå½÷À­, »ÒµÜ/»ÒµÜ¶Ú¼ð)

Âè55²ó¸ò¸«²ñ 2005ǯ¡¡7·î2Æü, 3Æü¡¡´ôÉì»Ô̱ɱ¡

´ôÉì»Ô̱ɱ¡¡¡»³ÅÄÅ´ÌéÀèÀ¸

¾ÉÎ㸡Ƥ 903-922

  • 903. Papillary glioneuronal tumor (20ºÐÂå½÷À­/ Ǿ/ ±¦Á°Æ¬ÍÕ¼ðáçºÆÈ¯)
  • 904. Anaplastic (protoplasmic) astrocytoma with extensive mucoid degeneration (40ºÐÂå½÷À­/ Ǿ/ Ǿ¼ðáç)
  • 905. Melanotic neuroectodermal tumor of the infancy (½÷»ù/ ÆðÉô¼ðáç/ ±¦Â¦Æ¬Éô¼ðáî)
  • 906. Nodular oncocytic hyperplasia (70ºÐÂåÃËÀ­/ ¼ª²¼Á£/ ±¦¼ª²¼Á£¼ðáç)
  • 907. Paraganglioma (20ºÐÂå½÷À­/ É¡¹Ð/ ËýÀ­ÉûÉ¡¹Ð±ê¡¦É¡¥Ý¥ê¡¼¥×)
  • 908. Hepatosplenic T cell lymphoma (70ºÐÂå½÷À­/ ´Î¡¡¦ç£Â¡/ ´Î磼ð)
  • 909. Pagetoid spreading of atypical intestinal epithelium (50ºÐÂåÃËÀ­/ ÈéÉæ/ ¿Í¹©æêÌçÉô¤Ó¤é¤ó)
  • 910. Pulmonary capillary hemangiomatosis (60ºÐÂå½÷À­/ ÇÙ/ ·ëIJ´âž°Ü)
  • 911. Glandular papilloma (60ºÐÂå½÷À­/ ÇÙ/ Çٴ⵿¤¤)
  • 912. Solitary fibrous tumor (70ºÐÂå½÷À­/ ÇÙ/ ÇÙ¼ðáç)
  • 913. Small cell carcinoma (40ºÐÂå½÷À­/ ÆýÁ£/ Æý´â)
  • 914. Dermatofibrosarcoma protuberans (30ºÐÂå½÷À­/ ÆýÁ£ÈéÉæ/ ÍÕ¾õ¼ðá絿¤¤)
  • 915. Myofibroblastoma (40ºÐÂå½÷À­/ ÆýÁ£/ Àþ°ÝÁ£¼ð)
  • 916. Intarahepatic cholangiocarcinoma, intraductal growth type (70ºÐÂåÃËÀ­/ ´Î¡/ ´ÎÆâÃÀ´É´â)
  • 917. Epithelioid hemangioendothelioma (50ºÐÂå½÷À­/ ´Î¡/ ¿ȯ´Î¼ðáç)
  • 918. Mucinous tubular and spindle cell carcinoma (60ºÐÂåÃËÀ­/ ¿Õ¡/ ¿Õ¼ðáç)
  • 919. Female adnexal tumor of probable wolffian origin (50ºÐÂå½÷À­/ Íñ´É/ ˵Íñ´É¼ðáç)
  • 920. Glomangiomatosis (60ºÐÂå½÷À­/ ÆðÉô¼ðáç/ ²¼ÂÜÆðÉô¼ðáç)
  • 921. Endometrial stromal sarcoma (40ºÐÂå½÷À­/ ÆðÉô¼ðáç/ ÁÍ·ÂÉô¼ðáç)
  • 922. Bizzare parosteal osteochondromatous proliferation (Nora's lesion) (40ºÐÂå½÷À­/ ¹ü/ ¾®»ØÃæÀá¹ü¹ü¼ðáç)

Âè54²óÃæÉô»ÙÉô¸ò¸«²ñ 2004ǯ12·î11Æü ̾¸Å²°»Ô¥ë¥Ö¥é»³²¦

¾ÉÎ㸡Ƥ case No.881- 902

  • 881. Invasive thymoma, rosette-forming thymoma, WHO typeA with B component (73ºÐ½÷À­/ ½Ä³Ö/ Á°½Ä³Ö¼ðáç)
  • 882. Bronchocentric granulomatosis (42ºÐÃËÀ­/ ÇÙ/ ÇÙ¼ðáç)
  • 883. Congenital pulmonary airway malformation, TypeIV (0ºÐ½÷»ù/ ÇÙ/ ÇÙ¼ðáç)
  • 884. Intravascular large B cell lymphoma (65ºÐÃËÀ­/ ¿Õ¡/ ¿Õµ¡Ç½¾ã³²)
  • 885. Plasmacytic myeloma with pseudo-Gaucher cells (64ºÐÃËÀ­/ ¹ü¿ñ/ ¿ȯÀ­¹ü¿ñ¼ð)
  • 886. Synovial chondromatosis (52ºÐÃËÀ­/ ¹ü¡¦´ØÀá/ Ƭ³¸ÄìÉô¼ðáç)
  • 887. Osteoblastoma (20ºÐÃËÀ­/ ¹ü/ ¾å³Ü¹ü¼ðáç)
  • 888. Chondroblastoma (61ºÐ½÷À­/ ¹ü¡¦´ØÀá/ ±¦³Ü´ØÀá¼ðáç)
  • 889. Pleomorphic xanthoastrocytoma with anaplastic feature (76ºÐ½÷À­/ ÀÔ¿ñ/ ¾å°áºÙ˦¼ð)
  • 890. Primary diffuse leptomeningeal gliomatosis (52ºÐÃËÀ­/ ÀÔ¿ñ/ ÀÔ¿ñ¼ðáçÇż¿ñËì±ê)
  • 891. Toxoplasmosis (45ºÐÃËÀ­/ Ǿ/ ž°ÜÀ­Ç¾¼ðáç)
  • 892. Carcinosarcoma ex pleomorphic adenoma (54ºÐÃËÀ­/ ÂñÕÁ£/ º¸³Ü²¼Á£¼ðáç)
  • 893. MALToma with Hashimoto's thyroiditis and lymphoepithelial cyst (73ºÐ½÷À­/ ¹Ã¾õÁ£/ ¹Ã¾õÁ£±¦ÍÕ¼ðáç)
  • 894. Diffuse hepatic hemangiomatosis (33ºÐ½÷À­/ ´Î¡/ ´Î¼ðáç)
  • 895. Hepatocellular carcinoma in non-alcoholic steatohepatitis (64ºÐÃËÀ­/ ´Î¡/ ´Î´â)
  • 896. Perivascular epithelioid cell tumor (PEComa) (48ºÐ½÷À­/ ´Î¡/ ´Î¼ðáç)
  • 897. Gastric adenoma, foveolar and pyloric gland type (89ºÐ½÷À­/ °ß/ °ß¼ðáç)
  • 898. Idiopathic myointimal hyperplasia of the mesenteric vein (69ºÐÃËÀ­/ IJ´ÖËì/ µõ·ìÀ­Ä²±ê)
  • 899. Neurothekoema (24ºÐ½÷À­/ ÈéÉæ¼ðáç)
  • 900. Myoepithelioma (6ºÐ½÷»ù/ ÈéÉæ/ Àг¥²½¾åÈé¼ð)
  • 901. Giant cell tumor, diffuse type (79ºÐÃËÀ­/ ÈéÉæ/ ±¦¼ê¾¸ÆðÉô¼ðáç)
  • 902. Myxofibrosarcoma (79ºÐÃËÀ­/ ÆðÉô¼ðáç/ ¿À·Ð¾ä¼ð)

Âè53²óÃæÉô»ÙÉô¸ò¸«²ñ 2004ǯ7·î3Æü, 4Æü¡¡Ä¹ÌîÀÖ½½»úɱ¡

¾ÉÎ㸡Ƥ No862-No880 (VS-stand by)

  • 862. Well differentiated adenocarcinoma, gastric type (84ºÐ½÷À­/ °ß/ »Ä°ß´âµ¿¤¤)
  • 863. Extramedullary plasmacytoma (26ºÐÃËÀ­/ °ß/ ¿ȯÀ­°ß¼ðáç)
  • 864. Enteropathy-type T cell lymphoma (73ºÐÃËÀ­/ ¾®Ä²/ °­À­¥ê¥ó¥Ñ¼ð)
  • 865. Pancreaticobilliary maljunction with adenomyomatous hyperplasia (56ºÐÃËÀ­/ VaterÆýƬÉô)
  • 866. Intrahepatic cholangiocarcinoma, mucinous carcinoma, multicystic variant, with oncocytic change (73ºÐ½÷À­/ ´Î¡/ ÃÀ´É´â)
  • 867. splenic hamartoma (52ºÐ½÷À­/ ç£Â¡/ 磼ðáç)
  • 868. Extrathoraxic solitary fibrous tumor (46ºÐÃËÀ­/ Ê¢¹ÐÆâ¼ðáç)
  • 869. Mucinous adenocarcinoma arising from ovarian teratoma (ÂçIJ¡¦ÍñÁã/ ¿Ê¹ÔÂçIJ´â¡ÜKrugenberg¼ðáç)
  • 870. Sertoli-stroma cell tumor group of intermediate differentiation (44ºÐ½÷À­/ ÍñÁã/ ÍñÁã¼ðáç)
  • 871. Large cell calcifying Sertoli cell tumor (11ºÐÃË»ù/ ÀºÁã/ º¸ÀºÁã¼ðáç)
  • 872. Papilloma (±é¼Ô¿ÇÃÇ¡§Mucoepidermoid carcinoma) (72ºÐ½÷À­/ ÇÙ/ ±¦Çٴ⵿¤¤)
  • 873. Microinvasive ductal carcinoma with fibromatosis-like metaplasia (64ºÐ½÷À­/ ÆýÁ£/ º¸ÆýÁ£¼ðáî)
  • 874. Composite pheochromocytoma (49ºÐÃËÀ­/ Éû¿Õ/ ³ì¿§ºÙ˦¼ð)
  • 875. Adenocortical oncocytoma (29ºÐÃËÀ­/ Éû¿Õ/ º¸Éû¿Õ¼ðáç)
  • 876. Congenital mesoblastic nephroma, cellular type (3¥ö·î½÷»ù/ ¿Õ¡/ ¿Õ²ê¼ðµ¿¤¤)
  • 877. Metastasis of thyroid papillary carcinoma (34ºÐÃËÀ­/ ÂçǾ/ Ǿ¼ðáç)
  • 878. Solitary fibrous tumor (51ºÐ½÷À­/ Ǿ/ ¿ñËì¼ð¡¦´ñ·Á¼ð¡¦Æð¹üÆù¼ð)
  • 879. Follicular dendritic cell sarcoma (65ºÐÃËÀ­/ ÆðÉô/ ±¦¾åÏÓÆðÉô¼ðáç)
  • 880. Hodgkin lymphoma, nodular sclerosis (29ºÐ½÷À­/ ÄǵÝ/ ²½Ç¿À­ÀÔÄDZꡦÀÔÄÇ¥«¥ê¥¨¥¹¡¦¼ðáç)

ÆÃÊֱ̹é

Ç´±ÕÁÈ¿¥²½³Ø¤ÎÉÂÍý¿ÇÃǤؤαþÍÑ
¿®½£Âç³Ø°å³ØÉôÊÝ·ò³Ø²ÊÀ¸ÂξðÊ󸡺º³Ø ÂçÅĹÀÎÉ

Âè52²óÃæÉô»ÙÉô¸ò¸«²ñ¡¡2003ǯ12·î6Æü¡¡Ì¾¸Å²°Âç³Ø°å³ØÉô°å³Ø¸¦µæÅï1¹æ´Û²ñµÄ¼¼

̾¸Å²°Âç³Ø°å³ØÉôɱ¡ÉÂÍýÉô¡¡°ËÆ£²íʸÀèÀ¸

¾ÉÎ㸡ƤNo843-861 (VS-stand by )

  • 843. Anaplastic oligodendroglioma (23ºÐ½÷À­/ Ǿ¼ðáç)
  • 844. Metastatic renal cell carcinoma in follicular adenoma (70ºÐ½÷À­/ ¹Ã¾õÁ£¼ðáç)
  • 845. Cutaneous sclerosing perineurinoma (11ºÐ½÷»ù/ ±¦¼¨»ØÈé²¼¼ðáî)
  • 846. Lipoma of the ileum (±é¼Ô¿ÇÃÇ¡§Angiomyolipoma of the ileum) (75ºÐ½÷À­/ ¾®Ä²¼ðáç)
  • 847. Micropapillary carcinoma of the colon (49ºÐ½÷À­/ ÂçIJ´â)
  • 848. Paraganglioma with massive extention (87ºÐ½÷À­/ Ê¢¹ÐÆâ¼ðáç)
  • 849. Non-alcholic steatohepatitis (80ºÐÃËÀ­/ ¼«¸ÊÌȱÖÀ­´Î±ê¤Îµ¿¤¤)
  • 850. Systemic light chain deposition disease (54ºÐÃËÀ­/ ¹ü¿ñ¼ð¤Ëȼ¤¦¥¢¥ß¥í¥¤¥É¡¼¥·¥¹µ¿¤¤)
  • 851. Undifferentiated carcinoma with osteoclastic giant cell (68ºÐÃËÀ­/ ç¹´â)
  • 852. Schwannoma of the pancreas with marked xanthomatous change (65ºÐÃËÀ­/ ç¹¼ðáç)
  • 853. Metastatic meningeal hemangiopericytoma (57ºÐÃËÀ­/ ±¦¿Õ¼ðáç)
  • 854. Cribriform hyperplasia of the prostate (66ºÐÃËÀ­/ Á°Î©Á£ÈîÂç¾É)
  • 855. Aggressive angiomyxoma (28ºÐ½÷À­/ ¹üÈׯâÇ¿áç)
  • 856. Small cell carcinoma of the ovary, hypercalcemic type (30ºÐ½÷À­/ ÍñÁã¼ðáç)
  • 857. Ovarian strumal carcinoid (42ºÐ½÷À­/ ±¦ÍñÁã¼ðáç)
  • 858. Endometrial stromal sarcoma, low grade (51ºÐ½÷À­/ »ÒµÜÂÎÉô¼ðáç)
  • 859. Churg-Strauss syndrome (60ºÐ½÷À­/ ÃÀǹ¼ðá絿¤¤)
  • 860. Localized epithelial mesothelioma (32ºÐ½÷À­/ °­À­¥ê¥ó¥Ñ¼ðµ¿¤¤)
  • 861. Metaplastic biphasic thymoma (57ºÐ½÷À­/ ¶»Á£¼ðáç)

Âè51²óÃæÉô»ÙÉô¸ò¸«²ñ¡¡2003ǯ7·î5Æü¡¡ÉÙ»³¹ñºÝ²ñµÄ¾ì

ÉÙ»³¸©Î©Ãæ±ûɱ¡Î×¾²¸¡ºº²Ê¡¡»°ÎؽßÉ×ÀèÀ¸

¾ÉÎ㸡ƤNo818-841

  • 818. Leptomeningeal melanomatosis arising in neurocutaneous melanosis (8ºÐÃË»ù/ ¼þ´üÀ­ACTH-ADHÊü½Ð¾É¸õ·²)
  • 819. Medullary carcinoma of the thyroid gland (34ºÐÃËÀ­/ ¹Ã¾õÁ£´â)
  • 820. Angiomyolipoma (±é¼Ô¿ÇÃÇ¡§Epithelioid angiosarcoma with fatty infiltration) (60ºÐÃËÀ­/ AV malformation·ìÀòÊĺÉ)
  • 821. Signet-ring cell adenocarcinoma (72ºÐ½÷À­/ º¸Çٴ⵿¤¤)
  • 822. Leiomyosarcoma (±é¼Ô¿ÇÃÇ¡§Large cell carcinoma with rhabdoid phenotype) (65ºÐ½÷À­/ rt. lung hamartoma )
  • 823. Solitary fibrous tumor (60ºÐÃËÀ­/ ¶»Á£¼ð)
  • 824. Cerminous adenocarcinoma, low grade malignancy (78ºÐÃËÀ­/ ±¦ËýÀ­Ã漪±ê)
  • 825. Epithelioid angiomyolipoma of the kidney (67ºÐ½÷À­/ ±¦¿Õ´âµ¿¤¤)
  • 826. Paraganglioma (pheochromocytoma) of the urinary bladder (61ºÐ½÷À­/ ç¯æù¼ðáç)
  • 827. Sertoli stromal cell tumor of intermediate differentiation (25ºÐ½÷À­/ µðÂçÍñÁãǹ¼ð)
  • 828. Angiosarcoma in ovarian mucinous cystic tumor of boderline malignancy (86ºÐ½÷À­/ ÍñÁã¼ðáç)
  • 829. Malignant solitary fibrous tumor (47ºÐÃËÀ­/ Ê¢¹ÐÆâµðÂç¼ðáç)
  • 830. Inflammatory myxohyaline tumor (Acral myxoinflammatory fibroblastic sarcoma) (19ºÐ½÷À­/ º¸Â­´ØÀáÆðÉô¼ðáç)
  • 842. Acral myxoinflammatory fibroblastic sarcoma (68ºÐ½÷À­/ º¸Â­Éô¥¬¥ó¥°¥ê¥ª¥ó)
  • 831. Palidading granuloma of the liver probably due to visceral larva migrans (61ºÐÃËÀ­/ ÇÙÌî±ê¾ÉÀ­ÉÂÊÑ, °ß´â, ´ÎSOL)
  • 832. Light chain and heavy chain disease (66ºÐÃËÀ­/ ËýÀ­¿ÕÉÔÁ´, PBC?)

ÆÃÊֱ̹é

¿·WHOʬÎà¤Ë´ð¤Å¤¯¶»Á£¼ð¤ÎÁÈ¿¥Áü¤È¤½¤Î´ÕÊÌ
̾¸Å²°Âç³Ø°å³ØÉôÂèÆóÉÂÍý¡¡Î©»³¾° ÀèÀ¸

  • 833. Undifferentiated epithelioid malignant neoplasm with rhabdoid features (16ºÐ½÷À­/ pyogenic granuloma )

Âè50²óÃæÉô»ÙÉô¸ò¸«²ñ¡¡2002ǯ12·î7Æü ¹ñΩ̾¸Å²°É±¡´ÉÍýÅïÆÃÊ̲ñµÄ¼¼

¹ñΩ̾¸Å²°É±¡¡¡»Ô¸¶¼þ

¾ÉÎ㸡Ƥ No.800-No.817

  • 800. Hyalinizing granuloma with marked lymphoid hyperplasia (36ºÐ½÷À­/MALT lymphoma)
  • 801. Osteoclast-like giant cell tumor of the lung (74ºÐÃËÀ­/ ÇÙ¼ðáç)
  • 802. Pleural fibrosis in asbestosis (48ºÐÃËÀ­/ ¶»Ëì¼ðá絿¤¤)
  • 803. Combined hepatocellular and cholangiocellular carcinoma, clear cell type (67ºÐÃËÀ­/ ´Î¼ðáç)
  • 804. Incomplete septal cirrhosis (78ºÐÃËÀ­/ ´Î¹ÅÊÑ)
  • 805. Splenic angiosarcoma (52ºÐ½÷À­/ 磼ðáç)
  • 806. Splenic angiosarcoma (91ºÐ½÷À­/ Ê¢¹ÐÆâ½Ð·ì)
  • 807. Papillary carcinoma, oxyphilic type (33ºÐÃËÀ­/ ¹Ã¾õÁ£¼ð)
  • 808. Follicular dendric cell tumor (16ºÐÃËÀ­/ ±¦²¼³Ü±±¸åÉô¼ðáç)
  • 809. Epithelioid sarcoma ? (22ºÐÃËÀ­/ ±¦¾å³Ü¼ðáç)
  • 810. Angiomyolipoma, epithelioid type, pleomorphic subtype (38ºÐ½÷À­/ ¿ÕºÙ˦´â)
  • 811. Sclerosing epithelioid fibrosarcoma (27ºÐ½÷À­/ º¸ç½Éô¼ðáç)
  • 812. Synovial sarcoma, monophasic type (51ºÐ½÷À­/ ±¦ÁÍ·ÂÉô¼ðáç)
  • 813. Malignant mesothelioma of the tunica vaginalis, mixed type (64ºÐÃËÀ­/ ±¦±¢Ç¹¿å¼ð)
  • 814. Glassy cell carcinoma (52ºÐ½÷À­/ »ÒµÜðô´â)
  • 815. Methotrexate-associated lymphoproliferative disorders (71ºÐÃËÀ­/ °­À­¥ê¥ó¥Ñ¼ð)
  • 816. Carcinoma with endocrine features (75ºÐ½÷À­/ ÆýÁ£)
  • 817. Low grade micropapillary ductal carcinoma in situ with mucinous differentiation (52ºÐ½÷À­/ Æý´â)

Âè49²óÃæÉô¸ò¸«²ñ¡¡2002ǯ7·î13Æü ¹ñΩ¶âÂôɱ¡¹ÖƲ

¹Ö±é

ÆÃ¼ì¤Êç¹¼ðáç¤ÎÉÂÍý- Ç´±ÕÀ­Ç¹Ë¦¼ðáç(´ÉÆâÆýƬ¼ðáç¤È¤ÎÂÐÈæ)¤Èsolid-pseudopapillary tumor(¼«Á³»Ë)¡¡Ê¡°æÀÖ½½»úɱ¡¡¡¾®À¾Æó»°ÃËÀèÀ¸

¾ÉÎ㸡ƤNo.775-799

  • 775. ATLL ŵ·¿Îã¡¡(75ºÐÃËÀ­/ ¥ê¥ó¥ÑÀá¡Ë
  • 776. dedifferentiation in adenoid cystic carcinoma of the salivary glands (¾å³Ü¹ü¼ðáî)
  • 777. small cell carcinoma with adenomatous and squamous foci (72ºÐ½÷À­/ S¾õ·ëIJ)
  • 778. epithelioid hemangioendothelioma (73ºÐÃËÀ­/ ´Î¼ðáî)
  • 779. myxoid malignant fibrous histiocytoma (58ºÐÃËÀ­/ âдݼðáî)
  • 780. pleomorphic angioleiomyoma of the testicular appendage (74ºÐÃËÀ­/ âдݼðáî)
  • 781. intravascular papillary endothelial hyperplasia (27ºÐ½÷À­/ ÇÙ¼ðáî)
  • 782. well differentiated fetal adenocarcinoma (50ºÐ½÷À­/ ÇÙ¼ðáî¡Ë
  • 783. solid pseudopapillary tumor (80ºÐ½÷À­/ ¸åÊ¢Ëì¼ðáî)
  • 784. solid pseudopapillary tumor (67ºÐ½÷À­/ ¸åÊ¢Ëì¼ðáî)
  • 785. malignant peripheral nerve sheath tumor (55ºÐÃËÀ­/ º¸ÀÔÃì¶ÚÆâ¼ðáî)
  • 786. pseudoangiomatous stromal hyperplasia of the breast ŵ·¿Îã(31ºÐ½÷À­/ ±¦ÆýÁ£¼ðáî)
  • 787. carcinoma with carcinoid features (51ºÐ½÷À­/ º¸ÆýÁ£)
  • 788. invasive ductal carcinoma with endocrine differentiation (43ºÐ½÷À­/ ±¦Æý˼¼ðáî)
  • 789. pilocytic astrocytoma (3ºÐÃË»ù/ °È¾åÉô»ë¿À·Ð¤ËÀÜÃ夹¤ë¼ðáî)
  • 790. macrocystic serous cystadenoma with ovarian-type stroma (49ºÐ½÷À­/ ç¹¼ðáî)
  • 791. lymphoplasmacytic sclerosing pancreatitis and cholangitis (68ºÐ½÷À­/ 繡¦ÁíÃÀ´É¡Ë
  • 792. adenosquamous carcinoma (56ºÐÃËÀ­/ ¶õIJ¼ðáî¡Ë
  • 793. malignant myoepithelioma (79ºÐÃËÀ­/ æêÌçÉô¼ðáî)
  • 794. mixed stromal and mucinous carcinoid tumor of the ovary with mucinous cystadenoma (60ºÐ½÷À­/ º¸ÍñÁã)
  • 795. intracranial desmoplastic small cell tumor (7ºÐ½÷»ù/ º¸ÎÞÁ£Éô¼ðáî)
  • 796. CASTLE (54ºÐÃËÀ­/ ¹Ã¾õÁ£)
  • 797. malignant peripheral nerve sheath tumor arising in neurofibroma (26ºÐ½÷À­/ Ê¢ÉôÈé²¼¼ðáî)
  • 798. angiomyolipoma ŵ·¿Îã (71ºÐ½÷À­/ ´Î¼ðáî)
  • 799. glassy cell carcinoma and scattered squamous cell carcinoma of the cervix (69ºÐ½÷À­/ »ÒµÜ·ÛÉô)

Âè48²óÃæÉô¸ò¸«²ñ¡¡2002ǯ11·î25Æü

¾ÉÎ㸡ƤNo.757-774

  • 757. germinoma with granulomatous reaction (22ºÐÃËÀ­/ ¾¾²ÌÂμðáî)
  • 758. adenoid cystic carcinoma (76ºÐ½÷À­/ ²¼¸ý¿°¼ðáî)
  • 759. Hashimoto's thyroiditis associated with Riedel's thyroiditis (38ºÐ½÷À­/ ¹Ã¾õÁ£)
  • 760. undifferentiated carcinoma intermingled with papillary carcinoma (67ºÐÃËÀ­/ ¹Ã¾õÁ£)
  • 761. marginal zone B cell lymphoma of the thymus (57ºÐÃËÀ­/ Á°½Ä³Ö)
  • 762. intimal sarcoma (DDx: inflammatory aneurysm/ thromboembolism) (56ºÐ½÷À­/ ¿´Â¡)
  • 763. malignant mesenchymoma of the lung (57ºÐÃËÀ­/ ¶»Ëì¼ðáî) liposarcoma with cartiragenous and osseous differentiation, pulomonary hamartoma¤Î°­À­Å¾²½¤È¤¤¤¦°Õ¸«
  • 764. metaplastic carcinoma of the breast (73ºÐ½÷À­/ º¸Æý˼)
  • 765. tubulovillous adenoma with serrated change (66ºÐ½÷À­/ ÂçIJ, UC¾ÉÎã)
  • 766. colitis cystica profunda (58ºÐÃËÀ­/ ľIJ¥Ý¥ê¡¼¥×)
  • 767. oxalate deposition (primary hyperoxaluria type­µ) (31ºÐÃËÀ­/ ´Î)
  • 768. idiopathic portal hypertension (Banti) (68ºÐ½÷À­/ ç£Â¡)
  • 769. inflammatory pseudotumor-like follicular dendritic cell tumor (71ºÐÃËÀ­/ ç£Â¡)
  • 770. serous adenocarcinoma of Müllelian duct(persistent Müllelian duct syndrome)
  • 771. low-grade dedifferentiated liposarcoma (49ºÐ½÷À­/ ¸åÊ¢Ëì¼ðáî)
  • 772. low-grade sarcoma (26ºÐÃËÀ­/ ¼ê¾¸Èé²¼¼ðáî)
  • 773. chorioangioma ŵ·¿Îã¡¡(26ºÐ½÷À­/ ÂÛÈ×)
  • 774. inflammatory myofibroblastic tumor of the lung (51ºÐÃËÀ­/ ÇÙ¼ðáî)

Âè47²óÃæÉô¸ò¸«²ñ¡¡2001ǯ11·î25Æü

¾ÉÎ㸡ƤNo.739-756

  • 739. solitary fibrous tumor of the CNS, subtentorium (57ºÐÃËÀ­/ ¾®Ç¾¼ðáî)
  • 740. small cell neuroendocrine carcinoma with skeletal muscle differentiation (37ºÐÃËÀ­/ ±¦¾å³Üƶ¼ðáî)--> Am J Surg Pathol 24(2):223-30, 2000
  • 741. multinodular oncocytic hyperplasia (63ºÐ½÷À­/ ¼ª²¼Á£)
  • 742. hyalinizing trabecular adenoma (69ºÐÃËÀ­/ ¹Ã¾õÁ£¼ðáî)
  • 743. non-cirrhotic portal hypertention (73ºÐ½÷À­/ ´ÎÉÂÊÑ Ë¶¸¡Îã¡Ë
  • 744. solitary fibrous tumor ? (79ºÐ½÷À­/¡¡Ä²´ÖËì¼ðáç)
  • 745. epithelioid mesothelioma (51ºÐÃËÀ­/ ¾®Ä²Ä²´ÖËì)
  • 746. juxuter glomerular cell tumor [rennin producing tumor] (57ºÐ½÷À­/ ¿Õ¼ðáî)
  • 747. mixed germ cell sex cord stromal cell tumor (speaker: juvenile type granular cell tumor) (1¥ö·îÃË»ù/ ÀºÁã)
  • 748. agressive angiomyxoma?? (difficult case) (22ºÐ½÷À­/ ³°±¢Éô¼ðáî)
  • 749. (20ºÐ½÷À­/ ¹àÉô¼ðáç)
  • 750. (19ºÐÃËÀ­/ ±¦ÇÙ¼ðáç)
  • 751. Hodgkin's lymphoma nodular sclerosis (22ºÐÃËÀ­/ Á°½Ä³Ö¼ðáî)
  • 752. tumor forming chronic pancreatitis (69ºÐ½÷À­/ ç¹Â¡¼ðáî)
  • 753. capillary hemangioma (64ºÐÃËÀ­/ ÂçÌÖ)
  • 754. juxtaglomerular cell tumor (reninoma) (22ºÐÃËÀ­/ ¿Õ¼ðáî)
  • 755. fibrosis (7ºÐÃË»ù/ ÊñÈé,Ǣƻ¶¹ºõ)
  • 756. sclerosing adenosis (72ºÐ½÷À­/ ±¦Æý˼¼ðáî)

Âè46²óÃæÉô¸ò¸«²ñ¡¡2000ǯ11·î25Æü

¾ÉÎ㸡Ƥ719-738

  • 719. aggressive papillary tumor of temporal bone (58ºÐÃËÀ­/ ±¦Â¦Æ¬¹ü¿íÂÎÉô)
  • 720. malignant melanoma of eye lid (70ºÐ½÷À­/ ±¦´ãâÛ)
  • 721. myoepithelioma of oral cavity, low-grade malignancy (21ºÐ½÷À­/ º¸ËËÉô¸ý¹ÐÇ´Ëì)
  • 722. invasive lobular carcinoma with apocrine feature (80ºÐ½÷À­/ º¸ÆýÁ£¼ðáî)
  • 723. invasive ductal carcinoma and lobular carcinoma in situ (53ºÐ½÷À­/ ÆýÁ£¼ðáî)
  • 724. myoepithelioma, spindle type (75ºÐ½÷À­/ ±¦ÆýÁ£¼ðáî)
  • 725. granulocytic sarcoma (50ºÐ½÷À­/ ±¦ÆýÁ£¼ðáî)
  • 726. paragonimiasis Westermani (58ºÐÃËÀ­/ Î×¾²¿ÇÃǤϹ¥»ÀµåÀ­ÇÙ±ê, ·ìÀ¶¿ÇÃÇ)
  • 727. Wegener's granulomatosis (61ºÐÃËÀ­/ ÇÙ¼ðáî)
  • 728. pulmonary hyalinizing granuloma (70ºÐÃËÀ­/ ±¦ÇÙ¼ðáî)
  • 729. MFH, giant cell and inflammatory type (59ºÐÃËÀ­/ ±¦ÇÙÌçÉô¼ðá˶¸¡Îã)
  • 730. paucity of intrahepatic duct (3ºÐ½÷»ù/ ´Î)
  • 731. Meckel-Gruker syndrome (23½µÂÛ»ù´ÎÁÈ¿¥¡¡Ë¶¸¡Îã)
  • 732. hepatic angiomyolipoma (41ºÐ½÷À­/ ´Î¼ðáç)
  • 733. granular cell tumor, malignant (48ºÐÃËÀ­/ ʢľ¶ÚÆâ¼ðáî)
  • 734. malignant fibrous histiocytoma (speaker: pleomorphic leiomyosarcoma) (48ºÐÃËÀ­/ ¸åÊ¢Ëì¼ðáî)
  • 735. leiomyosarcoma with epithelial feature (67ºÐÃËÀ­/ ¸åÊ¢Ëì¼ðáî)
  • 736. leiomyoma with myxoid change (58ºÐÃËÀ­/ ±¦ÀºÁã)
  • 737. malignant mesothelioma (serrous carcinoma) (47ºÐ½÷À­/ ¹üÈׯâ¼ðáî)
  • 738. Wegener's granulomatosis ¡Ê51ºÐÃËÀ­/ ±¢·Ô)

Âè45²óÃæÉô¸ò¸«²ñ¡¡2000ǯ7·î1Æü

¾ÉÎ㸡ƤNo.699-718

speakers diagnosis:

  • 699 (65ºÐ½÷À­/ ³Ü¹ü¼ðáî)
  • 700. (87ºÐ½÷À­/ ¼ª²¼Á£¼ðáî)
  • 701. (45ºÐÃËÀ­/ ¼ª²¼Á£¼ðáî)
  • 702. (52ºÐÃËÀ­/ ±¦·ÛÉô¼ðáî)
  • 703. (36ºÐÃËÀ­/ 磡¦¥ê¥ó¥ÑÀá, ˶¸¡¾ÉÎã)
  • 704. (68ºÐ½÷À­/ º¸Æý˼)
  • 705. Äê·¿Îã¡¡(14ºÐ½÷À­/ Ǿ¼ðáç)
  • 706. (21ºÐÃËÀ­/ ¿´Â¡¼ðáî)
  • 707. (43ºÐ½÷À­/ ÇÙ¼ðáç)
  • 708. solitary fibrous tumor (69ºÐ½÷À­/ ¶»¹ÐÆâ¼ðáî)
  • 709. plexiform schwannoma of the small intestine (57ºÐÃËÀ­/ ¾®Ä²¼ðáî)
  • 710. desmoplastic small round cell tumor (22ºÐÃËÀ­/ ¾®Ä²¼ðáî)
  • 711. billiary cystoadenocarcinoma (commentator; mucinous cyst adenocarcinoma) (72ºÐÃËÀ­/ ´Î¿ȯÀ­Ç¹Ë¦)
  • 712. hepatocellular carcinoma with hepatoblastic appearance (55ºÐÃËÀ­/ ´Î¼ðáî)
  • 713. mucinous (cyst)adenocarcinoma (83ºÐÃËÀ­/ ÃÀǹ)
  • 714. malignant GIST (digestive tube stromal cell tumor) (74ºÐ½÷À­/ ÂçÌÖ¼ðáî)
  • 715. lymphoepithelioma like carcinoma (27ºÐ½÷À­/ Éû¿Õ¼ðáî)
  • 716. peripheral PNET of the kidney (28ºÐÃËÀ­/ º¸¿Õ¼ðáî)
  • 717. neuroblastoma in mature cystic teratoma (22ºÐ½÷À­/ º¸ÍñÁã)
  • 718. mixed tumor of the vagina (41ºÐ½÷À­/ ç´¼ðáî) AJSP 5:413-422, 1981

Âè44²óÃæÉô¸ò¸«²ñ¡¡1999ǯ12·î4Æü

¾ÉÎ㸡ƤNo.675-698

speakers diagnosis:

  • 675. malignant granular cell tumor (61ºÐ½÷À­/ ¾å½Ä³Ö,ÇÙ,¶»Êɼðáî)
  • 676. myxofibrosarcoma (71ºÐÃËÀ­/ ÇØÉô¼ðáî)
  • 677. clear cell sarcoma, metastasis(19ºÐ½÷À­/ º¸Â¦Æ¬ÉôÈé²¼¼ðáî)
  • 678. chondrolipoma (79ºÐ½÷À­/ ±¦ÇØÉôÆðÉô¼ðáç)
  • 679. liposarcoma (round cell liposarcoma) (º¸ÂçÂÜÉô»éËüð)
  • 680. unknown, dendritic cell sarcoma or histiocytic cell sarcoma? (46ºÐÃËÀ­/ ·ÛÉô¼ðáî)
  • 681. ¾ÉÎãȯɽ±ä´ü
  • 682. precursor B-lymphoblastic lymphoma [ floar¤ÏEwing sarcoma] (10ºÐ½÷»ù/ ²¼³Ü¼ðáî)
  • 683. leiomyosarcoma (73ºÐÃËÀ­/ ±¦ÇÙ¼ðáî)
  • 684. leiomyosarcoma(intimal sarcoma) (57ºÐ½÷À­/ ÇÙÆ°Ì®Æâ¼ðáî)
  • 685. sclerosing hemangioma ( papillary angiosarcoma? ) (43ºÐ½÷À­/ ÇÙ¼ðáç)
  • 686. periarterits nodusa ( favor microscopic polyangitis ) (68ºÐ½÷À­/ ˶¸¡Îã)
  • 687. electric injury (26ºÐÃËÀ­/ º¸¥Ò¥Õ¥¯¶Ú, º¸¼ê¾¸ÉôÀµÃæ¿À·Ð)
  • 688. cardiac MICE (67ºÐÃËÀ­/ ÁÎ˹ÊÛ)
  • 689. large degenerative nodule with fatty change (73ºÐÃËÀ­/ ´Î¼ðáî)
  • 690. multiple hepatic hilar cysts (Nakanuma disease) (79ºÐÃËÀ­/ ´Î)
  • 691. giant pseudopolyp/polyposis related with Crohn disease (49ºÐÃËÀ­/ ²¼¹Ô·ëIJ)
  • 692. basal cell adenoma (atypical) [duct adenoma?] (52ºÐ½÷À­/ º¸¼ª²¼Á£)
  • 693. endometrial stromal sarcoma variant resembling ovarian sexcord tumor (49ºÐ½÷À­/ »ÒµÜÆâËì¼ðáç)
  • 694. mucinous cyst adenocarcinoma with malignant mural nodule (21ºÐ½÷À­/ ±¦ÍñÁã)
  • 695. micro papillary variant of TCC (64ºÐÃËÀ­/ ç¯æù¼ðáç)
  • 696. alveolar soft part sarcoma (76ºÐ½÷À­/ Ê¢Êɼðáî)
  • 697. papillary adenocarcinoma with Warthin like tumor ( 52ºÐ½÷À­/ ¹Ã¾õÁ£)
  • 698. gonad blastoma ŵ·¿Îã¡¡(23ºÐÃËÀ­/ âдݡ¦Î¾Â¦ÄäαâдݡË

Âè43²óÃæÉô¸ò¸«²ñ 1999ǯ7·î3Æü¡¡

¾ÉÎ㸡Ƥ No.652-674

speaker's diagnosis. ±é¼Ô¤Î¿ÇÃǤ¬¤ï¤«¤é¤Ê¤¤¾ÉÎã¤â¤¢¤ë¡£

  • 652 ±¦ðôÉô¼ðáç
  • 653 º¸æú¹ü¹ü¼ðáç
  • 654 polymorphous low grade adenocarcinoma ¹Å¸ý³¸
  • 655 mucoepidermoid carcinoma, sclerosing type ±¦¼ª²¼Á£
  • 656 combined adnexal tumor of the skin Èý´ÖÉôÈéÉæ¼ðáî
  • 657 Myelocytic sarcoma( Granulocytic sarcoma ) ¾®Ä²
  • 658 Myelocytic sarcoma ( Granulocytic sarcoma ) a leukaemic case ? ¾®Ä²
  • 659 Desmoplastic small round cell tumor Ê¢¹ÐÆâ¼ðáç ˶¸¡¾ÉÎã Ë­¶¶»Ô̱ɱ¡ Á°Â¿¾¾´î¤Û¤«
  • 660 undifferentiated embryonal sarcoma of the liver
  • 661 Primary pulomonary sarcoma with features of monomorphic synovial sarcoma
  • 662 º¸Ù¨Åí¼ðáç
  • 663 adenosarcoma , heterogenous, with giant cells
  • 664 Glial polyp of the cervix uteri
  • 665 ç´Êɼðáç
  • 666 low-grade fibromyxoid sarcoma (º¸ÂçÂÜÆðÉô¼ðáî/ 29ºÐ)
  • 667 low-grade fibromyxoid sarcoma ¡Êº¸ÁÍ·ÂÉôÈé²¼¼ðáî/ 68ºÐ)
  • 668 perineurinoma
  • 669 angiolymphoid hyperplasia with eosinophilia (epithelioid hemangioma)
  • 670 Gliosarcoma in low-grade astrocytoma
  • 671 Ǿ¼ðáç
  • 672 stromal sarcoma of the breast
  • 673 Myoepithelioma of the breast
  • 674 Melanocytoma of the lt. iris

Âè42²óÃæÉô¸ò¸«²ñ

Âè41²óÃæÉô¸ò¸«²ñ

ÃæÉô»ÙÉôÂè41²ó¸ò¸«²ñ¡Ê1998ǯ6·î¡¡±÷¡§´ôÉìÂç³Ø°å³ØÉô¡Ë

¾ÉÎ㸡Ƥ¡¡case No.605-623

  • 605. lymphepithelioma-like large cell carcinoma ( ÇÙ¸¶È¯/48ºÐ)¡¡¾®ÎÓ´ð¹°¤Û¤«
  • 607. solid papillary caicinoma¤Î°ìÎã¡ÊÆýÁ£/ 49ºÐ¡ËÁ°Åĵ¹±ä¤Û¤«
  • 608. benign proliferative lesion of the accessory mammary gland (æþãÝ/ 50ºÐ)¡¡ÀîÅçÆÆ¹°¤Û¤« ¡¡
  • 609. papillary cystadenocarcinoma of the tongue (Àå/ 51ºÐ)¡¡¸¶ÅÄÂç ¡¡¡¡
  • 610. tumor of the soft palate with follicular dendritic cell differentiation (Æð¸ý³¸/ 52ºÐ) ±ºÌî¡¡À¿¤Û¤«¡¡
  • 611. Salivary Duct Carcinoma¡¡(53ºÐ) µ×¸¶¡¡È¥¤Û¤«¡¡
  • 612. teratocarcinosarcoma (É¡ÉûÉ¡¹Ð/ 54ºÐ) Ì«¡¡¹¨¤Û¤«
  • 613. a metastatic case of retroperitoneal paraganglioma(¸åÊ¢Ëì/ 55ºÐ) Á°Â¿ ¾¾´î¤Û¤«
  • 614. Carcinoid of the kidney (¿Õ¡/ 56ºÐ) »ûȪ¿®ÂÀϺ¤Û¤«
  • 615. leiomyosarcoma of the vena cava inferior (²¼ÂçÀÅÌ®/ 57ºÐ) ÁýÅÄ¡¡¿®Æó¡¡
  • 616. ¿ÕÉôÈé²¼¤Ë¸ºß¤·¡¤epithelioid sarcoma¤È¤Î´ÕÊ̤¬º¤Æñ¤Ç¤¢¤Ä¤¿ÇÙ´âž°ÜÁã¤Î°ìÎã¡¡¡¡¡¡¡¡Â¼À¥¡¡µ®¹¬¤Û¤«
  • 617. clear cell sarcoma arising at inguinal region (óë·ÂÉô/ 59ºÐ)¡¡»³²¼ ¹°»Ò¤Û¤«
  • 618. omental spindle cell tumor with ectopic decidual tissue (ÂçÌÖ/ 60ºÐ)¡¡¹õÀ¥¡¡Ë¾¤Û¤«
  • 619. secondary endometrial mucinous carcinoma (61ºÐ)¡¡ËÙ¡¡Íµ»Ò¤Û¤«
  • 620. intrauterine parvovirusB19 infection (62ºÐ)¡¡±©ÅÄ¡¡¸ç¤Û¤«
  • 622. glioblastoma multifome showing prominent epithelioid arrangement (63ºÐ) º£Â¼¡¡¹¥¾Ï¤Û¤«
  • 623. µÞÀ­²½Ç¿À­¿ñËì±ê¤Îȯ¾É»þ¡¤È¯¸«¤µ¤ì¤¿Central neurocytoma with acute suppurative meningitis (64ºÐ)¡¡¶¬ Á±Ï°

Âè40²óÃæÉô¸ò¸«²ñ¡¡

¾ÉÎ㸡Ƥ¡¡case No588 - No603 Speaker's diagnosis

  • 588 (Adamantinomatous) craniopharingioma [ÌäÂêÎã]
  • 589 Atypical feature and variants of glioblastoma
  • 590 Paraosteal osteosarcoma (very low malignancy)
  • 591 Bizarre paraosteal osteochondromatous proliferation of Bone (Nola's lesion)
  • 592 Osteosarcoma, small cell type [°Û¤Ê¤ë¿ÇÃǤ¢¤ê]
  • 593 Granulosa cell tumor, diffuse sarcomatoid( with fibrothecomatous lesion)
  • 594 Sertori-stromal tumor (ŵ·¿Îã¡Ë
  • 595 1. Hodgkin's disease, 2. AILD-like T cell lymphoma
  • 596 Polymorphous low grade adenocarcinoma
  • 597 ¿ÇÃǤĤ«¤º¡¡AFIP¾¤Îconsultation¤Ç¤Ï metastatic carcinoma
  • 598 GIST uncomitted
  • 599 Hepatocellular carcinoma
  • 600 Solitary fibrous tumor
  • 601 Adenosarcoma
  • 602 Eosinophilic granuloma, Lung (ŵ·¿Îã¡Ë
  • 603 Bronchiolitis oblitelans (BO)

Âè39²óÃæÉô¸ò¸«²ñ

¾ÉÎ㸡Ƥ¡¡case No564 - No587

Speaker's diagnosis

  • 564 Papillary ependymoma of the caudaequina
  • 565 Renal cell cnrcinoma with neuromelanin and lipofustin
  • 566 Atypical Oncocytoma-rt., Granular cell carcinoma-lt.
  • 567 Testis-Myeloid sarcoma (Granulocytic sarcoma), AML-M5
  • 568 Sinus histiocytosis with massive lynmphoadenopathy (Rosai-Dorfman)
  • 569 Mycobacterium avium-intracellulae infection in AIDS patient
  • 570 Lymph node-Angiomyomatous hamartoma
  • 571 Skin-Epithelioid sarcoma
  • 572 Skin-Merkel celltunmor
  • 573 Skin-Malignant change of Seborrheic keratosis (clonal type) or Polocarcinoma¤ò¶¯ ¤¯»Ù»ý¤¹¤ë¿Í¤¬Â¿¤«¤Ã¤¿¡£
  • 574 Trichilemmal carcinoma and Merkel cell carcinoma
  • 575 Glycogen-rich clear cell carcinnma, intradermal type A
  • 576 Dysgerminoma with syntitial trophoblastic giant cclls(STGC)
  • 577 Carcinosarcoma of the ovary, Endometrioid mucinous carcinoum ¤Î°Õ¸«¤¢¤ê¡£
  • 578 Carcinosarcoma of the uterus
  • 579 Angiocentric lymphoma of the uterus (REAL classification)
  • 580 Wegener's granulomatosis, bronchocentric variant
  • 581 Basal cell carcinoma or large cell neuroendocrine carcinoma
  • 582 Granular cell tumor of the pharynx
  • 583 Pancreatoblastoma
  • 584 Epithelialmyoepithelial carcinoma, Metastasis to the liver.
  • 585 Clear cell carcinoma of the lt.salivary gland
  • 586 Gastric intestinal autonomic nerve tumor (GAN tumor)
  • 587 Small intestinal metastasis of leiomyosarcoma,½é¿Ç¤Ï MFH

¥È¥Ã¥×   ÊÔ½¸ Åà·ë º¹Ê¬ ¥Ð¥Ã¥¯¥¢¥Ã¥× źÉÕ Ê£À½ ̾Á°Êѹ¹ ¥ê¥í¡¼¥É   ¿·µ¬ °ìÍ÷ ñ¸ì¸¡º÷ ºÇ½ª¹¹¿·   ¥Ø¥ë¥×   ºÇ½ª¹¹¿·¤ÎRSS
Last-modified: 2019-12-17 (²Ð) 15:46:30 (407d)